<SEC-DOCUMENT>0001193125-13-033652.txt : 20130201
<SEC-HEADER>0001193125-13-033652.hdr.sgml : 20130201
<ACCEPTANCE-DATETIME>20130201085936
ACCESSION NUMBER:		0001193125-13-033652
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20130225
FILED AS OF DATE:		20130201
DATE AS OF CHANGE:		20130201
EFFECTIVENESS DATE:		20130201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARCA biopharma, Inc.
		CENTRAL INDEX KEY:			0000907654
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				363855489
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-22873
		FILM NUMBER:		13564831

	BUSINESS ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021
		BUSINESS PHONE:		720-940-2200

	MAIL ADDRESS:	
		STREET 1:		8001 ARISTA PLACE
		STREET 2:		SUITE 200
		CITY:			BROOMFIELD
		STATE:			CO
		ZIP:			80021

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUVELO INC
		DATE OF NAME CHANGE:	20030203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HYSEQ INC
		DATE OF NAME CHANGE:	19970610
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>d469192ddef14a.htm
<DESCRIPTION>DEFINITIVE PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Definitive Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>(Rule 14a-101) </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>INFORMATION REQUIRED IN PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A INFORMATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section&nbsp;14(a) of the </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Securities
Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by the
Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Filed by a
Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to &#167; 240.14a-12 </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="6"><B>ARCA BIOPHARMA, INC. </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified In Its Charter)
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy Statement if Other Than the Registrant) </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box) </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Aggregate number of securities to which transaction applies: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated
and state how it was determined): </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Proposed maximum aggregate value of transaction: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Total fee paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials. </FONT></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Amount Previously Paid: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Form, Schedule or Registration Statement No.: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Filing Party: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Date Filed: </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:0px;margin-top:0px;margin-bottom:2px;margin-left:8%;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="font-size:8px;margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARCA BIOPHARMA, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8001 Arista Place, Suite 430 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Broomfield, Colorado 80021 </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">February 1, 2013 </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear Stockholders of ARCA biopharma, Inc.: </FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">You are cordially invited to attend the Special Meeting of Stockholders of ARCA biopharma, Inc., a Delaware corporation (the &#147;Company&#148; or &#147;ARCA&#148;). The meeting will be held on Monday,
February&nbsp;25, 2013 at 9:00 a.m. local time at the Company&#146;s Headquarters, 8001 Arista Place, Suite 430, Broomfield, CO 80021. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The matters scheduled to be considered at the meeting are (1)&nbsp;to approve a series of certificates of amendment to the Company&#146;s Restated Certificate of Incorporation, as amended, to effect a
reverse split of the Company&#146;s outstanding common stock, pursuant to which any whole number of outstanding shares between, and including, three and twenty would be combined into one share of common stock and to authorize the Company&#146;s
Board of Directors to select and file one such certificate of amendment and abandon the other certificates of amendment, or to abandon all such certificates of amendment as permitted under Section&nbsp;242(c) of the Delaware General Corporation Law,
to be determined by the Board of Directors within one year of approval; and (2)&nbsp;to conduct any other business properly brought before the Special Meeting. These items of business are more fully described in the enclosed proxy statement, which
you are encouraged to read in its entirety. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>All stockholders of ARCA biopharma are invited to attend the Special Meeting
in person. Whether or not you expect to attend the Special Meeting, please vote your shares as promptly as possible using the enclosed proxy card, or via the Internet or telephone as instructed in the enclosed materials, in order to ensure your
representation at the Special Meeting. Even if you have voted by proxy, you may still vote in person if you attend the Special Meeting. Please note, however, that if your shares are held of record by a broker, bank or other agent and you wish to
vote at the Special Meeting, you must obtain a proxy issued in your name from that record holder. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:53%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sincerely, </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:53%; text-indent:-2%">


<IMG SRC="g469192g95l79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:53%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CHRISTOPHER OZEROFF </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:53%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary, Senior Vice President and General Counsel </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARCA BIOPHARMA, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8001 Arista Place, Suite 430 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Broomfield, Colorado 80021 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF SPECIAL MEETING OF STOCKHOLDERS
</B></FONT></P>  <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>TO BE HELD ON FEBRUARY 25, 2013 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Notice is hereby given that the Special Meeting of Stockholders (the &#147;Special Meeting&#148;) of ARCA biopharma, Inc., a Delaware corporation (the &#147;Company&#148; or &#147;ARCA&#148;) will be held
on Monday, February 25, 2013 at 9:00 a.m. local time at the headquarters of the Company, 8001 Arista Place, Suite 430, Broomfield, Colorado 80021, for the following purposes: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of a series of certificates of amendment to the Company&#146;s Restated Certificate of Incorporation, as amended, to effect a reverse split of the
Company&#146;s outstanding common stock, pursuant to which any whole number of outstanding shares between, and including, three and twenty would be combined into one share of common stock and to authorize the Company&#146;s Board of Directors to
select and file one such certificate of amendment and abandon the other certificates of amendment, or to abandon all such certificates of amendment as permitted under Section&nbsp;242(c) of the Delaware General Corporation Law, to be determined by
the Board of Directors within one year of approval; and </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any other business that is properly brought before the meeting. </FONT></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Please refer to the proxy materials accompanying this Notice for further information about the business to be transacted at the Special Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The record date for the Special Meeting is January 24, 2013. Only stockholders of record at the close of business on that date may vote
at the meeting or any adjournment thereof. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; margin-left:53%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors: </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:53%; text-indent:-2%">


<IMG SRC="g469192g95l79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:53%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CHRISTOPHER OZEROFF </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:53%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary, Senior Vice President and General Counsel </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>B<SMALL>ROOMFIELD</SMALL>, CO </B></FONT></P>  <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>EBRUARY</SMALL> 1, 2013 </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If your shares are registered directly in your name with Computershare Trust Company N.A., our transfer agent, you are considered a
stockholder of record. If you are a stockholder of record of the Company at the close of business on January 24, 2013 (the &#147;Record Date&#148;), you will receive a &#147;full set delivery&#148; of our proxy materials, which include this Notice
of Special Meeting, the Company&#146;s Proxy Statement, and a proxy card. All stockholders of record on the Record Date are entitled to vote their shares on the matters under consideration at the Special Meeting. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>All stockholders are cordially invited to attend the Special Meeting in person. Whether or not you expect to attend the Special
Meeting, please vote by proxy, as promptly as possible, to ensure your representation at the Special Meeting. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>You may
vote by proxy by completing and mailing the enclosed proxy card, or by voting on the Internet, or by telephone. If you submit a proxy card, Internet or telephone vote, we will vote your shares as you direct. If you submit a proxy card, Internet or
telephone vote without giving specific voting instructions, those shares will be voted as recommended by our Board of Directors. </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

  <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>You may also vote by proxy via the Internet by going to the website
<U>http://www.investorvote.com/ABIO</U>, and following the instructions provided there, or by telephone, by calling the following number:&nbsp;1-800-652-VOTE (8683)&nbsp;using a touch-tone phone and follow the recorded instructions. You will be
asked to provide the company number and control number found on the proxy card. Your proxy card, Internet or telephone vote must be received by 1:00 a.m. Mountain Time on February 25, 2013 to be counted. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We will make all of our proxy materials available on the Internet at <U>http://www.investorvote.com/ABIO</U>, beginning on or about
February 5, 2013, and permit voting via the Internet and by telephone as of that date.</B> </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>If your shares are held by
a broker, bank, or other agent, you are considered the beneficial owner of those shares, and your shares are held in &#147;street name.&#148; If you hold your shares in &#147;street name&#148; you will receive instructions from your broker, bank or
other agent describing how to vote your shares. If you hold shares in &#147;street name&#148; and do not receive instructions on how to vote your shares, you should contact your broker, bank or other agent promptly and request this information.
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Even if you have voted by proxy via one of the procedures listed above, you may still vote in person if you attend the
Special Meeting. Please note, however, that if your shares are held of record by a broker, bank or other agent and you wish to vote at the Special Meeting, you must obtain a proxy issued in your name from that record holder. </B></FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ARCA BIOPHARMA, INC. </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8001 Arista Place, Suite 430 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Broomfield, Colorado 80021 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON </B></FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>February 25, 2013 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This proxy statement (this &#147;Proxy Statement&#148;)
is being furnished to holders of ARCA biopharma, Inc. (sometimes referred to as the &#147;Company,&#148; &#147;ARCA,&#148; &#147;we,&#148; &#147;us,&#148; and &#147;our&#148;) common stock, par value $0.001 per share (the &#147;Common Stock&#148;).
Proxies are being solicited on behalf of the Board of Directors of ARCA (the &#147;Board of Directors&#148;) to be used at the Special Meeting of Stockholders (the &#147;Special Meeting&#148;) to be held on Monday, February 25, 2013 at 9:00 a.m.
local time at the headquarters of the Company, 8001 Arista Place, Suite 430, Broomfield, CO 80021 and at any postponement or adjournment thereof, for the purposes set forth in the Notice of Special Meeting of Stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">ARCA is using the Securities and Exchange Commission (the &#147;SEC&#148;) rule that allows us to deliver a &#147;full set&#148; of our
proxy materials by mail to all of our stockholders of record as of the Record Date. Our proxy materials include the Notice of Special Meeting (the &#147;Notice&#148;), this Proxy Statement and a proxy card (collectively, the &#147;Proxy
Materials&#148;), and we will mail our Proxy Materials on or about February 5, 2013. In addition to mailing our Proxy Materials, we will also provide access to our Proxy Materials over the Internet, by February 5, 2013. The Notice and the Proxy
Statement instruct you on how to access and review all of the important information contained in the Proxy Materials via the Internet. The Notice and the Proxy Statement also instruct you on how you may submit your vote using the enclosed proxy
card, via the Internet or telephone as instructed in the enclosed materials, or in person at the Special Meeting. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">All
stockholders may view and print ARCA&#146;s proxy statement at www.arcabiopharma.com. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>QUESTIONS AND ANSWERS ABOUT THESE
PROXY MATERIALS AND VOTING </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why did I receive a notice regarding the availability of the Proxy Materials on the Internet?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As described above, pursuant to rules adopted by the SEC, we have elected to provide the Proxy Materials by mail as well
as over the Internet. Accordingly, the Notice describes how you may access the Proxy Materials on the Internet if you choose to do so. The Board of Directors is soliciting your proxy to vote at the Special Meeting, and you have the option of voting
by either mailing in the enclosed proxy card, voting on the Internet, or voting by telephone. Instructions on how to access the Proxy Materials and vote via the Internet or by telephone are described below and in the Notice. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How do I attend the Special Meeting? </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The meeting will be held on Monday, February 25, 2013 at 9:00 a.m. local time at the Company&#146;s headquarters, 8001 Arista Place, Suite 430, Broomfield, CO 80021. Directions to the Special Meeting may
be found at www.arcabiopharma.com. Information on how to vote in person at the Special Meeting is discussed below. </FONT></P>  <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Who can vote at
the Special Meeting? </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on the Record Date (January 24, 2013) will
be entitled to vote at the Special Meeting. On the Record Date, there were 15,961,898 shares of Common Stock outstanding and entitled to vote. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If on the Record Date, your shares were registered directly in your name with ARCA&#146;s transfer agent, Computershare Trust Company
N.A., then you are a stockholder of record. As a stockholder of record, you may vote in person at the Special Meeting or vote by proxy. Whether or not you plan to attend the Special Meeting, we urge you to vote by proxy over the telephone or on the
Internet as instructed below and in the Notice, or return the proxy card we have mailed to you to ensure your vote is counted. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of a Broker or Bank </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, on January 24, 2013, your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, or other
similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and the Notice is being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of record for
purposes of voting at the Special Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Special Meeting. However, since you are
not the stockholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent. </FONT></P>  <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What am I voting on? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approval of a series of certificates of amendment to
the Company&#146;s Restated Certificate of Incorporation, as amended, to effect a reverse split of the Company&#146;s outstanding Common Stock, pursuant to which any whole number of outstanding shares between, and including, three and twenty would
be combined into one share of Common Stock and to authorize the Company&#146;s Board of Directors to select and file one such certificate of amendment and abandon the other certificates of amendment, or to abandon all such certificates of amendment
as permitted under Section&nbsp;242(c) of the Delaware General Corporation Law, to be determined by the Board of Directors within one year of approval. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What if another matter is properly brought before the meeting? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board
of Directors knows of no other matters that will be presented for consideration at the Special Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those
matters in accordance with their best judgment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How do I vote? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may either vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. The procedures for voting are fairly simple:
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder of Record: Shares Registered in Your Name </I></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a stockholder of record, you may vote in person at the Special Meeting, vote by proxy using the enclosed proxy card, vote by
proxy over the telephone or vote by proxy through the Internet. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already
voted by proxy. </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote in person, come to the Special Meeting and we will give you a ballot when you arrive. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote using the proxy card, simply complete, sign and date the proxy card and return it promptly in the envelope provided. If you return your signed
proxy card to us before the Special Meeting, we will vote your shares as you direct. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote over the telephone, dial toll-free <B>1-800-652-VOTE (8683)</B>&nbsp;using a touch-tone phone and follow the recorded instructions. You will be
asked to provide the company number and control number found on the enclosed proxy card. Your vote must be received by 1:00 a.m. Mountain Time on February 25, 2013 to be counted. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote through the Internet, go to http://www.investorvote.com/ABIO to complete an electronic proxy card. You will be asked to provide the company
number and control number from the enclosed proxy card. Your vote must be received by 1:00 a.m. Mountain Time on February 25, 2013 to be counted. </FONT></P></TD></TR></TABLE>  <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Beneficial Owner: Shares Registered in the Name of Broker or Bank </I></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you
are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a Notice containing voting instructions from that organization rather than from ARCA. Simply follow the voting instructions in the
Notice to ensure that your vote is counted. To vote in person at the Special Meeting, you must obtain a valid proxy from your broker, bank, or other agent. Follow the instructions from your broker or bank included with these proxy materials, or
contact your broker or bank to request a proxy form. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px; margin-left:1%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We provide Internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the
authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your access to the Internet, such as usage charges from Internet access providers and telephone companies.
</B></FONT></P></div> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How many votes do I have? </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On each matter to be voted upon, you have one vote for each share of Company Common Stock you own as of January 24, 2013. </FONT></P>  <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What if I return a proxy card or otherwise vote but do not make specific choices? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#147;For&#148; the approval to effect the reverse stock split.
If any other matter is properly presented at the meeting, your proxy holder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Who is paying for this proxy solicitation? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will pay for the entire cost
of soliciting proxies. In addition to these proxy materials, the directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for
soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What does it mean if I receive more than one Notice? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you receive more
than one Notice, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the Notices to ensure that all of your shares are voted. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Can I change my vote after submitting my proxy? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may submit another properly completed proxy card with a later date. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may grant a subsequent proxy by telephone or through the Internet. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may send a timely written notice that you are revoking your proxy to ARCA&#146;s Secretary at 8001 Arista Place, Suite 430, Broomfield, CO 80021.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="1%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may attend the Special Meeting and vote in person. Simply attending the meeting will not, by itself, revoke your proxy.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your most current proxy card or telephone or the Internet proxy is the one that is counted.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your
broker or bank. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How are votes counted? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Votes will be counted by the inspector of election appointed for the meeting, who will separately count &#147;For&#148; and &#147;Against&#148; votes, abstentions and broker non-votes. Abstentions will be
counted towards the vote total for the proposal (&#147;Proposal No.&nbsp;1&#148;), and will have the same effect as &#147;Against&#148; votes. Broker non-votes have no effect and will not be counted towards the vote total for Proposal No. 1.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What are &#147;broker non-votes&#148;? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Broker non-votes occur when a beneficial owner of shares held in &#147;street name&#148; does not give instructions to the broker or nominee holding the shares as to how to vote on matters deemed
&#147;non-routine.&#148; Generally, if shares are held in street name, the beneficial owner of the shares is entitled to give voting instructions to the broker or nominee holding the shares. If the beneficial owner does not provide voting
instructions, the broker or nominee can still vote the shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to &#147;non-routine&#148; matters. Under the rules and interpretations of the Nasdaq Stock
Market (&#147;Nasdaq&#148;), the matter under consideration at the Special Meeting granting the Board of Directors the authority to conduct a reverse stock split is considered a &#147;non-routine&#148; matter. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How many votes are needed to approve this proposal? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">To be approved, Proposal No.&nbsp;1, the approval of a series of certificates of amendment to the Company&#146;s Restated Certificate of Incorporation, as amended, to effect a reverse split of the
Company&#146;s outstanding Common Stock, pursuant to which any whole number of outstanding shares between, and including, three and ten would be combined into one share of Common Stock and to authorize the Company&#146;s Board of Directors to select
and file one such certificate of amendment, must receive &#147;For&#148; votes from the holders, either in person or by proxy, of a majority of the outstanding shares of Common Stock. If you &#147;Abstain&#148; from voting, it will have the same
effect as an &#147;Against&#148; vote. Broker non-votes will have the same effect as &#147;Against&#148; votes. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What is the quorum
requirement? </B></FONT></P>  <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A quorum of stockholders is necessary to hold a valid meeting. A quorum will be present if stockholders
holding a majority of the outstanding shares entitled to vote are present at the meeting in person or represented by proxy. On the record date, there were 15,961,898&nbsp;shares outstanding and entitled to vote. Thus, the holders of
7,980,949&nbsp;shares must be present in person or represented by proxy at the meeting to have a quorum. </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your shares
will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the meeting. Abstentions and broker non-votes will be counted towards the
quorum requirement. If there is no quorum, the holders of a majority of shares present at the meeting in person or represented by proxy may adjourn the meeting to another date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>How can I find out the results of the voting at the Special Meeting? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary voting results will be announced at the Special Meeting. In addition, final voting results will be published in a current
report on Form 8-K that we expect to file within four business days after the Special Meeting. If final voting results are not available to us in time to file a Form 8-K within four business days after the meeting, we intend to file a Form 8-K to
publish preliminary results and, within four business days after the final results are known to us, file an additional Form 8-K to publish the final results. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>ROPOSAL</SMALL> N<SMALL>O</SMALL>.&nbsp;1 </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF CERTIFICATES OF AMENDMENT TO THE COMPANY&#146;S </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>RESTATED CERTIFICATE OF INCORPORATION TO EFFECT A REVERSE STOCK SPLIT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Introduction
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board has adopted a resolution approving, and recommending to the Company&#146;s stockholders for their approval, a
series of proposed certificates of amendment to the Company&#146;s Restated Certificate of Incorporation (as amended, the &#147;Restated Certificate of Incorporation&#148;) to effect a reverse split of the shares of the Company&#146;s Common Stock
at a ratio ranging from 3:1 to 20:1 (the &#147;Reverse Stock Split&#148;). The texts of the forms of the proposed certificates of amendment to the Restated Certificate of Incorporation are annexed to this proxy statement as Annexes A-1 to A-18.
Assuming the stockholders approve the proposal, the Board will have the sole discretion under Section&nbsp;242(c) of the General Corporation Law of the State of Delaware (the &#147;DGCL&#148;), as it determines to be in the best interest of the
Company and its stockholders, both to select the specific exchange ratio within the designated range of 3:1 to 20:1 and also to decide whether or not to proceed to effect a Reverse Stock Split or instead to abandon the proposed certificates of
amendment altogether. If a certificate of amendment is filed with the Secretary of State of the State of Delaware, the certificate of amendment to the Restated Certificate of Incorporation will effect the Reverse Stock Split by reducing the
outstanding number of shares of the Company&#146;s Common Stock by the ratio to be determined by the Board, but will not increase the par value of the Company&#146;s Common Stock, and will not change the number of authorized shares of the
Company&#146;s Common Stock. If the Board does not implement an approved Reverse Stock Split prior to the one-year anniversary of this meeting, the Board will seek stockholder approval before implementing any Reverse Stock Split after that time.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By approving Proposal No.&nbsp;1 and the Reverse Stock Split, stockholders will approve each of a series of certificates of
amendment to the Restated Certificate of Incorporation pursuant to which any whole number of outstanding shares, between and including three and twenty, would be combined into one share of the Company&#146;s Common Stock, and authorize the Board to
file only one such certificate of amendment, as determined by the Board in the manner described herein, and to abandon each certificate of amendment not selected by the Board. If approved, the Board may also elect not to effect any Reverse Stock
Split and consequently not to file any certificate of amendment to the Restated Certificate of Incorporation. The Board believes that stockholder approval of the series of certificates of amendment granting the Board this discretion, rather than
approval of a specified exchange ratio, provides the Board with maximum flexibility to react to then-current market conditions and, therefore, is in the best interests of the Company and its stockholders. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Company&#146;s Nasdaq Listing Compliance </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s Common Stock is listed on the Nasdaq Capital Market under the symbol &#147;ABIO.&#148; To maintain a listing on the Nasdaq Capital Market, the Company must satisfy the applicable
listing maintenance standards established by Nasdaq. Among other things, the Company is required to comply with the continued listing requirements of the Nasdaq Capital Market (the &#147;Nasdaq Capital Requirements&#148;). To comply with such
requirements, the Company must substantially meet each of the following requirements: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>a minimum bid price of at least $1.00 per share; </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Stockholders&#146; Equity of at least $2.5 Million </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Publicly held shares of at least 500,000 </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>Market value of publicly held securities of $1 Million; and </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B>At least 300 beneficial holders and holders of record of its Common Stock. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Currently, the Company meets the Nasdaq Capital Requirements, except the $1.00 minimum bid price. Assuming the stockholders approve
Proposal No.&nbsp;1, the Board will determine whether to effect a Reverse Stock Split in the range of 3:1 to 20:1, at the ratio determined by the Board to be most likely sufficient to allow the Company to meet and maintain the $1.00 minimum bid
price requirement. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Reasons for the Reverse Stock Split </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On April&nbsp;12, 2012, Nasdaq notified us that the bid price of our Common Stock had closed below the required $1.00 per share for 30
consecutive trading days, and, accordingly, that we did not comply with the applicable Nasdaq minimum bid price requirement. We were provided 180 calendar days by Nasdaq, or until October&nbsp;9, 2012, to regain compliance with this requirement. We
did not regain compliance with the minimum $1.00 bid price requirement and on October&nbsp;10, 2012, we were notified that unless we requested a hearing before the NASDAQ Listing Qualifications Panel (the &#147;Panel&#148;), our securities would be
delisted. We requested a hearing before the Panel, which was held on November&nbsp;15, 2012. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On November&nbsp;30, 2012, we
were notified that the Panel had granted our request for continued listing on the NASDAQ Capital Market and an extension of time to comply with the minimum bid price requirement. We have been given an extension until April&nbsp;8, 2013, to meet the
continued listing requirement of a closing bid price of at least $1.00 per share of the Common Stock for a minimum of ten consecutive trading days, conditioned on our meeting a certain milestone or taking certain actions prior to that time.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board has considered the potential harm to us of a delisting of the Company&#146;s Common Stock and has determined that,
if the Company&#146;s Common Stock continues to trade below $1.00 per share, the consummation of the Reverse Stock Split is the best way to maintain liquidity by achieving compliance with the Nasdaq Capital Requirements if the Company&#146;s Common
Stock continues to trade below $1.00 per share. Approval of Proposal No.&nbsp;1 will permit us to file one certificate of amendment to the Restated Certificate of Incorporation and the certificate of amendment filed thereby will contain the number
of shares selected by the Board within the limits set forth in Proposal No.&nbsp;1 to be combined into one share of Common Stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board also believes that the current low per share market price of the Company&#146;s Common Stock has had a negative effect on the marketability of the Company&#146;s existing shares. The Board
believes there are several reasons for this effect. First, certain institutional investors have internal policies preventing the purchase of low-priced stocks. Second, a variety of policies and practices of broker-dealers discourage individual
brokers within those firms from dealing in low-priced stocks. Third, because the brokers&#146; commissions on low-priced stocks generally represent a higher percentage of the stock price than commissions on higher priced stocks, the current share
price of the Company&#146;s Common Stock can result in individual stockholders paying transaction costs (commissions, markups or markdowns) that are a higher percentage of their total share value than would be the case if the share price of the
Common Stock were substantially higher. This factor is also believed to limit the willingness of some institutions to purchase the Common Stock. The Board anticipates that a Reverse Stock Split will result in a higher bid price for the
Company&#146;s Common Stock, which may help to alleviate some of these problems. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If Proposal No.&nbsp;1 is approved by the
holders of the Company&#146;s Common Stock and the Board decides to implement the Reverse Stock Split, the Board will determine the ratio of the Reverse Stock Split, in the range of 3:1 to 20:1, as determined in the judgment of the Board to be most
likely sufficient to allow us to achieve and maintain compliance with the minimum $1.00 per share requirement for listing on the Nasdaq Capital Market for the longest period of time while retaining sufficient number of outstanding, tradeable shares
to facilitate an adequate market. By way of illustration, assuming a per share price of $0.40 immediately prior to the filing of the appropriate certificate of amendment to the Restated Certificate of Incorporation, the Board may determine that we
should effect a 3:1 or 20:1 reverse stock split, with the goal of achieving a bid price of $1.20 or $8.00 per share, respectively. Please refer to the section entitled &#147;Effects of the Reverse Stock Split&#148; below for more detailed examples
of the effects of the range of ratios. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We believe that maintaining listing on the Nasdaq Capital Market will provide us with
a market for the Common Stock that is more accessible than if the Company&#146;s Common Stock were traded on the OTC Bulletin Board or in the &#147;pink sheets&#148; maintained by the OTC Markets Group, Inc. Such alternative markets are generally
considered to be less efficient than, and not as broad as the Nasdaq Capital Market. Among other factors, trading </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
on the Nasdaq Capital Market increases liquidity and may potentially minimize the spread between the &#147;bid&#148; and &#147;asked&#148; prices quoted by Market Makers. Further, a Nasdaq
Capital Market listing may enhance our access to capital, increase our flexibility in responding to anticipated capital requirements and facilitate the use of our Common Stock in any strategic or financing transactions that it may undertake. We
believe that prospective investors will view an investment in the Company more favorably if our shares qualify for listing on the Nasdaq Capital Market as compared with the OTC markets. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We expect that a Reverse Stock Split of our Common Stock will increase the market price of the Common Stock so that we are able to
maintain compliance with the Nasdaq minimum bid price listing standard. However, the effect of a Reverse Stock Split on the market price of the Common Stock cannot be predicted with any certainty, and the history of similar stock split combinations
for companies in like circumstances is varied. It is possible that the per share price of the Common Stock after the Reverse Stock Split will not rise in proportion to the reduction in the number of shares of the Common Stock outstanding resulting
from the Reverse Stock Split, effectively reducing our market capitalization, and there can be no assurance that the market price per post-reverse split share will either exceed or remain in excess of the $1.00 minimum bid price for a sustained
period of time. The market price of the Company&#146;s Common Stock may vary based on other factors that are unrelated to the number of shares outstanding, including the Company&#146;s future performance. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to maintain the listing on the Nasdaq Capital Market, the Company must maintain a minimum market value of listed securities of
at least $1 million and a minimum market value of Publicly Held Shares of $1 million. The Company, in addition to other listing requirements, must also maintain a minimum Stockholders&#146; Equity value of at least $2.5 million. As of
December&nbsp;31, 2012, the Company&#146;s market value of listed securities was $6,065,521 million, our market value of Publicly Held Shares was $5,041,760 million and our Stockholders&#146; Equity was $3,000,000. Even if we meet the bid price
requirement, if we are unable to comply with the other Nasdaq Capital Requirements, Nasdaq may determine to delist the Common Stock from the Nasdaq Capital Market. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board does not intend for this transaction to be the first step in a series of plans or proposals of a &#147;going private transaction&#148; within the meaning of Rule 13e-3 of the Exchange Act.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Board Discretion to Implement the Reverse Stock Split </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If the Board determines to effect the Reverse Stock Split, it will consider certain factors in selecting the specific exchange ratio, including prevailing market conditions, the trading price of the
Common Stock and the steps that we will need to take in order to achieve compliance with the bid price requirement and other listing regulations of the Nasdaq Capital Market. Based in part on the price of the Common Stock on the days leading up to
the filing of the certificate of amendment to the Restated Certificate of Incorporation effecting the Reverse Stock Split, the Board will determine the ratio of the Reverse Stock Split, in the range of 3:1 to 20:1, that, in the judgment of the
Board, is the reverse split ratio most likely to allow us to achieve and maintain compliance with the minimum $1.00 per share requirement for listing on the Nasdaq Capital Market for the longest period of time, while retaining a sufficient number of
outstanding, tradeable shares to facilitate an adequate market. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding approval of the Reverse Stock Split by the
stockholders, the Board may, in its sole discretion, abandon all of the proposed certificates of amendment and determine prior to the effectiveness of any filing with the Secretary of State of the State of Delaware not to effect the Reverse Stock
Split prior to the one year anniversary of this Special Meeting of stockholders, as permitted under Section&nbsp;242(c) of the DGCL. If the Board fails to implement any of the certificates of amendment prior to the one year anniversary of this
meeting of stockholders, stockholder approval would again be required prior to implementing any Reverse Stock Split. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Consequences if
Stockholder Approval for Proposal Is Not Obtained </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If stockholder approval for Proposal No.&nbsp;1 is not obtained, we will
not be able to file a certificate of amendment to the Restated Certificate of Incorporation to effect the Reverse Stock Split. Unless the bid price for the Common Stock increases to greater than $1.00 for ten consecutive business days prior to
April&nbsp;8, 2013, then </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
we will not meet the listing requirements for the Nasdaq Capital Market. If compliance is not achieved by April&nbsp;8, 2013, our stock will be delisted from the Nasdaq Capital Market. If we are
unable to qualify for the additional compliance period, or if it is unable to regain compliance during any such period, the Common Stock will likely be transferred to the OTC Bulletin Board or OTC Market. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If we fail to meet all applicable Nasdaq Capital Requirements and Nasdaq determines to delist the Common Stock, the delisting could
adversely affect the market liquidity of the Common Stock and the market price of the Common Stock could decrease. Delisting could also adversely affect our ability to obtain financing for the continuation of our operations and/or result in the loss
of confidence by investors, suppliers, commercial partners and employees. In addition, the limited number of authorized shares of the Common Stock that are neither outstanding nor reserved for issuance could adversely affect the ability of us to
raise capital through equity financings. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Effects of the Reverse Stock Split </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth the number of shares of the Company&#146;s Common Stock that would be outstanding immediately after the
Reverse Stock Split at various exchange ratios, based on the 15,961,898 shares of Common Stock outstanding as of December&nbsp;31, 2012. The table does not account for fractional shares that will be paid in cash. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="28%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Ratio of</B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Reverse Stock</B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000;width:48pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Split</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Approximate&nbsp;Shares&nbsp;of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Common
Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Outstanding</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>After&nbsp;Reverse&nbsp;Stock&nbsp;Split</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">None</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,961,898</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,320,632</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,990,474</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,192,379</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,660,316</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,280,271</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,995,237</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,773,544</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,596,189</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,451,081</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,330,158</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,227,838</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,140,135</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,064,126</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">997,618</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">938,935</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">886,772</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">840,099</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-left:1.00em; text-indent:-1.00em" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20:1</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">798,094</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If a stockholder owns 10,000 shares of Common Stock prior to the Reverse Stock Split, after the Reverse
Stock Split that same stockholder would own 3,333 shares in the case of a Reverse Stock Split at the ratio of 3:1, 2,500 shares in the case of a Reverse Stock Split at the ratio of 4:1, 2,000 shares in the case of a Reverse Stock Split at the ratio
of 5:1, 1,666 shares in the case of a Reverse Stock Split at the ratio of 6:1, 1,428 shares in the case of a Reverse Stock Split at the ratio of 7:1, 1,250 shares in the case of a Reverse Stock Split at the ratio of 8:1, 1,111 shares in the case of
a Reverse Stock Split at the ratio of 9:1, 1,000 shares in the case of a Reverse Stock Split at the ratio of 10:1, 909 shares in the case of a Reverse Stock Split at the ratio of 11:1, 833 shares in the case of a Reverse Stock Split at the ratio of
12:1, 769 shares in the case of a Reverse Stock Split at the ratio of 13:1, 714 shares in the case of a Reverse Stock Split at the ratio of 14:1, 666 shares in the case of a Reverse </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Stock Split at the ratio of 15:1, 625 shares in the case of a Reverse Stock Split at the ratio of 16:1, 588 shares in the case of a Reverse Stock Split at the ratio of 17:1, 555 shares in the
case of a Reverse Stock Split at the ratio of 18:1, 526 shares in the case of a Reverse Stock Split at the ratio of 19:1, and 500 shares in the case of a Reverse Stock Split at the ratio of 20:1. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The lasting effect of the proposed Reverse Stock Split upon the market price for the Company&#146;s Common Stock cannot be predicted, and
the history of similar reverse stock splits for companies in like circumstances is varied. We cannot assure you that the market price per new share of the Company&#146;s Common Stock after the Reverse Stock Split (which we refer to as &#147;New
Shares&#148;) will rise in proportion to the reduction in the number of old shares of the Company&#146;s Common Stock outstanding (which we refer to as &#147;Old Shares&#148;) as a result of the Reverse Stock Split. We also cannot assure you that
the market price per New Share will either exceed or remain in excess of the $1.00 minimum bid price as required by the Nasdaq Capital Requirements, or that we will otherwise meet the requirements of Nasdaq for inclusion for trading on the Nasdaq
Capital Market, including, for example, the applicable minimum market value requirements of the Nasdaq Capital Requirements. The market price of the Company&#146;s Common Stock is dependent on our financial condition, performance, prospects and a
number of other factors, many of which are unrelated to the number of shares outstanding. If our efforts to meet the Nasdaq Capital Requirements are unsuccessful, the Company&#146;s Common Stock would remain subject to delisting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The liquidity of the Company&#146;s Common Stock could be adversely affected by the reduced number of shares that would be outstanding
after the Reverse Stock Split, and the reduced number of shares may make it more difficult to trade shares of the Common Stock. In addition, the Reverse Stock Split will increase the number of the Company&#146;s stockholders who own odd lots (less
than 100 shares). Stockholders who hold odd lots typically will experience an increase in the cost of selling their shares, as well as possible greater difficulty in effecting those sales. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Reverse Stock Split will affect all of the Company&#146;s holders of Common Stock uniformly and will not affect any
stockholder&#146;s percentage ownership interests in the Company or proportionate voting power, except to the extent that the Reverse Stock Split results in any of the Company&#146;s stockholders owning a fractional share, in which case such
stockholders will receive a cash payment in lieu of such fractional share. The Company&#146;s issued Common Stock will remain fully paid and non-assessable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Reverse Stock Split will not affect the par value of the Company&#146;s Common Stock. As a result, upon the effectiveness of the Reverse Stock Split, the stated capital on the Company&#146;s balance
sheet attributable to our Common Stock will be reduced proportionately based on the exchange ratio selected by the Board for the Reverse Stock Split, and the additional paid-in capital account will be credited with the amount by which the stated
capital is reduced. The per share net income or loss and net book value of the Company&#146;s Common Stock will be increased because there will be fewer shares of the Company&#146;s Common Stock outstanding. In addition, proportionate adjustments
will be made to the per share exercise price and the number of shares issuable upon the exercise or settlement of all outstanding options, restricted stock units and warrants to purchase or acquire, as applicable, shares of Common Stock of the
Company, and the number of shares reserved for issuance pursuant to our existing equity incentive, stock option and employee stock purchase plans will be reduced proportionately based on the exchange ratio selected by the Board for the Reverse Stock
Split. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Reverse Stock Split will have no effect on the total number of shares of Common Stock the Company is authorized to
issue under the Restated Certificate of Incorporation. Therefore, upon effectiveness of the Reverse Stock Split, the number of shares of Common Stock that are authorized and unissued will increase relative to the number of issued and outstanding
shares. We may use the additional authorized and unissued shares of the Company&#146;s Common Stock resulting from the Reverse Stock Split to issue additional shares of our Common Stock from time to time in equity financings, under our equity
compensation plans or in connection with other matters. The Board currently has no plans, arrangements or understandings regarding the issuance of such additional authorized and unissued shares of the Company&#146;s Common Stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Company&#146;s Common Stock is currently registered under Section&nbsp;12(b) of the
Exchange Act, and we are subject to the periodic reporting and other requirements of the Exchange Act. The proposed Reverse Stock Split will not affect the registration of the Common Stock under the Exchange Act. If the proposed Reverse Stock Split
is implemented, the Common Stock will continue to be reported on the Nasdaq Capital Market under the symbol &#147;ABIO&#148; (although Nasdaq would likely add the letter &#147;D&#148; to the end of the trading symbol for a period of approximately 20
trading days to indicate that the Reverse Stock Split has occurred). </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Potential Anti-Takeover Effect of the Reverse Stock Split
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Upon effectiveness of the Reverse Stock Split, the number of authorized shares of Common Stock that are not issued or
outstanding will increase relative to the number of shares of Common Stock that are issued and outstanding prior to the Reverse Stock Split. Although this increase could, under certain circumstances, have an anti-takeover effect (for example, by
permitting issuances that would dilute the stock ownership of a person seeking to effect a change in the composition of the Board or contemplating a tender offer or other transaction for the combination of the Company with another company), Proposal
No.&nbsp;1 is not being proposed in response to any effort of which we are aware to accumulate shares of the Company&#146;s Common Stock or to obtain control of the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Effective Date </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Reverse Stock Split will be effected at 5:01 p.m.
Eastern time, on the date that the certificate of amendment to the Restated Certificate of Incorporation is filed with the Secretary of State of the State of Delaware. Beginning at the effective time of the Reverse Stock Split, each certificate
representing Old Shares will be deemed for all corporate purposes to represent New Shares. The texts of the proposed certificates of amendment to the Restated Certificate of Incorporation are in the forms annexed to this proxy statement as Annexes
A-1 through A-18. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Exchange of Stock Certificates </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The transfer agent for the Company will act as the &#147;exchange agent&#148; for purposes of implementing the exchange of stock certificates. Holders of Old Shares will be asked to surrender to the
exchange agent certificates representing Old Shares in exchange for certificates representing New Shares in accordance with the procedures to be set forth in a letter of transmittal to be sent by the exchange agent. No new certificates will be
issued to a stockholder until the stockholder has surrendered the stockholder&#146;s outstanding certificate(s) together with the properly completed and executed letter of transmittal to the exchange agent. Stockholders should not destroy any stock
certificates and should not submit any certificates until requested to do so. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Fractional Shares </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fractional shares of Common Stock will be issued as a result of the proposed Reverse Stock Split. Instead, stockholders who otherwise
would be entitled to receive fractional shares will, upon surrender to the exchange agent of certificates representing their fractional shares, be entitled to receive cash in an amount equal to the product obtained by multiplying (i)&nbsp;the
closing sales price of the Company&#146;s Common Stock as reported on the Nasdaq Global Market on the effective date of the certificate of amendment to the Restated Certificate of Incorporation by (ii)&nbsp;the number of shares of the Company&#146;s
Common Stock held by such stockholder before the Reverse Stock Split that would otherwise have been exchanged for such fractional share interest. Holders of as many as nineteen shares (if we were to implement a 20:1 Reverse Stock Split) of the
Company&#146;s Common Stock would be eliminated as a result of the cash payment in lieu of any issuance of fractional shares or interests in connection with the Reverse Stock Split. The exact number by which the number of holders of the
Company&#146;s Common Stock would be reduced will depend on the Reverse Stock Split ratio adopted and the number of stockholders that hold less than the Reverse Stock Split ratio as of the effective date of the Reverse Stock Split. As of January 24,
2013, there were approximately 74&nbsp;holders of record of the Company&#146;s Common Stock with less than 20 shares. As a result of the Reverse Stock Split, assuming the maximum Reverse Stock Split ratio of 20:1 were selected, we estimate that
cashing out fractional stockholders would potentially reduce that number of stockholders of record to 798,020. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Federal Income Tax Consequences of the Reverse Stock Split </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of certain material federal income tax consequences of the Reverse Stock Split to certain holders of Old
Shares, but does not purport to be a complete discussion of all of the potential tax considerations relating thereto. This summary is based on the provisions of the United States federal income tax law (including the Internal Revenue Code of 1986,
as amended (the &#147;Code&#148;), Treasury Regulations promulgated thereunder, and judicial and administrative interpretations thereof) as of the date hereof, all of which are subject to change retroactively as well as prospectively. Our view
regarding the tax consequences of the Reverse Stock Split are not binding upon the Internal Revenue Service or the courts, and there can be no assurance that the Internal Revenue Service or the courts will accept the positions expressed below. This
summary assumes that the Old Shares were, and the New Shares will be, held as a &#147;capital asset,&#148; as defined in the Code (i.e., generally, property held for investment). Further, it does not discuss any state, local, foreign or other tax
consequences. In addition, this summary does not address the tax consequences applicable to a holder&#146;s particular circumstances or to holders that are subject to special tax rules, including without limitation banks, insurance companies,
regulated investment companies, personal holding companies, foreign entities, nonresident alien individuals, broker-dealers, traders, tax-exempt entities and persons who hold Old Shares as a position in a hedging transaction, &#147;straddle,&#148;
&#147;conversion transaction&#148; or other risk reduction transaction. THIS SUMMARY OF CERTAIN MATERIAL U.S. FEDERAL TAX CONSIDERATIONS IS FOR GENERAL INFORMATION ONLY AND IS NOT TAX ADVICE. EACH STOCKHOLDER IS URGED TO CONSULT WITH SUCH
STOCKHOLDER&#146;S OWN TAX ADVISOR WITH RESPECT TO THE TAX CONSEQUENCES OF THE REVERSE STOCK SPLIT. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Other than the cash
payments, if any, received by a stockholder in lieu of fractional shares as discussed below, no gain or loss should be recognized by a stockholder upon such stockholder&#146;s exchange of Old Shares for New Shares pursuant to the Reverse Stock
Split. The aggregate tax basis of the New Shares received pursuant to the Reverse Stock Split will be the same as the stockholder&#146;s aggregate tax basis in the Old Shares exchanged therefor, less any basis attributable to fractional share
interests. Stockholders who receive cash in lieu of fractional share interests in the New Shares as a result of the Reverse Stock Split will be treated as having received the fractional shares pursuant to the Reverse Stock Split and then as having
exchanged the fractional shares for cash in a redemption by the Company, and will generally recognize gain or loss equal to the difference between the amount of cash received in lieu of a fractional share and their adjusted basis allocable to the
fractional share interests redeemed. Such gain or loss will be long term capital gain or loss if the Old Shares were held for more than one year. The stockholder&#146;s holding period for the New Shares will include the period during which the
stockholder held the Old Shares surrendered in the Reverse Stock Split. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">No gain or loss will be recognized by us as a result
of the Reverse Stock Split. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>No Dissenters&#146; Rights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under applicable Delaware law, the Company&#146;s stockholders are not entitled to dissenters&#146; or appraisal rights with respect to the proposed amendment to the Restated Certificate of Incorporation
to effect the Reverse Stock Split. We will not independently provide our stockholders with any such right. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of all outstanding shares of the Company&#146;s Common Stock on the record date is
required for approval of the proposed certificates of amendment to the Restated Certificate of Incorporation set forth in Proposal No.&nbsp;1 and included as Annexes A-1 through A-18. Broker non-votes with respect to Proposal No.&nbsp;1 will be
treated as votes &#147;against&#148; the proposal because they represent shares entitled to vote that have not been voted in the affirmative. Abstentions will also have the same effect as votes &#147;against&#148; the proposal because they represent
shares entitled to vote that have not been voted in the affirmative. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL>
U<SMALL>NANIMOUSLY</SMALL> R<SMALL>ECOMMENDS</SMALL> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A V<SMALL>OTE</SMALL> &#147;<SMALL>FOR</SMALL>&#148;
T<SMALL>HIS</SMALL> P<SMALL>ROPOSAL</SMALL> </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>ECURITY</SMALL> O<SMALL>WNERSHIP</SMALL> <SMALL>OF</SMALL> </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>ERTAIN</SMALL> B<SMALL>ENEFICIAL</SMALL> O<SMALL>WNERS</SMALL> <SMALL>AND</SMALL> M<SMALL>ANAGEMENT</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the ownership of the Company&#146;s Common Stock as of December&nbsp;31,
2012 by: (i)&nbsp;each director and nominee for director; (ii)&nbsp;each of our named executive officers; (iii)&nbsp;all executive officers and directors of the Company as a group; and (iv)&nbsp;all those known by the Company to be beneficial owners
of more than five percent of its Common Stock. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="76%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom">&nbsp;<FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial&nbsp;Ownership&nbsp;(1)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1px solid #000000"> <P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficial Owner (1)&nbsp;</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Shares</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;of<BR>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Directors and Named Executive Officers </B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael R. Bristow, M.D., Ph.D. (2), (3)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,798,984</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Patrick M. Wheeler (4)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">76,473</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher D. Ozeroff (5)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">170,905</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jean-Francois Formela, M.D. (6)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,911,191</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Linda Grais, M.D. (7)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Burton Sobel, M.D. (8)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">John L. Zabriskie, Ph.D. (9)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">289,059</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>All current directors and executive officers as a group (7 persons) </B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4,285,487</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5% Stockholders </B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Atlas Venture Fund VII, L.P. (10)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,893,025</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael R. Bristow, M.D., Ph.D. (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,798,984</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Investocor Trust (2)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,460,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Represents beneficial ownership of less than 1% of our Common Stock. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Beneficial ownership is determined in accordance with Rule 13d-3 under the Exchange Act and generally includes voting or investment power with respect to securities.
Applicable percentages are based on 15,961,898 shares outstanding on December&nbsp;31, 2012. Shares of Common Stock subject to options and warrants which are currently exercisable, or will become exercisable within 60 days of December&nbsp;31, 2012,
are deemed outstanding for computing the percentage of the person or entity holding such securities but are not outstanding for computing the percentage of any other person or entity. Except as indicated by footnote, and subject to the community
property laws where applicable, to our knowledge the persons named in the table above have sole voting and investment power with respect to all shares of Common Stock shown as beneficially owned by them. Unless otherwise indicated, the address for
each person is our address at 8001 Arista Place, Suite 430, Broomfield, CO 80021. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes the following owned by Investocor Trust: (a)&nbsp;834,495 shares and (b)&nbsp;625,871 shares issuable upon the exercise of warrants, which warrants are
immediately exerciseable. Dr.&nbsp;Bristow is the sole trustee of Investocor Trust. Excludes the following owned by NFS as Custodian for Michael Bristow&#146;s IRA as of January 25, 2013: (a) 1,069,290 shares and (b) 748,503 shares issuable upon the
exercise of warrants, which warrants are immediately exerciseable. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes options to purchase 58,547 shares that are exercisable within 60 days of December&nbsp;31, 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes options to purchase 73,135 shares that are exercisable within 60 days of December&nbsp;31, 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes (a)&nbsp;options to purchase 18,066 shares that are exercisable within 60 days of December&nbsp;31, 2012, and (b)&nbsp;47,606 shares issuable upon the exercise
of warrants, which warrants are immediately exercisable. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(6)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes the following owned directly by Atlas Venture Fund VII, L.P. (&#147;AV VII&#148;): (a)&nbsp;1,579,542 shares and (b)&nbsp;313,483 shares issuable upon exercise
of warrants, which warrants are immediately exercisable. Atlas Venture Associates VII, L.P. (&#147;AVA VII LP&#148;) is the general partner of AV VII. Atlas Venture Associates VII, Inc (&#147;AVA VII Inc.&#148;) is the general partner of AVA VII LP.
Each AVA VII LP and AVA VII Inc., may also be deemed to beneficially own these shares. </FONT></TD></TR></TABLE> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Formela, a
director at AV VII Inc., and one of the Company&#146;s directors may be deemed to beneficially own these shares. Dr.&nbsp;Formela disclaims beneficial ownership of these shares except to the extent of his
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">
pecuniary interest therein. Each of AV VII, AVA VII LP and AVA VII Inc. disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein. Also includes options
to purchase 18,166 shares that are exercisable within 60 days of December&nbsp;31, 2012. These options were granted to Dr.&nbsp;Formela and the proceeds of any sale of the Company&#146;s Common Stock issued to Dr.&nbsp;Formela upon the exercise of
this option will be transferred to Atlas Venture Advisors, Inc. (&#147;Atlas Advisors&#148;) and therefore Dr.&nbsp;Formela disclaims beneficial ownership of such shares which belong to Atlas Advisors. The address for Dr.&nbsp;Formela is 25 First
Street, Suite 303, Cambridge, MA 02141. </FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(7)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes options to purchase 18,000 shares that are exercisable within 60 days of December&nbsp;31, 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(8)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Includes options to purchase 20,875 shares that are exercisable within 60 days of December&nbsp;31, 2012. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(9)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of (a)&nbsp;options to purchase 37,715 shares that are exercisable within 60 days of December&nbsp;31, 2012, and (b)&nbsp;156,131 shares and 95,213 shares
issuable upon the exercise of warrants, which warrants are immediately exercisable, owned directly by Lansing Brown Investments, LLC. Dr.&nbsp;Zabriskie, one of the Company&#146;s directors, is the President of Lansing Brown Investments, LLC.
Dr.&nbsp;Zabriskie has shared voting and dispositive powers over the shares held by Lansing Brown Investments, LLC. He disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest in them. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">(10)</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consists of the following owned directly by Atlas Venture Fund VII, L.P., or AV VII, (a)&nbsp;1,579,542 shares and (b)&nbsp;313,483 shares issuable upon exercise of
warrants, which warrants are immediately exercisable. AVA VII LP is the general partner of AVA VII. AV VII Inc. is the general partner of AVA VII LP. Each of AV VII, AVA VII LP, and AVA VII Inc. disclaims beneficial ownership of the shares except to
the extent of its pecuniary interest therein. The address for Atlas Venture Fund VII, L.P. is 25 First Street, Suite 303, Cambridge, MA 02141. </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">*</SUP>&nbsp;</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Also serves as a director. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>H<SMALL>OUSEHOLDING</SMALL> <SMALL>OF</SMALL> P<SMALL>ROXY</SMALL> M<SMALL>ATERIALS</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Proxy Materials with respect to two or more stockholders sharing the same
address by delivering a single &#147;full set&#148; of Proxy Materials addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings
for companies. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This year, a number of brokers with account holders who are ARCA biopharma, Inc. stockholders will be
&#147;householding&#148; the Company&#146;s proxy materials. A single &#147;full set&#148; of Proxy Materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the affected
stockholders. Once you have received notice from your broker that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your consent. If, at
any time, you no longer wish to participate in &#147;householding&#148; and would prefer to receive a separate &#147;full set&#148; of Proxy Materials, please notify your broker or ARCA biopharma, Inc. Direct your written request to Secretary, ARCA
biopharma, Inc., 8001 Arista Place, Suite 430, Broomfield, CO 80021 or contact Investor Relations at 720-940-2100. The Company undertakes to promptly deliver a separate &#147;full set&#148; of Proxy Materials promptly upon receiving your written
request. Stockholders who currently receive multiple &#147;full sets&#148; of Proxy Materials at their addresses and would like to request &#147;householding&#148; of their communications should contact their brokers. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>O<SMALL>THER</SMALL> M<SMALL>ATTERS</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors knows of no other matters that will be presented for consideration at the Special Meeting. If any other matters
are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%">


<IMG SRC="g469192g95l79.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christopher Ozeroff </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:54%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary,&nbsp;Senior&nbsp;Vice&nbsp;President&nbsp;and&nbsp;General&nbsp;Counsel </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">February&nbsp;1, 2013 </FONT></P>  <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">We will provide
without charge to each person, including any beneficial owner, to whom a copy of this proxy statement has been delivered, upon written or oral request, a copy of any or all of the documents referred to above that have been or may be incorporated in
this proxy statement by reference. Requests for copies should be directed to: <B>Corporate Secretary, ARCA biopharma, Inc., 8001 Arista Place, Suite 430, Broomfield, CO&nbsp;80021.</B> </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

  <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g469192g16d04.gif" ALT="LOGO">
 </P>  <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Electronic Voting Instructions </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Available 24 hours a day, 7 days a week! </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Instead
of mailing your proxy, you may choose one of the voting methods outlined below to vote your proxy. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VALIDATION
DETAILS ARE LOCATED BELOW IN THE TITLE BAR. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Proxies submitted by the Internet or telephone must be received by
1:00 a.m., Mountain Time, on February 25, 2013. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Vote by Internet </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">&#149; Go to www.investorvote.com/ABIO </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">&#149; Or scan the QR code with your smartphone </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">&#149; Follow the steps outlined on the secure website </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Vote by telephone </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Using a black ink pen, mark your votes with an X as shown in X </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">this example. Please do not write outside the designated areas. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">&#149; Call toll free 1-800-652-VOTE (8683) within the USA, US territories &amp; Canada on a touch tone telephone </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">&#149; Follow the instructions provided by the recorded message </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Special Meeting Proxy Card </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1234 5678 9012 345
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">qIF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM
PORTION IN THE ENCLOSED ENVELOPE. q </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">A Proposal &#151; The Board of Directors recommends a vote FOR Proposal 1.
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">For Against Abstain </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">1.Approval of a series of certificates of amendment to the Company&#146;s Restated Certificate of Incorporation, as amended, to effect a reverse split of the Company&#146;s outstanding
common stock, pursuant to which any whole number of outstanding shares between, and including, three and twenty would be combined into one share of common stock and to authorize the Company&#146;s Board of Directors to select and file one such
certificate of amendment and abandon the other certificates of amendment, or to abandon all such certificates of amendment as permitted under Section 242(c) of the Delaware General Corporation Law, to be determined by the Board of Directors within
one year of approval; and </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">2.Any other business that is properly brought before the meeting. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">B Non-Voting Items </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Change of Address &#151; Please print your new address below. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Comments &#151; Please print your comments below. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">+ </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Meeting Attendance </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Mark the box to the right if
you plan to attend the Special Meeting. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">C Authorized Signatures &#151; This section must be completed for your
vote to be counted. &#151; Date and Sign Below </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please sign exactly as name(s) appears hereon. Joint owners
should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Date (mm/dd/yyyy) &#151; Please print date below. Signature 1 &#151; Please keep signature within the box. Signature 2 &#151; Please keep signature within the box. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">C 1234567890 J N T MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">MMMMMMM 1UP X 1512361 MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND + </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">01KFUC </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

  <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g469192g28z04.gif" ALT="LOGO">
 </P>  <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Important notice regarding the Internet availability of proxy materials for the Special Meeting of stockholders.
</FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The ARCA biopharma, Inc. Notice of Special Meeting is available at: www.edocumentview.com/ABIO </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">qIF YOU HAVE NOT VOTED VIA THE INTERNET OR TELEPHONE, FOLD ALONG THE PERFORATION, DETACH AND RETURN THE BOTTOM PORTION IN
THE ENCLOSED ENVELOPE. q </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Proxy &#151; ARCA BIOPHARMA, INC. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">PROXY SOLICITED BY THE BOARD OF DIRECTORS OF ARCA BIOPHARMA, INC. </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">FOR THE SPECIAL MEETING OF STOCKHOLDERS TO BE HELD ON FEBRUARY 25, 2013 </FONT></P>
<P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The undersigned hereby acknowledges receipt of the Notice of Special Meeting of Stockholders and Proxy Statement of ARCA
biopharma, Inc. (the &#147;Company&#148;), dated February 1, 2013, in connection with the Company&#146;s Special Meeting of Stockholders to be held at the Company Headquarters, 8001 Arista Place, Suite 430, Broomfield, CO 80021, at 9:00 a.m.,
Mountain Time, on Monday, February 25, 2013, and does hereby appoint Michael R. Bristow, M.D., Ph.D., Patrick M. Wheeler and Christopher D. Ozeroff, and each of them (with full power to act alone), proxies of the undersigned with all the powers the
undersigned would possess if personally present and with full power of substitution in each of them, to appear and vote all shares of Common Stock of the Company which the undersigned would be entitled to vote if personally present at the Special
Meeting of Stockholders, and at any adjournment or adjournments thereof. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">The shares represented hereby will be
voted as directed herein. IN EACH CASE, IF NO DIRECTION IS INDICATED, SUCH SHARES WILL BE VOTED &#147;FOR&#148; PROPOSAL 1. AS TO ANY OTHER MATTER THAT MAY PROPERLY COME BEFORE THE MEETING OR ANY ADJOURNMENTS THEREOF, SAID PROXY HOLDERS WILL VOTE IN
ACCORDANCE WITH THEIR BEST JUDGMENT. THIS PROXY MAY BE REVOKED IN WRITING AT ANY TIME PRIOR TO THE VOTING THEREOF. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">PLEASE VOTE, DATE AND SIGN ON THE REVERSE SIDE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE. </FONT></P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Please be sure to sign and date this Proxy. </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g469192g16d04.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g469192g16d04.gif
M1TE&.#=AHP)G`^<``/___\/%Q^_P\+6WN9J<GUA86DE)2]'2U*>IK",?(#8T
M-HV/DH&"A69G:71U=]_@X>P`C/G(W?6@Q?!KJ/WQ]OK5Y?SB[?:MS?*'M^TE
MD^]9H?BZU?%YK^Y'FO.4OF]P<O#P\>'BXY.5F$9&2*RNL<?(RC0R,V)C9;F[
MO7Q]?Y^AI%155^?GZ-K;W+.UN,#!Q,W-S]K;W:JLKW^`@UU>8&%A8VUN<(2&
MB8F+CC(O,4-"1%-45GEZ?</$QE!04L[/T8^1E.?<XN?0V^B[S^C&U>Q&F.IH
MI.J"L>B9O.BDPNF.MNLEDNBPR>IVJK>XN^M8GFEJ;*ZJJG%L:XZ)B9F4E-/1
MT0```#XY.$]*2>+AX<?$Q,&^OG][>A@5%#$L*E=24>KIZ2,>'6!;6F1?7H2`
M?RTG)A(/#OK7YO!FIO..NO>RT/G+W_2:P?SD[O'Q\N+CY*VOL;J\ONOL[<C)
MR]76U]G:VZ2FJ>7FYLW.T)Z@HV-D9G!Q<XB)C'Q]@%566$='2:"BI34S-5%1
M4SP[/$1#182$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$
MA(2$A(2$A(2$A(2$A(2$A"P`````HP)G`P`(_@`!"!Q(L*#!@P@3*ES(L*'#
MAQ`C2IQ(L:+%BQ@S:MS(L:/'CR!#BAQ)LJ3)DRA3JES)LJ7+ES!CRIQ)LZ;-
MFSASZMS)LZ?/GT"#"AU*M*C1HTB3*EW*M*G3IU"C2IU*M:K5JUBS:MW*M:O7
MKV##BAU+MJS9LVC3JEW+MJW;MW#CRIU+MZ[=NWCSZMW+MZ_?OX`#"QY,N+#A
MPX@3*UY<6`(`QX\O6)`@^<+CRY$G5[X,F;)F"Q<<=Y;LV;)H@9Y+<T9->O/I
MS*5?IW:->3;HU;!IC_X<NG;KVX$9,![^%@(`X\<G1("@?,+QY\F7-W^.G+GT
M"!.,5U=NW;EV@=:[_E,'SWWZ]^C=SX<W#WT]]O'HV6^_GKU]^?>!!1#?OU;]
M?>_VT0>?>_7-)YY_`B)X8(#I,2@?>0DZ^)Z"S5&('W\89FB5A0`:^&!\V'$X
MX'\C1NAAB!)V".&")ZH(8H$K3J?AC#0Z)>*-*>+88HDLQHCBCCKZZ"*!(M9H
MY)%%!?DBCQ6FR.2$3G*H)(%/#OE?D4AFJ>5.4Y(H991@`IECF$)662666Z:I
M9DQ=FBADFSTN^:68=)8Y9YEKYJFG2G!^2"29<@+Z9YV!$CHHGGLFJBA(?4+9
M8J-6NODBI&;>N>2BF&:*$:664LGIF(9Z*>B53FIJZJD/??KHJ))Z"JJ=_JS&
M>>BEJ-9J:T&JOAFKGZ*N&FJKO>JZXZW$VIKKI+LZ"JNORS9;J+"(%BMMIL?.
MZNJOLI**+:_`TH?FM.#N6:VVSEY;+KG/IFLNLL.&*Y`;<\01;QQQ#$"OO'/D
M:R^]\]8K+QWN!BRP6?#*>^^^^.I[;[_VS@'PP!!'O%6^^=9!\0`46ZQOQA=G
M[(;$((<,U1QV+(POQA5WG'*\",?[L46`#(`3R2+4;#,<#E<D0APB]YRA''7@
M4<?0=PP=M!Q(WX&T'$HG;;301`]MD1P))/`0U54GX,#66P^2==6#.""S1'?<
M\/799],041T)#.+SV\316[*\&L^!\AP6TT''_MUUHVRPO!4!4C7/#O6A!]I9
M!Z*''U\/(L++#-%Q>-5_W(!SOG#T@79$FB?P,-R@&_;&QBGK[;#>==#A!AVG
MTR&'WGMS;'=%?U3=AT2"?]V''`3-P7C5?D">D`B)`X*0&V9G#9$;@53-1^C0
M$V;W`'D,8#T>UENO\1UXVUTQ'OI6?[WU>=0QT1Q?3S1YU0?)X775>B@DAP-9
M$V*^0NA7/<=#`V0M2/0`!,R][)`OU\'.8:M+W>H0:$#3L0YO<GO#1#HW.(D0
M3WD'N6#5QG:0WR7`#[QC2.[VYY`]?.US`4PA7E36/=-)\(5O<$,=7I@ZT\EN
M`!*,B!R:E[7;142#_E8["!V^]K^#4#`0.6S(X43@D#><[7DJC*)=#G:ZU]%A
M=%<$P`P!\`;SO:&!6&2=Q>)@!Q0ZA'CK2X#P&@+$A)SM(''X&AP@,D0?,H1X
M)J2<%/<XEZ<9K6CF:YI`0GB'0182:5"K`R#Q$$*(5`UK&_QA^A!RMD8.1!#^
MDP@AXM<03$(R`1SDHRC7PB^4T:&&;Y"#&W+XAACRKI6J=.#*RA@1.'P0`'E,
M@!W/.,F#O+$@=OB:\4#2OST`8'V<'*4RT7(QV,FAE:D$P"J?V<HZN.%EJ^PB
M[#2&PX@<;HZVS)HE[]A+@Q#1(.^KVAHY@DF>Y:]J25RF/,5B!_)A3)%R_L`;
M(S$&R*!)K9]%LQOVJ$="AV"-=Y_,`T3:>)!W)D"AO?N:`T*2OX&DDXGSS"A8
M*-:Z9P[RBZF,(38_1M(9HHYUW7P(&@="OZH5D9<8-(@&DSD0(-HA))JS(P7]
MH-&>=N5DV[RB&_*I-VJ2=)I<#.,I]67&A=3N?EK\&N'86,Z!T(&'P3-(+A,`
MU8XP+P%3C6/6XNG3LE+ECTL#P-*:QK2$)&VM0&/D0]#W4H%@LFHW4&E5M?@^
M/8Q3(&D,2?\(49"O8=2LB)4*4*^HRFOF#8;8[*(TA_K%I=JMJ0G1W&$%PH>L
M_4&O6;.9"/IPUS_<%"&!!8D)-PN`G2;VM2.C_IC>CJK%;8JTL4D<ZNI.J;>4
M,F2'"2#K$+-6T(4`$7&?54AJ/>+$!(Q3K/"$K727LM@N0E-C`+NN=JM966YB
M-H/PTX-XQZL[F+(/`'3P8`)86Y#E=H1XBALO>4,[W?H>)7MWXUX=>(<R\.ES
M:',HI!;O!C[J=54AB$.<VZ@:4_=]3<`'22.$.9+.!+O4OA@>2L=0-]EG5DQO
MUOUB8]7:77V1%2'A/#$`H`M*!I]7(+ESZ3HY^[50:J1_@9AQ.*MVX`S[."?5
M1>\5S5<ZUF4QJ:SK+DJ_6Q#&&1,AM;LP.6,*V*]!T2`LIJE&,+E+@KA!HC\.
MLT[\2+2T&M*/`UGK_A^')M>%L"T!ISU(\G@\Y1<+Y`X5[K%:*\F1_-F8("U]
MI)@'79-2%A"5214(-%\IP=V>KGLD8W)-HXL0%K-7IGL%HI8',N<$S%$B=+BT
MY@*!/SD2^M0Q:69103Q#5@K$?-.4H)%19V*&U"ZO"DEG<A7"T()$N8(&`:X>
M):*'70_DJUTVB`<WC>IFG\0.T!;?`,"73XPY3:U"RZ=_O3<^.^"@N`VM&AX6
M@H.OZ9D@O29(_[*V8$QG+<X.P4,"-KWN/Q<$B']UMKY%HK(&)CG6JYSA-`]H
M.FZJF"":,S9"WERU2Z-[KU7.VD0-XH9?(_$A;O`:>P_7[H0,MVJ?WK?(_D4R
M0-D96<17G#5O>YLQN4GZS0YO<N)F/&DJ$^3C51MF0:Z:-1`VQ`V_FZI`\A=S
M@OQ:X2-/^D9&Y[U\65'E"E3YTSG*39I+\WU%'TAGL_9DA*CWN\&4JA#3.0BA
M"]&#\93#[^"=D#0F6^EPKT@^FZY(/R)-K6\%6C^A-@?_VOO5=VW;A`^"Y[,1
MXL]W"#38_IY&K>E9\;@^2!Y^^6I"U._<`ZE#A1-``\S'_?,-(1VDH4[P58N^
M;AEL//`V+;E?H^T/QG1#L2T\;[,[U+-='P@<+&XYB@&B#SS,&B=%H-Z>YUX@
M<=!#X-'FAXF#_OD.<0,9%\;"OLG.;B8S.TOU_B!:F^GA^%P4;_=MQH?O2U/\
MXZ_9'O2@_=%VOP_@'SH?BN]9/?`!$'BK*??'KX=D)W__XU=^S@=]!"@_TC90
MU),]"'B`V<.`^;84"&@]!3B!,S%WD-9T%\@W+*1*%-B!BF$Z!\,OUA<O#(-`
M'GB"*)B"*KB"+.AC!T<2GM>",I@50^4R"=%*7O4&@#.#/.@5=E-/"8$'T-81
M)&,'@]>#2'@5`P`'+R@'<*!]&`$'(9>$5%@5HP.%%[$Z+ZB#DK9OLO$;IN$;
MO($;MM$;NZ$:7SB&:8B&8A@;;:@;K*&&;W@;:U@9=4B'<QB&9PB'N0$<`^,]
M'E$'`X!Y@AB#^C8N_MZ2+)&2+8FX+<JB+NBR+I(8++0B,/(B4@M'<]$D1''@
M.C-&+^_R@IG75-8D33U&4HH660PQ.CV#B`WBB(O(+:]X+MW"B+,(B;4HBS(B
M,&\`!P-`!W$`!W8@/-)G!U,H$'2`,_82;%)(1G!@1DX(!VZPA#B#$*Q3+U/8
MBTO8BR5S<\(X!V]`C:?4C`N'.6P7,:[8)+!8*:^"B[:HBS]"B^_XB%3RA].&
M,GE@2?F2!^"F/0(QB&G6=Q@#`-@#;@4Y`$4C@09A;=-64'*`,0-5!_R89AC#
MCP$V/1BCD`71=T`S;:VHB&<"DI"2CO08B90XB;EX(>[B!E(X`!]C-TET_D5S
M(`+QM#=Q\#%.6%"KLXU:)(7W)H4YY),%04;2Y(N0\T5V\X1J11`WZ8O2"`!2
M.$?):$;2YSHK!@</*#`D"2/N"(^Q&(]=69(IR94H.8]?Z1R\2"\A1)1>)B_"
M0S(Y%"_Q=(6OMH.*9B])!(J]0T+`>&#2ER\(H8-V($'S\I(WN9$DQ(4^LY5;
M&9+K.)(B"9("`Y3("`<'-@?5.!#:2%)+B$*^^#!UD)G(N#-6Q82]\VDL>8Q<
MY(L')X5>M(3[@YEFA)DO0YD?^9CM6)9>Z9CRN)N=<I+`.98"PST%93$&`9@$
MH6V#!#X;*33_.`>6Y$\!J8\A9#$]EB_CAA#(_MEW)$1M!0&0!(F<M]F;8GF+
MNEF>7MF8ORF<E*(0V($!`^$!`N$!\@D`'@`9CT$!DR$!&_`8\AD:$N`8]#F?
M^"D8G5F9PH4SI3ATECETRUB:+LE%#ZI[F]6)IRE!QBB-<R`\4OB`F-EHG\E%
M(@".D`.(20F.61DPC!F9L*B>N1F<9FDF";$<'C`!SH$!QL$!&C`!',`!$Z`!
M\KD<DY$!$Q"@.\H!&#`!&:`!&*`!3*JC0$H8=6"A<F"7`T$OK-.67N26-[>#
M)",\.NA%J728`Q$O*/4OQ:68E48X?>F@P'AS@TF"G0AN$K.BN-FB+$J>9`FC
MOEDJ"%&D`C$!'I`!_L:!`12P')+A`1P``!T``1:0I);1`?QI&<=1`44J`4H:
M`<M!&`,`;?64;]#V9]H#A,!43X)HA!MIA'40JN/4J?4DA*1:IG;P@)UZ/T,H
M$-XV`/J8!Z;JJBFJHGG*+GK*CLP2EF?)F\9*K-%B$!#0GP-A`<@!`$@*`#BZ
M`1?``8ZJ`1G0`3@*`1#@&!>@`0"P`=ZZ`1T0&M$J&$F6$#E#<19S8KW80@>Q
M2LCX74=V9%[6A)\30V5*IZ/#K^VZF,%J+7R*G@:[I^RIB"[:+@=QK@+1G]`Z
MG^**&AH``3B*`14``!50KA&0`0``J!I@I,OAK8IB@S-HI\,*F7>JIPN[_JP%
M@0&+NK$`$+$7T`$4```:4`$;L*39X:05T+$:L`&;"@$WFP&::K&@,;%[HI$R
MB++)JK(IJ[`#6[!HB1`4D`&$:AD12Z@0$+)9"QZ3X:T70*X9X!C((0&$&J"$
M&@&)4J5TNH).>Y['NIXQ"K5/*YD*L0$9*Q`WJY\6<+,1L+<`<+,`$+@"\;-\
M.Q":*A`18`%[LDI+2*95.+F46[F6>[F8NQ&TM[F<V[F>^[F@&[JB.[JD*[J9
MJU%!!"ZI>[K+M+K2XKJL*TJP2RRSFQ$;X*1."AFWB[NZB[LA^["^V[N\^[#P
M&;N(4;NV@KP7H0$=T*,5*Q#,Z[S($;TZ.KW-_EN]T'N]SVN?'FL!&D"XQBL8
ML-L`6Y,``?``!F``]*.^^L$`"5``!P``[IL`#1``!I`U"P``!Y``!""_#0``
M`:``]ULU^0O`!6``_;N^#B``@391`N"^#?``Y*N__"L0##"`]'.^Z0L`#=S`
M`TR_#L``_QO`%OR^`3`0Y"O"`*P`')PU!."^\"N_55._+:S!!D#!_?O!$PS#
M\:O")$P0RFL14?H8TUN?$E#$J('$1`R]1HP<@PH`%P`!@AN^@`&["3"_"."^
M]VL`[NL`!7#%]PL`"@#&"L``8\P`,O/%_SO&`6#&9GS%8_.^[ML_7*PU"<#%
M:`P`7^P``GS%>DR__@*A``-8-5E\QP!PQPR`QHC,`"]\QE?,QF:LQPJP`%_\
M``+QR.8;R8M<-0P0QF=L`"Q,R%K\QQ'\QN[+`%_<R58#R2P,Q"`QQ$?,Q$DL
MRTN,LTU,R[',O5`LQ50LO@6QOP1`P#-\Q0APQRW6/_W3``C@R?\+`/U3``H@
M`%7CQ6O<S(&L``0P`-+,`,6LQ8DL`/V#```<S`CPS"PLS?TK$-*<``LPS=*,
MQ^_\S6+<`,`\S070`/T3``+P``R@'_6L-?<LS05``,$L,\A,O\N<`.O<SEIC
MSH%,SPE0S`8-2O9LS9?\RK=LR[.LT;4,RTJ<RX-:`1[`R[U<Q041S,%\_K]C
M',Q54P#N*Q`HG34&$+_L',@&T``1;<<U7=,#<0`X;0#%W-+!?,__&\SJ',P"
M(,`X#0#%?,("4<PJS;_%3-13W0#-S,XQW5(+T,YB?%Y93<!!3;]!%--5,]-0
MG0`KK=1!A-57/-;\J],%/!!!7!$>C<L??==V/9_>ZJV+.A53_-<$`=@#(=B#
M'=@&0=@::]B%K=@S@=B.S=B)O=B'>Q"/+=F1/=E_X;KTH\IBO=0P;;[H6\<`
ML-3(#``L7=8)\``;5-H"L=2;G;HO/1`2'0!V?-J9O+J<C=,'$-LRK&Z@]-JJ
M#4K!?``/(,`"`=P;1#^?;<,OO=2Y_=99$P#(_DP_P<S<J1U)KOP1=<W1N;S=
MWIW1H'$!(\VV44$!%?N]YMVU%)#>Z'W>Z^W>[/W>ZCVX\.W>?%O?ZAW?^FW?
M\<T0%5"\(;'?^8W?[3W@!E[@"`Z^`I[@"R[?W]L0__T6KDN_!:#5[UL`!#'`
M"O``!8#AR,S5VPP`TJP`_[O47#T0M,W)'3X07XQ!`ZS&?BS-"-#B@%SAPOS'
M64/C5L/5%%[B:^W"E]P`]SS:5F,`&"X0&L[A'@Y*-L[.G"SB$<WC_YOD0^[9
MV>T1.WH!%X"CT#L!6L[E..OE6SZ]8@[F63[F!1'%4^P4F(JS`>H<(=OF<0[G
M;^[F<E[GOWOG=XX:_G2NYWW^YV[^&'3.$!*@M"#AYW8.Z'.>Z(R^Z(Z.GXC^
MZ)&.YP6:$(4NX04A`)J^Z9S^G4ZMZ0+Q`)L>Z@,AZOH!ZJ#^G?&;ZB+^`*ZN
M'_]XPIINR:2^SZ\NXIQ^ZJYNZKM^ZKZ.ZK#NS$ZMSJ,.[.KVZ;!NZKE.ZP!@
MR<8N[,2.Z^8$$MWJK1-;[5TK$-A^[7N=[=3:[8:NL8XJ%8`J`3XJ&N?^&.EN
M[N6^[N[^L>C>[H$:[_2N[NTN[_(^N-DQ`10`J!U`KM\J$O=>[^Q.\.X^\/:.
M[@.!\`6?\`[?\.8^$/W.'/WN&/_NK96>%G-M*AM/$190`2!/$!\?\L\*_O)3
M//(G;_('`;Y0H0&FX:0O[_*/`?,S+_.%;O,T?^DXC_/0&_,^7_,_K_,O/Y\3
M8`&"NAQ-:I\V*Q(['_0Y__1-#_12?^D]/_50[_0\3_1&[P%(+ZX>L/1MT?&9
M(O88$O4WC_5H/_,XZ_15?_96;_;BFO4[6J/BBJT92_4A`?=ZG_9NW_=*N_=O
MS_9=3O?2RLMXSQ:EF_B*O_B,W_B._[EY4NXV*AJ3+^B2?_F4+_GP;OF4/^^<
M__F8BOF"OOEM'N;T:1G8RK:'_Q&B'_J9__J@7_FN'_L+#_NS?_NRG_L#,?<>
M@/H0H/KA7M*)HJCP3OQ%:OP2@/S*OZC'S_P"_NK\R'^HRU_\T%_]FX_\`C&M
MBMKU:B\2T]_\U!_^X#_^R6_]17JH]FG^Y2_^ZT_^`Z']',#]JR_\>T(!';"M
MZWW_-FO_^,__^Z__`$&!0H<,'002-`A@8,&###=D6&@P8D.)""E24&@1```+
M!2%$T"`!0(8+$2!@V)A2Y4J6+5M.A&DQ)L.9%6E:?)CQYDZ;/2^F[-CA8\B1
M)4^Z1)I4Z5*F39T^A1I5ZE2J5:U>Q9I5ZU:N7:%2V(!18=B-8,6:+4MV[%FU
M:].*K>!6+MJY;>FFM0`@+L>\%?)Z34E7L-K!;`V_1:PW<>'%A-OB5<Q7[U_`
ME2U?QIQ9\V;.G3U__@8=6O1HTJ5-.]V`0?6&D@I%7E!](64$#A@PPL;@`:.'
M"1LVIEY]020`UL`Q^&Y-04+MU2M;`XB`/()KX[Y/.^5MW0+*C1$F<&\=P0/P
MX=MG?]\8WL-U]NW=OX<?7SYG#!U63\C`$0*`"?8SB*P``M[RZP\##2;P((,$
MIZOOOOU&^LZ^X_C+SP((.-#@).M2FF`X"5#"3[\&)YQOI007!,"#CZ`3<(()
M^),@P`@:[&`]%:<SB;<7.Y2Q1!]_!#)((8?$#(/A^!/00AA9!("#]0#HX((.
M69R``P`N\,U(#B$("X+OCD32`R4O>'"E*0'X,$P+M22RRBM]Z\"^)?GC_@\#
MD@#04H(7XP1QN!WME(U(05G::Z-"(S-4I4,778G11A6%-"5')65O4D0OM333
MEC2EM--$!R42`PA&]8X#+O<[<S\(`E5M`B]/"O`H/$?]R%4CO1255/Y,W6`_
M,ELZ,\TJ3\UUQ2!C18F"CU3=$,D':=1M60"X5,G5,D$5E((,-1!HVVXAX%9;
M<+\-UUMQN57(7&_+4G?<<\F%-]UQEZJ`N\K>Q;?=<MW5%]YW`^LW7WX'1I=>
M>[$=#8,)+KB`@@XY$&K._30(U$D7157L@@Q04IAAASG(H,KO%FX81HA]O99#
M#_L\N>.2C[UR8PEHC2#*W_B[&$_[1)J95)N)_L,9/82)U!.`D(H^^L6DC98`
MZ::5?III-*%V>B.GKZ8Z:ZFK5DH"#2[#FNFPER8[ZK*YGEILK<]>&TRDO"Y1
M2A?GIKONT-B$T4)4>>X@Q1>5]4ZD[RCV&\\C.QQ52KSS'O7*E#<*MD^]%P^2
M<!TY4!P#*P-DO-[#,?].<[WVMO#0H7^<<KG4.5B]=9Y9?WWU)55_'?+8;T<3
M]MQEEUTA5R=P6*0.>H7`;:Y<WQUWVI-G?GGGK;2]>=V?1WZYP'X/'DKBC6_/
M@@B^!S]\\>^F57>,K85@+X*.FC)`,C-8L5C865>\_"4Q_I4E:__K<U;YA30)
M_$S2'8AD`'ZRF9*!_O#VH`@4\(#W^]KI*B<;KQ&N@A34@`4SB$$-:M!H',3@
M1CH(0C1ML(0>]*#?+(`@DQ@H10FIS`A/2,(+SM"&-<1A!#]X0Q/F4(9PVPAO
M5NB!%G[-`S",C]SJMD07A88"%H"B0`*C$"BN9`-[$8M"%/*R)T;Q+`KIH@4P
MDL4O4D`UJJE`%\>HQ;*$T8QGK-<90X>!.+8*CF=4V!WEJ$<[HA&/<YSCH2A0
M,C+^!HM`R2(;V7C%LDCJCWS,HQ_W*,D^TO&1E(QD)DTG01'2L(>?_.$G=YC#
M3O(PE"@,H=$0-(&OF2HN0(RA)T\I2UJ6,"6S-*4G;[G*5J;/EO/I&:V$_CG,
MQW'2*@SS&%20V;!E2@"9@T2F,SW6S&=2<YK1K"8V&2;-EWW&FLS4)CBWF<UQ
M7K.<XA1..!-IS-FYB&?NG%KJX*DG><JSG?:\YSOKJ<]WME.$"/*`;$PU'5@"
M9I_QY"="%4K/A#(T;=%S:$3G.5%\JM(#`6W2B@H*'^^)SZ/@8V=(13I2]WC`
M2ATR*8Q2BM*32F"E+FWI2U,4TY920#PT52E.6;HDF38))28MXB\K\U*BZA2F
M.47J3I4J`9O.-*E'76I1Y^33F09UH^]1(A/M1E*N=M6KFJG)1<(:5IWXY"%C
ME4E:&5)6L01E*"(A20LM@U:>B%6M/IE(3NB*_M>[9M&M((&K40[VGF`2DYA?
M16QB%7L5QM3E,(X-C&/@`EG*WN4N8^G+1JKHE\LTUK.2;<QCL0C:RI(VLIF5
M#&<7NY7&*24-:0#`&=!P!I>\=B5J@*U+T*`&`*@!#4C9K4M\NQ+9$G>V3K&M
M;&G;$MNJ!+?`Y>UP=<O;ED@WN,55"JU6NUWN=M>[5FEM4M#PVS5`8`VZ_:U*
MV)#>ED"`#0!@0S$WXEZ7Q'<EY;VO>9TR7@"4][PMX:]ZV<L2^MK7)?1MB8'I
MB]_LAO>[#X9PA#%36,,*$S0.1F]_]0O@`<.WPRHIL'RG]=X$IXS!*?'O?LF[
M898$."7K14J(8TQB_I8H^+TGCC&&);QC'O?8F#IN\8K_&^25P/C`[S5P>VE<
M9!,W><A+X6^*.5SD#Z=$QD>N[X,6+&(K`]G'7P9SF"E<82]CILPIB3*+5^+B
MC1A9R?`5,8)KW.3\/EDI:;8SFCOL9@(C.<Y+5J^6;\SE^9XYS)?AU*<4C:E'
M><K1B;Y4I$D#:4I':M&/MC2C'7UHK!@:`'C.L(!G#.=1ESB_=5:QAO.\$39[
M>-1)[G.6YSOHI6B7TYP1V+YT[:]^R6O7["(8KX/MZW5N:K!=R;6P=YWL9`,L
MV,SNM<'BIE4F7G@_;6!#&WK+6VQK&]1JX':V/_W;;KL:ON==`XFOS`9T_JO[
MQB1F-ZG/K>&-@%O5VP9`N>U=[F^'V]OD%K>1XYWN6<M[X.[N+[S/:V-ZXUO?
MO+7UK34S-K-5G.)5H[C5VG9QJ*6-*%W3(6`XKC:2LZWD%4_)R$U>-J9<U3T=
M_:A'K7UO4-=<R..^MY&OO',_%YSA#&>PS6E^<Z&G&-0Z[_F(Y<WSI2=]RZPF
M^F\C+G',5&]Z5[<Z[Y0'O:QO7>NY*POVIC2\47%/*UV7'MJI5SN(8MWK6[^>
ME[)']N+-)ZO4;N)G&F?TJ`_=[RE&>M,%_W-!"S[H?>?[W_5;=/T&GO`^+_SC
ME7YXOT^=ZI;!I0]K";=0EE+SN;1E"H7(PI,8_A&)7LD\*#>O>J&F/O4I&3T1
M2__"8K=GS&2>>>)UOWC$-SZ]3)<\\`M/^=V?E_'&[_W"?^]TY@\^\L-_D-`M
M?WG`N'[UJ.2AYUG_><ZG\D"\Z>4K0X[ZZY<?]+"T_OEU^'U69E3\)8)YS,,W
M<^4"(+G'O3]M\V]_V-;_N9^.KO0*+NL*0%8K0`#L+0'D+>S:OP;L/_Q[0/V+
M0/Z+K>/ZOP%4P`0T0`U$0`+DP.M*+P><%D^COJLX*(DZ08KJIQ2$*!5<J(GR
M)XO"J($2*H-J*!=$P1MDP19,P1[LIW^Z*('2J/'#*KS;JA)$PB2\"JF**J-B
M0I%X0IMZPBEL*:<Z_I/:J*K9<[FMH,*GZL(FA)&F^D*H(L.>HBJ@TD(B=(_;
MJS`E=,,W_(J^VBN[6JNP.BLYQ,,ZU`B.\`C`*@JYNI<\Y*NZFD.]$D0Z]`F@
MZ$.BB"M9@<-'A$22^JS'FL3($JW2HD2[>`RP0*W-H@S`J$1,#*W$&*U,-,7$
M.*W(\,1(9,56=,57C#`V-"Q8I,5:M,5;Q,5<U,5==$59/"Q>!,9@%$;ONCN\
M&\9C1,9D%*GXD[_O4<9GA,9H#))BI#9IM,9KQ,;2\,5ARL9N%)(!<(!P#,<%
M`,<!8`H!"("H*,>D:``&2`D$<(!T7`ET!(!U=`I[7`IZC`IZQ,=A9,9F_O3&
M@/01`DB`@BS(`B!(`EB*!S"`!8B*A$P*`TB``]@(B7R`E6!(AX1(IR!(AUS(
MAHR*C`2`C3Q&:M0J@43)^"#(!D"`ECR`C7R`BTR)!Z!(`$"`!/#(C:A)`:A)
ME8A)`!``!!"`F>S)C6"`!%#(!T@``P#*GKQ)APS*H=R(G]1)J52)CO1)F02`
M`Y#)IU2)HL3(FO3*J-P(GL1(K=Q*M(S$;;2PE'1+]L#*E(#(!BC(!C#*@C0`
MI2S(!;A)!4!*@DP`!4C'FZ1+G+Q)!+C+I=3*`$@`N[Q)!@!,P00`@^3+!&C)
MQMQ+`"A,BY1+G+1)S,3)!_#+!"@``:#,OD1*_LL$@`)(@,3,R]-4S<@,`,+,
M3-$\2*M\R]S43:P`3(-$@(0D3+I$@`%82@=H3-8T@`$`3`,@2`,P3@40`()4
M@*-,384D3N=L3)4H2``PSNM\3@%`3N7\R\"DSILL`.KL2:R43NHT3@(0SO!<
M3HADS7HLSN-<2O$D`.\,S/7<SO84SMT$T`"5BLA4``7X3:2DRP!@S'9,@'0D
M1Z_$RNX$@*,43X=D38@\2@<UQY003K^44`J%T/&T4,Q,1]9,3\_$2M:DRP)8
M@,%$T1=5R/G,4`!X4!C]T-0<40$P3A:51U9DR^G3#.'X#891#=T`BL'*#LT"
MC^$H#M5XC>D@CC-J_A8!Y;2XW(B$9$V#+`#C=$H8U<R)',GQ5$BZA$@N;0GS
M;$RZI$C@A-&YQ$R*--,K]5(U'<T&#5&%E,_6C-//U$@$!=.$1,HO/8`#J-,>
MI=*F<)6-")D".1#8,Y8449`,F(X;01)%C9#ZX(WA&)$I/50PL](P=<^_9`!P
M;%#-K,P^54CC3,>C/-!4K4[N+-4&R$D`T$O+5-4)M<P[+5/,1$R)/%%4A=4#
M:$FZ=(`[!54`D$A834=9O=-;/<I='=1A30`':,4?)4&O<)4N@:<!V@@^X1`K
MP1(HD9-L598O42C#Z=3+D\X"8-<&2$B"=("C'%72/$J6)$W\I$\#H,[H_@S4
M]@Q4XCS/[%2)+!6`Z]Q7\\3/797.POS58S7.O5R`!&``A(5(@(W8U@38>J58
MI#38@H16UER`B'7'=&4*6YD9%WD5[@"<,D$6A9`6D\45^ZB1,RD6*"593S7(
M@E2`/%W*H7Q8!3@``?#0C:3.4E780(75P`3+B"V`Q"Q5H9W6=^W7B3Q*!?#5
MS@16+AW-O(1:!X!(`9#(I6S-I`7:KL50@PP`:"54O%1+.#3):ON,*@D9UKF8
M,@DF*(T+C;D54I%;D6D0P=%4DJF]FY4PGAS407T`GI1*!?W*`)#*!Q!*Q4T)
M895*R57<H)U<QV4)R=5)H9S)R`U:RSV``8!,_@&@2ZL4W:$T2W3L4<@5`,X-
MRL35R@/07%H%7:FDW*94W9UD7%?\1_D##<19%7@2FBI1G%*Z',417L4Y'$TU
M.\*%WC,-3.2,WJ=XVR4*7M61&P"!@+Q@H/Q@$0'ZWH=9&'.%G%'9&/NIWO5E
MB04HT`(`2_9U"6LEM'MI)"EJ)$4B(T(*C#)*)#5R(_D5X`%^BM^-.0)&X`26
ML.L]0@5VX`=.+/J%X`FFX&'$#=FH#K_QC>C0"P[@@+R=#N7@")1@CN/@8-JP
MC>0`DZ;9`.,H%/-0X2;1+`\XM@I^CP<P5)=87;`TRY3H89?(84/]8<O0QZLH
MXLX8XAQVRP+A'PG9_H`3D=0/"1#50)4*V8\;P1`-D>(6"1DK!K$/&9%"N9$0
M41($J1,/>%X;/@W65.*5B%@:'=N4>&,YCF.,E$@%D$F"[-$YO@P];HHL)4V6
M\&//X&/BW-`>D^"X%8D6^IPW^1`LQ),*<!4QV0]OS9]'?A*A2!*[-1(G90D^
MF60E"9!>T0OP5>,;+LB110IPA&,WKF,^7HEGG5:@],L]KN/*&.2E8`!VG>65
MR&7.*.0$..2W3)6:;=D/L9FFD61>@8"5=1RK$156&192MATP'A4=6MEI?A!3
M"93Z/>70Z$L%```%<$CW94BE)0!QCMAS!MJ(E4B%C%CP;$RK1`"'-("F_J5.
M6P;9C7C.M!7G=![)`FT`O\S+F;SCGI1GB0P`=B94=W1?04X`U$7.!F7HZ:11
MH"5HK63HE-C9`%"``1@`H%71UQWI>#:`!C#D+TMDSRAFP<U;F3&0AG$5/5D.
MH;C;2X[IC9B?B($<X6B5<+4:8:II!BJ3#/C$;SZ-@=;C@1YG!B5(!GACD4U-
MJ)Y6UGR`B(W8=)Y5`&#,!5#*!*5C!YA/>)7(HVQEIMW/G4T)659EK%9HMF9J
M!;#+E;!H.EZ`MY[JN&X`I5;KNWSJE"@`=Y58!B!GI"3GK#[LQL1CQHQ?E$R=
MG;DEV<C4W(B@D.@0O3'>[\!IWG#9XM$;#O%I_LK)[,MN+269K\%%ZM`P3824
MV,.,3>-T@*AN30*`[3<V9*8E9P5HVIFT6M/=6:2%XP?0XP(09^+TR[..Z.=<
M`-RD[5Y>3:;TX^8N5F%6394@3D,M`.@V6MB^2>*$Q\!<[JN$;3I>4><D;O=E
MU]QFT53F:C#U,0:FF^"EE7HIGP#ZB#3)$`@PZ@1JK0;":2B!'X41"8P)(C3V
M9!#KCKHC<-.>EM1FCYLT2.@T2`$XRMIN3:FV</JLYZ54@'!4960%VLG,63H.
MTP#([O8^;MD&RH>EUKL<[XTX<3VN\&E52K]42[,>6.T.@!EW@!I/@,1E\;6>
M5N=F3+&U3`/H\'A%_G(/OUCHG$PP,^"/`HTN*@LH$J,M^B+HL`XR*J1"(HZX
M\'*]Z!O\58DP]_(+@!X'-PTR#=4`H$N[S&Z/CNT+)TT#D'.LYM*('>@`T%<Z
M9M%Z7@!B)7$9MTQB%>;Y?.,&*`"/WNWGEG,A1P`VCO,.7\U[;7$8GVM(EW0[
MIW36;%I%9W3`YO1+%W$(?X`]UU=4IVK&)(`#@-\O@^^Y^2X-V"2HZ("C5G/5
M%M@#:&W5;/+UAN-?CU@/A>.U+=6*U-*-N.Y!;U"P]5A>-\A6)LZ"/.1?Y^W`
M;%!K[TA8IG2?],M:UG;/G'9AIN/I'=C6M-JM',T`,/8`>&/B3FD?6^E<_C_4
MVDU+KDZ)A:;)'>;JF`Q:KI3'U1T`M*1=!5U,E5C='F7WJ71<BNSA!QCXE=#W
MHJ1'>9SX8E?*KVS;BM^(BX_8FH1XM;QXHJ15F2Q8DX_XA,?W+XMRF0,-\[B2
MV(AY#`@4V*/WFV<)3Q])Q*0*G7_&6,^[SZ!4)M83_S@2`L?YI$];W*2*I8?&
M>>\,;YT2DYCZ!TD0;T[ZK-?ZJ'#F5$D5H,#ZK1?[L9]?FO'ZX2@3!B?[M==-
MJ-^,S!9P-.F`QP9[MG^P`!CFKU0*8=W<>%0*!!#6P!<IP-\,'95'P7\*Q`?&
M\9UO]'GAL+?[D2*`#U]KA4P*!,CTM7[UI&AU_I9L=9%BR<W898J$S-!W"LC\
M?)%R>[#JWRJB(EQ'[<C_JLG?9<$DSL)DR(+F=<$D5+G620-XS8B>4)#]Z-W?
M<3='``:X9]Z_YY$5YQT_`.!_``904`90?H]4?J!5_@:0?O@E`(#><8[F:@:(
M_KRD_O`??IPL_L!,Q^=WQ]P_]0)E=^DO?XC/3OC_??,G[H66_LF5_H($"`$`
M$B1HH$!!@`<&##P``,``@`$+#BQ\0)!!``8%$%(LP,`AR)`B1Y(L:?(DRI0J
M5[)LZ?(ES)@R9]*L:?,FSIPZ=X(DP*`!@Y\&?";02(!``0`-$"QH4("`@P8.
M"RQ84*"!`X=`'3R]_LJTP=*P17]2C3H5@0.D5;TB`.L@@%8&2+%2M4I`00(!
M!=`2`+DW;5VV4I4RX#KW*X"_?1LL*(R5[-K`0QD,>(ITZEJ@9(\FQ6P5:]S'
M3CE/'0`X\\^V09TN,,OS]<D+$V;3KFT;-N[<NG?S[NW[-W"'/I>V79#@*@&"
M!`$$,%`P`8"V#J$/E*L5@4^+S0N&;9L`@7?F@Z$FL#B=.%@$(!O`+8B`.O2B
M`,@W%.Z@/'STU[,GV"Z5_D#UH0<??,858)%RTYT'7@/*43?0=-8!(->`"<YW
MGP#P4=@6@]`%,%AP.ED0`8DEFGABB"FJN"*++;K(XG`,.G``4'<E])$"_D<U
M>(!T`"APP`%%]:44=@Q8E",!Z8G%X(]).I2A`CX"Z5Y;2ZV'0``*+/5CD`,L
M!V5(8'))Y6!+\8>D5&`^%(!IZ(TYYHQ`(?3`1U(&Z>:-((TIX89MS5FG11#M
MF22'?A[@Y(LSR68;H[2E:`$&#EV``087`#!II2)YX$&BG7KZ*:C`Q=C6?<<E
M<%<""R3FW%!XC7>03T.::>1QK';7((/O%022`1_=A21!Z:V7@`(<_GK7`(P]
M5%A6#O4Z'ZS)[4HD?P6PZFR="."5+(/''EMJ`*BJ"FV.Z(G;$ZP2&F<N7N,.
MI.JQZQ:Z5+"ANB0!!/GJNR^_*7H`000`3-`!_@892#!PP1*`Q($&$W!@+\01
M2SQQ2@((!(!``QP`0$,!P.70`!@S=\#%S,%5\L4"98RQRBP_^593>G[LL4,!
M6%RR4@N<7#-<]0F$$%,R\URSQ4\:O?+%"($4P,8IFSQT1!L_O?3.(M,<$LTX
M/^#TU49#O;7(&,,,(L4EC7@BVB6FV`'!`BL<`003O`T!2!A0`'?9>>N]-]^X
MZ2JUEBPY$#)*@4OM(]DP!=[W27\S'M*BC3(:(@4`TRVW0W$K#`#=(7$0Z>.A
MBSXZZ:6;/CJ^_*JN;XBI`XPYY[!W[I`'&IQ^.^ZYB\3CX;NKMQ+O"/3N.TC"
MCV0\2L.?I+SNS8_N_K!L&&`N00?3=P#2!1U0X#SWW>^]84D]IK0A`<P[)+Z5
M(J5ODH3C#^D]_'QW'D$&$^A;@?WY5@!2!OG:'C\``^@;C:1*`0-0"$."=1"F
M5>0`!VF`ET!$$89@)"/!0@`##+"1A#3P@>O!RP$0^(`&$*`B22G``3`RG01,
ML#X0D4@+"2)"AT0I(RVL8%`,,*X,_BB##3#AH>["G#H)T$6N6UV_@K,]AU"`
M`A:P`!.?*!(G6F")1;PB%G&RE:Y8YBH_<0!DK/*4J$R&<(%!#U#$LIHNCA%$
M6$%*%PVR%OPDYV)`"4QI3O,9HUPF,7PY(X.P\K$:784K:T&57OB2Q44R_K*1
MCES1K!"DG#XU:(718<QQZI,?!FT(5]YQT"77$S('/><\SJFD0^0"'_OD14/2
M6LZ%\+.@*OU.*>VAEX+D`Z!'`N>(2&0=+X,IS+U%DE@WHN286$@J&M5I3.CI
MY'?\="-ENA%+QJ230::4'`8DH%D3NLN4'!(H.PGI3T\B%CG16,NE9&E+4_(2
M=-0T3-Y$3G*UF2<^\PFJ8HI+7FWQEJO`)9QH!4M>GB1ANU#E1F)AIUT(S5&0
M,E1+XQP+)*DB%P$HVBY>^8J@W%DG0\T$*P,JJU<.\*8^>7*VM*'M4:##E*5@
MJJG-I;2F\7.:0*X&-JO-C&11P]K,B@:VHO&T_F8^?=(#9K:SJ[4L)!W[F->F
M]M20*&UJ-B.J5G06-IKYS$=7M2E/ZFG/V?@+8`(CF,$09K"%34`#G`(K7./Z
MN,6I9'`IH:M<<>++7\X..&R+%.;@%MC97<`"'GA87A.KV,4F=J4L-1'E+.>V
MS,DN)!B`P`88J]G-<C:88AUKZ_05`=E5-B02^%]G4ZO:U7)OK[\,$?0F(#V%
M4<]Z(-%`!3:0`=;RMK>^[>W\ZG>__$%@?PZ10/\L]=OE,K>Y<+5B$Z4(`"J.
M)`+&=2YV<T/$!=#I?#,;``89\+ON`@",01E`R`(`1H%@"6-#"J]Z!A`4RIB7
M,N1E4WL=TA3"B3-;_D%9@`#D>U[O+FV]-0-*?\L[7_0N&+[%&["`*9-?YA@X
M*P*HT[CP>[(AU1>\&XXPX3ILF@9_#,3G&S#'_,L``$O,M4C,+HP9J;3B]$<I
M0QI.KW($`./`A2M"8D"0FA(E@W",.C]D0(XR>%X?4X;'\_G)D!:@`"E#U<E'
M]F*O**.5(069R`%(%5AVW!\FRS?+R<JQK`QPGXR8F80.Z7*4\O(>]$+DR40V
M3WD+4)1D]<4B2M9RGG],9C=/R,Q:47.-K=RKJ\2XT8[.25!LO)"/$'HX??GR
M0YX5'>CXQ`'C,H!WN&OD2PLI).]QUK,LK96L(("_D[8Q<TH=$D)[VEG__M1*
MIC]RZF^NA]1;MG'[:/UI#G&S*LT:3JKPO.E?^_E]Q>.TKD>=2F?#VLVO=C.F
M(^;BU;E44I2*Z;='(@$K/KK<,&G.0#*$Z4I#>3KJILZIB?*[U=S'2[^NCG+@
M<NIWVYG+%P$)OQO4H*#D^][?224W^<OO77.3(!\:DI&5<^%\$_K@$UIQ!C_S
MN^'4^T&[;M`D"WX^:"\;UA,2.<CS$O#G$%&Q_PJ86@^&5IH"`&Y0-#?.7_*=
MIU#\QNT>R"OU#>V].,33)'2`<PR>&@2PE]/Y5C4`-J:M.@4=+-R<$''L."2B
MEW<!H`99T!F>]8JO.EFK`8\`",UU3U<F/GD1_@Z4D>YQ(SL@J47)^K.?7')"
M+]V.@ZL1Q8'R((A]UIYK:]M@!QN2#D#@YCE_?%U/A175L-O-)9P\@N.]XC3U
MAX0(^G4)V[=LS,OEYT2/F5(<0/G%!(7:A(Z9N@L3]8*H'B@,?Y_EZ^SFU@0[
MRIQO3U+PTA,H?W[DS):UJ4G^\2&)'M:M(;V;$1PQQSZ61)'%&VDW1U@.-![R
MWD>)E_#<3H(D.>5!JEF4-/\0O%"Z+U=7BG)2J!Q6QP?]R#8FL6H,(>9HJ2]W
MFK]6D-_ZR8<`',1W4$>6,-S\F5\`.ES#=1/(18D!L-]TJ(IK]-O)Y1VL^1D`
M&I]/[!WY/6"SI%RV_K63_W432GU*X4E.:.7+:&E?:7'.98'.]]7@2#05RSS`
M4`F`#D:5TX2-QO@@4OF,#NX4#JH,#PX5TP$<P*%,$AJA#EY,$()$$*),V#RA
MQ?0@P&DA%B:A%!Z.%38A$XZA$Q8ASOQ@RD0A%@ZA#SHASGS*MJD.;'%`]%B/
M;3E$PT``:MD@'_9A9U%?]85(<!$7_MR/2'2?'R:B(B;6"C8*Y8!$=-T<=8T$
MN2VB)5XB/L5A$F$B)W:B)WXB*(:B*(XB*9:B(FKBOG3;I82;3(&$!4B`!&26
M*397>%$;28`'3.!B^*@'7$!5F##`Q>AB202`,!Y/+2V-2_BB22AC,9K:_C'N
M!%0U8RX^HTA<6#!2XSR]W%DE3,R!!'+!SBPN5\JY2TF<%$R$63EZF@[5F4A8
MA(`D3DAX'3J2Q#SJ%SNJA->E1#[.&CQJ13_>Q#XJQ3^VA#F:A#OZXXN@(C`%
MQU]-EF#-3=U,@'*%HSA"AP'<T4462V*L15"(T`"`$!6"4%`48(-,V81L1`:9
MEX,@@`@%"5X("+%(V0"@VPJ%(,=4A#]JA`)\!$$@0$5HQ*+MY$TFT,&EG48"
MY0JQ9$6`A0C]Q)25Y$<8)0:AY%#6ATZFY,45X$>R4$\&H$G.T$DR1$4\P$8<
MT$\BF<<H0$OF'TR:I`'1)"]5#O;!H/;=5@:T_@U%_I;`W5U!:$EY2$N2.$4!
M#.9"2%^FI5$#6(1!W`>-*(">W0=8X`5>!,!@#J9!-(B`*$"IG!0[X@5!8$AE
M=@98[&4!'D=E-DA4/(=>5.9D*H5?CE`WT5!_A"98T&91S%]>7.9S-,AJ#J96
M.&8WY69B)D!A(IG^+28+A68`<L5I7J1I6N8/<29MON9O,J::(5V(-.+D!(?K
MO"!EU:5#[$\%]%5>LA;(945D\J1Z+`=8.$BIU-)[@D4$2<5W@$5R**;@79V#
M[.27O>-`'(1)IA)WN",H"213EL<#!HM4'*@DW28-J><\ZJ=RM.>$TF=!N*-0
M!@N!6HA]XL<(05!P_G['^PGD0.@*+(79?M:)@X"%<:1*BO8G0GZ'E`4H<`#B
M8\UA'=)6]>CH;54`_92G;Z&20%[%E[$)022+07@$&'%%E*02DSK%>^Q(`B#I
M?7('-UV=8Q;&1;X'3`:)M!P.-S%HEH[@:+HC-XUIF(FIDKX?D78>B&"IDD9F
MG!I`D%QH>;2IG3[`F/ICE8[07A0%DXZHE'ZDDB+DF%[DK\3I<);'H=)+ETYI
MG9J/;FCG;03'(`Z7(1Y7ODPDD*Z6D(+%EQW'0T1FAZ9*J1#1J;Y2R@EDE;*H
MBRZ`M"R`B<+D<AQ$/`[H7Q+$N(SF<#Y`B^IJFO9JK!J'JH1J4LPCL<9J_JDV
M186ZH[$R:*SRJ8>^TJD2:P,ZW461:*SJ2EH`JU0DW;8J!ZU2AZVV(%\MY&]`
MUR1.8DA85Z?V%E8)%>'4Q];DE%*)Q-783+T23M$(1+U&!,!:E1:R3,A\9`H.
M@%!!#<LD+,!F#1)R#-3PUP/P*\X0CL,^C7RZ#+V&#,-V3;]"+'/PX-0H7(!1
MC1A.S0'<:[]>3+X.K,40CL$^2O6AR+O6;.XXAZ1&3$'"#\ZF"*7>D\T&K=`&
MDT+FR]`>+4@\`$I5A7Z1XTM@4`B)%TOXHC0J6%!4;2[.5^]@;4LPK0`<Q3,R
M[8Z-B]+JERV:(J1X6Z:THC>^%=)JEI"V:%7H_JI,-`BL3HL^WN/.A@0II6#=
M*@=_D>A,E`J]H!-($*[<PE]YT6U>:F/,=>-Q-0QBO:UB-5QT6`MG7B<[.I`!
MI1)*JME("!QD2F56[B15$L2O1!A5]@1TS-?G9@58/HE!J,=5!F#2+F5,`N5(
M1@GGRI>>S20[ID7&G8I(".]"<*;E$L``7&1B%2UY^D9#)AY$.D0'Q"*G4JY<
M#4!R7.Y.(EGW-FEY">9O/N;;S1JQG))N?JABJJ9D"N9HJB;K&BAP@F9ESMIK
MDB;\H=-T0B8$#F?X6N9G8B?`:2;()4X!.L#W:B]UW`<VCJ)<7@Y=9@Y(Z`O-
M8:]<[=JR9%"6L>-6_AH9"7FH^GBFEF1HE<RGF4ZI9_+J00H'=/!JGQ;H@Y8H
M@\+?40Q$A=KP@H)H1*0P8QP$.6Z$``")<8@$$&]PR='(X,&5\YJK=\8.>'+.
M!ORH!2?6J1V*99YF9_A(:J)7AUJ$\J*7/WZF4[!'Y_TI@YYI:JIP><2O"WOH
MF()Q8I#QA_2JXM)0G'+EKD`I=!`P=T0J2!@'90"%<<`Q(%?&523%J9F4`04N
M*<;6;`%`;?$H'D;Q\TZQ3<7;E!XI//%7!+8Q?J)C;?8*&8NJJO;JNI"?&M?'
M?+3P:/:IL@Z&L0KD00JILM[P*^6OEDA%N=;DJ:`N.CK()B\;8-8C*5ZJ_OX0
M(DAL``2LE27G55?EJS(B[,U\;+VVQI-,L[_RE[XR;,%BL[]6X\*V3'W0C#6+
M$\6"+%8]S<NZ3,C6AS2_K&8Z510^33F;X=2`[,7.HKI*%[N"A(\V,\XAK*<(
M=&_T+/B](4`GM$(O-$,WM$,_-$1'M$1/-$57M$5?]&O8S),H(TH$<4?G+$:'
M]$)GR&#<ARJ+C?D,\4FH=)C,"$P(@$N+M$S/(BHYID@D!T?K5Q*/!$NS;DZG
M!$[/M%"38G)HC*D:DPWGA9XU0,D8AW/<Q4=(V1]SF@:Y*$'H14%\[4&D154#
MV%)G""P-M5@#4!1(@5F?-5I/`4A(010X1!6<_C5(3($4`$!92X%:.P1:Y[59
M5T%.-%LORYT`G))&N8MQ^!B1T=40%[:>"?:I3)F!9%0WZ=E@G])85S;\2($5
M9+9F;_85@(05S#5=:S9(7($5``!F6T%G.\1FKW9FMW5.%*9C1HF78,=L3IE-
MZW1$]/)L3[68?6TO4Z9M4\7;&8=O;X24\=Q/6[9REPYFEP1J`P`6E+9#D#9K
MM[5FN[9J8P%)1($58/=--!Q70,27T79S:"88\?9LLR5O#W%RX/0$GM2*40=[
M$Z=YJU)R+S=^/TYS9T$4]'<4\/5S1[=_>P%G7\$53`%WA\$5;`$81$$6`(`5
M:/<6^'=;<[=WVT2H_LI7?>9JDB"$IHE9:R2GJ*ZWT[6W031'?..VM'BX*IUM
M?K]XWS0W%6SV7`<X:XOV=&<V:',W%4"X=E-W9H?VA=O$50<VZL8:"WEFE>5?
M5B0'.2:VTX6J`SF<2L\WJO1'J,*XEH>.C-,XA'>V%G"W9GM!%'P!:ALX@O\W
M`(P!@?=XA`,`D)>VA>\$D"S-X=1Y@)UT$">53O>.1_\Y7.#Y`6&,U``ZQ@QZ
MU('TEB]ZJ'2Y9M=X:D.X9G?V:;=V2%"WF__X9@OYI^A9%C,ZJ#>2H^OXET.W
M=(?$:6OZ=8?$F\<YIWM*N"!TJ,^Z`#6W%J"U=7=V=+,U`$R!6J=ZKU?Z_A?<
MM8\'.US/.:TGN_<U-TG8^&?#.:5GMG:K]J1[]K2+!+(KN[:;&V8;N+=[NXV7
M]8%/P16P]9N/P164N15P`;E;=Q=\N[<3^)!O.[UC%[G#^[>/@:F+^X0_^[FG
MNQ0<.!=808_C.[QO`6P<P$F9CZ*K!-<N8S+2A`/P()!%QW]%!R\"Q4G7.[U'
M][.'=HU?^[-C>HH$"<&11//%Q-[BXSWF[4QDR"JCYP*.LN%RO);7=8_+]5KK
MM114P5NW]5GS-:]?01A(@1:8]EFK=5T3.TZ4K(*E$I#@I`VWD)[0R%'\"`E!
M!=8?159$VE4B1)9X)`CUI%0")=@K@%3V)%B2_J4!E?WK1@1$Z%D+M_!%1N;L
MN;C-5S:PD[9G9W:/FW9WB\2,>[>!]WUF1_MSZT2#A,S7'<4!X!%A0+Z/<--@
MWN9@(AGE>P2)[J7FAF9Q3J9NHJ;FZN9D*J=2.&?HSV]>M$:&)-PXMF>SR$?>
MO_BHAP2/X_7A&[YU[_AF3SMW\_Z\RP0W;<Q>I%TO*\@WK5+1[>=*EDI7!JM%
ME,JOAB@&[3%/[HK<9NAR%*A03CX.]VG6FTIJ(@5W,&]US/Z+DSM=7X$9=#=?
M1\'`][BZ>X&^3S>:<_<7]/?`3[K^6T'^1P%`3+FR!4!!@P<1)E0(0$#!!04*
M%B"@X,"!!`493*QX_K$@@@0%$B3P"/+BR)`#!C1H`$#E@P0N7RHHP,`!S0(*
M&%PLT"!`R)4P'^SL:>"B3)HH#328*-0G@9<Q`S10(#6!5`0-JC9PD&#``JX+
MP885.Y9L6;-GT:95NY9M6[=OX<:5.Y=N7;MCKUBQ(@6`7BM4^NJ-HC"O7\.'
M#U^Y:Y"D@@<3%1!PF`"RY(("$BPP8`"S9@,,,V]6J9)E`Y</B`)PFGEK`@9>
M%_3\2!I`:MD%8*]>H-)C`@>W53H]?3$S`-DA?;=4$-+!8N?/H4>7/IUZ=>O7
ML:O-&T7*E2A<K)3Q'B4*F(-7T$\A_\4*%_*%O7M)##W``(,!`AQ\8#S__L&&
M`OYCJ"&&!`000`$!V.]`_@K"KR#[$K1OP04?@!!"!P\\H+\*$6QH/_OV*^@!
M`1X8$4$`!N@ONQ59;-'%%V&,4<;I\@)`"BL`B,*OA?P:S$8K?,1"+RP`*,PO
MQ69,4LDEF6S2R2>AC/*Z&WLLB$HD$=*1+X,*V[(@(:T@,L>]`@-2RC/13%/-
M-=ELTTVS;I1"SBJLW&L*@^24D[TMM<A3BL&F\%,*P`"H0E`IZ'Q3T449;=31
M1R$MZ\:$)CT(L2VI,)-+O0A%J-)(00U5U%%)+;6Z2:-`3[$;547/BB_(`P]3
M*[S`<@ORQ&B5H!]5W=747X$-5MAA0;V1NQZ[_E.U"RNN^!,,'6&-@HPKS`"2
M//,``+.+*]3C+B\S!EHL@)H&;.L`!`X(*RH&!$"`@=?*#>M<L=`%X-QTH\.W
M(WV)[=???XM%C$R#A/R1/,.(-%)3,!/6BR]FG;-H-P7<RJ@!!,#J:;>D#&!@
M)[*N$HN``RS&&+J,#KH8X)59;GG-8_7Z@E4Y[RSX1IF[TZN,/)FE.=N]`)MB
MS[ZPE$L`"!U8H"`#W#5`:12K0LV`!RQ2(`"/K2[()P6LECI$EIX.2;*>#/+Z
M@,VHYMHTM","H`"2#9!-JJP!H/CJLZ=F`+]WG7ZP*H\S4V"`JJ]V.B0&#*!H
M[@#P?@#K`+QV6?+)_BFOKDK#%+-9KU4-&XQ,]'X^2$NBZ\+*/I$P8D"K_@P@
M(*<%:+IXMP;>78DEU6MJ0"("(-(:::RP8L"@!F!W`+>')')`=P)XU]HEIRZF
M72O5(T+``=X7>.CBJU9?VG77C.===I5^DSZCG7(_?J?:=^^]\O?AC]^M,(O$
M\5,\-34H4\^]_)G^A'3DH[CD)%T%,%G25#89D(0H`$3A3<@`4+*K((<CM4':
MWRH(@)=H36LEP0IR"M(`!U;%7038GNT(L!67:.V$"02`5W:"`->YI(%9P9C%
M\D/"";(0`1,$H?R`&$0A)J0*J1)#%+[@'?9$@2!:($]W=E7$'(6+6P<!_I-W
MP/`L.GTG?W$9T&Y`$Q63`<`!!Q!A?1P0&1.>$",F[*%4("<\C/`$>)*AG4'B
M-H`T;B0!YX*CXPKBE)PHKX1L!`W%*&*1%HZQC+R980+4R)L(NC$`4WEC(G7X
M1SD.D9.=K-RD]E<FB(&I?_=3")@$,[HJW25QKF$)(T."@.4,H`!$2<H;)W/"
MB10'C\NIBF0L$B)9<J4RNU3*<IYF$<Q<!0%>,61MA%=,G[BP-2)Y9"T3<,L7
M5@62S+Q*972)3$^.DYPKDV(HD0@D@9!A=&,8PX\0TBKTL)-9Y=%BF01HE\%=
M!B'[9-R#3E0N$Q'(0?W4$(0(=!]\%91Q#2DH_C\#E*`!E8MN##6002=*(`D)
ME'CYR2B&^/G0<HZ4I,$*)3QU!)C/<0XAB%&IF"PE&').93$.0&A)<9I3?YGR
M1Z,4V,,,TU.!08RG.C7J49'*2>X`T&="RE,8-B<G5.9("E`-DY_"P+D\)2JI
M7?7J5X-8L((H#`"9TLNF_G(>SJT2K&UUZUM#)1!YMNJ=0JJBPJYP1/E4<0O@
M`4RSBJ28(M*J/'`U[&$1NR96S34OJTI/_8YTQ"0VJSPI+1)?0#?8HB66LYWU
M+(R*2KIX!O6DQK(LE]:Z6;H,X%T,X!>ZZB66>Y&%7VJY5VP5,B_:XG8ZO`5`
MO6K[6>%^=E)]RI/G_K#TU##X24@RH^I@L8#5Y0J*JW1!W+OX%;TQ+J1D8T$9
M6THV,K!`4"S=K8X+`TDRRPR7O9X%I6$>AB7,&>0PHAOJP`(XEZ.UT2"-BQX!
MT`:1M^FM@XN+'-16$A*O(8XB`ZA*?]&FMZOYI&DW@1S:#J`V".?-P@7FVH6G
MYK>?H&W!>T.<`]CF-K>1#,0/H,H!'$P[V1RXO35^ZWO]$E__87:M,AV8I1I&
M)HC1Q701#(F`LQ=#J23Y*4X9D/32Q[S>M8X!*?&8E&G'.RI#2'TM5-T$V2?E
MY-G.;4FF'?5N-[WE-:\VKJ,EEHO7PO"QN<D)$$#[M*+E[UWERFRV\9^__HIC
MAY$N67^J54^WI9Y7D:>)J<)LS%(%*VP-L(\1O-CI>(@5%H[0(!+\8$@4Z+C5
M^"2',`P11S)9,JR\D8(>-`BJ#>EI"H:ZU2%:Y*Q9PFD*-N!T,+Q81G`-:&$C
M5=!"+MJ5>AKD(X5NK$'-KW[Y6Q!,1@^3@O1-I]UXE:[)L9'OFD@<+U;);DM[
M(R=4M4BT'<<^DG?:N)SD";==D&YO.X^$Y)XLXQA(UUQ[V^'VC1E__6U`#IO@
M.IU4%LA#'CH1-;6%(H\6`'`KOW!!(,OBDA<2?@5)W^6[JN&:&X\9&66B+I=O
MW.736A,`KYP<*PJP7DCZ(\VJ.'.")D>F,0T"_DYWT_R;XB0CS$\^S`&LQI$^
M'SG&6-[-:C:3,CXO^--'&EJ?]E2U!>F1CLXZ5OE6W6@(`:E#^Q/1LGU412C"
MUWX<U-$'\<NB'OH/V1MT@'B!-*$2#6G9]\D@XRSTHGJ'Z'T\^H#^#&Y`:"\[
MU!'?22H--7/VL]:.%H+U^5B=ZVZR:>(QGWDF<>=0>;H3%?C"G2H82DY@(;V@
M[F2EU&N>]:UW_>MA'WO9SY[VM;?][7&?>]WOGO>]]_WO@1]\X0^?^,4W_O&1
MGWSE+Y_YS7?^\Z$??>E/G_K5M_[UL9]][6^?^]WW?NL#,-'#BT4`P25+^<EO
M_N^OG_:8L9T*_5/&_H5XA?SR/PC]PX)_]N_?]IJNF_OT;?PF0V02X/#T;_XR
MB/\4$/:<8G!8`Y)R*"3NK"K*Q2N(8B*$9P$HIH/L#"0:0`#H;P(_<"DH`X9X
M:2NL!L!`0FE$,%X6\`4_RR6`S2E0S,X<:.44X&FVR7BJ`I'([`:;+GLN`@>%
M4'=\PS=`0C5\@R@&*0F)$`:A4+A$0R8HQL%DJ`!O0@/=A_X<K`%)3@D#(`ME
M@O[$$#?LK">6XS&PL`HAR<Z<(@QS4":B<`XY*R>0\#-ZX@H;2`$<H"8,@@M%
MH@V_Y@T3IP]?XR(*L2;H#PTOX@UKR3C:$`P3<9/HL!+=2C982R2P0@U-_LAJ
M.N8/'_``0`(`G:(3&^@06<(3#Q%VN`D,<V*"M@(,X>@3+;$6VTH"!8`H*`,2
M^\B75,0KEJ,YG$('>3'#8([^C+$`@=$WZ.\-<U%LFK$`DU$`;;$:<ZHB%*J_
MTN5HOH8A#D#P)J.VL)$;O?$R!F`_O`(<T4\`5.2?UC'LSM$:Y1'01I$M#G`>
M\1'V`H``7/`L="L?`3(@!7(@";(@#?(@$3(A%7(A/VM=$`*V\.6U9HLA?J,L
MB#%['.)I,/(@"$!I'H,`[&,C(^@/C8-<R*BU6.M=$$J\-K(C,](A)(,2'S)=
M)M*W"F(B$P(!/$HR=@-"!NX@=)(A>)+7$$+]_H!+(6P2*!V@'QD2^32&-D*(
MF28I9:0R@MZ&+'*BTPI@)I`GR7`CY]!G(I3">+1"VO+C*B1&*L@()!"G8ZKL
MU:QR)L2G)K8R=HYGO1!B9,Q+O!#"O!)"*1(D<#0P/[SB\`#3)31P,+%M(?02
M+W-._4"C+)OR^/8KA"RC`0A'NS2HC]!&,S?SQ$@LQ5YH.8:'><Z(EO+(?5IG
M`-Q%9=B%;")(>,;R:9CFMRZBXP))-DUS-;_)C1Y@`<IH`U5LP.)F:ZP&<3K,
MP[HFQ0ZS*IH#`>QC,V2R.<L2.E_M)2*L8SI&-AH'<6`'`=`FQ@S"_8AQ,H>O
MR#0(H<9',VFGRZI2_BNTHGW:1S\JR,&XXB4>(`WS\SHIXR9HT0^-XS/LC.3>
MQ3:-#.8L$VKN4VSLTSYR`M.<AS)(",I4)WC0+,VBC,V:TR)<"3-@LS0#DT,I
ML3VQ;"NV@L^ZK'S4J);<3$26@RG-\_<(:&E,)D4<2#.!+=-,IF1:[8=$I"C$
MAG<<PR6&M`T;L))H<@@A8CF<`@$$[("4QB,LK8>>#&/:ARLJ:3Y58TEM;80"
MKH70C<QD[8>N)T1_"R=&K>S*U"72198V"=B00[L"#M8PYM,RXR-L30-Y*4:'
MKUQHPEX@R31Q5",4J2I+9MOBK6PN@C6MIB<*@#6W$E)9,RA2Y",TQ.4X_@-%
M$.`!MF(HP\A`<?.5Z@8_/J)2&]52!X!B[$S?!NE+WVC5R,O3$O5/><>`7HA\
M^.P@:'4K,0:,VJC?F"G@VBT5XVC<TM/!J)%/@4\`N$8DL.F65`8'(\,SP^OF
MG"XP<XY)4Y4KMA6A'$R-8LF7W,?!0J25Y$A*[?#:7DAI=@DD`[5==PEC*NCH
M9">38)7,>.Z8>(E(L;0-85/<FB,P9XD1?['I,D-.F4[G6.+D4D[?LHG,E-7X
M\FZCZL[P"*1<(HJAQF_N^N.?]JXH.W8;2R1>XB7O(*I$!NIL&J0_-&1EX^ZW
M`O;O"F^B)D0_X&X\XY$A$$#LVD4'R5%G7=!B_@.D\!CD9DWV8[LQ8I56+J[2
M+$+L12!S::5V:JFV:JWV:K$V:[5V:[76(<OB']DB:O>E*,VBMI(R*;DV;>'B
M*2$V+,AK+4)5(=`K;KG+,=%K>+9+;?7V+0"3)0CG<0@GPZ:"<&XRPI(34.DF
M)+IS;[QF<3JH.RWLP!2,;2XF.Q7GPR!W.9]V;SEW(;XB*F>G=L9GS,8G(LRL
M=O#65]O3S%XUSG(GA#SF=%5'2TFT>:0"R\Y'S;HLS/RL<WT7CVJTAAZ()SCM
M*H27@S3HF8YWDNAT@FS-W7(T>5GMA^`4U.R4)Z1WA[+73G^W>S&B.:I&4"_)
M--?M=DV(W`J5W4SS_E?+[8WJ+=8(-9-F5>!D$U@K"=[:-]U^TGL[EUF7PTEM
MZ82>U9B>-9`^[ID*>)MD[F)FR9"D-=OT52,-5FDBN.6\*>0@^.3XUWLG-J!0
MA*#D[H/+A>Y*MF+U+OP<:AOY242*]N[T0^_`#FP\RH5O=H-M>%0N[X9U>(=Y
MN(=]^(>!.(B%>(@?)25=RR`@<BQP<B;!0FR7^"V`*V_M98S0]HG-18JGF(@5
M\+J.."KO-B'\,B_5CVZQC2_C0KS>MB/([(O?#8O7(HW56(NQHT?IN(Y;[;,J
M<RKMI3._*<!6C,`VT\!23&\>1SP/9SNOQFL.!\`XS&K$$R,2!VX6H'$^_J,K
M,D)MS$;#0F@Y,LPXA,<X\^/`0'-JS"8[YV9M0DQP;0=P-/`<P_/!8BQP#6`F
M:$R.P2(!U0*7#PL][7`K67?)'J+.G@QW9E?*O+AVM@S*PI1X8D=U<E![D+E%
M;V<NP]`K]:@34VC-MC*;A^=Z>+5,*70E:'?.=J)X4G3,YG/,8#=\MEG/JHS*
M1&(W<$-YM-26;_DM=-FP9G1*'2S38(W3VNB$<$V[KL+45(W50L1BFI=X\#2$
M<DAE4"V%[$S3?`B$R(LH*0/^/&TS0>V5:@UY2<B#9LW57NF1*,C48`@\6S$J
M@NU7@E(`\!)M%Z*'D-B-:;JF']*-X4*FUT)L_H&2)GFZ+^W#)<LBJ)'2IQ4B
MG\]"J>'*3RVCW:1B(ZPM9F4UWU[IA+KMH*^BWBRFW:["6,/-DNIF(USB,[#"
MC[:M?/&V)S!C`S<Z41DXCNJMW<HWWM2ZI!F`2(O5C&C"C"BC$P_`%/?75)J3
M(Y%Z>-:X;1'[(/H0(:"R='1:+<A8(1J3C;FK`'>Q+"P[+,QXJ?&YQKY+YS#X
MZ$`QG'B)H+7B&$F(Z(3.F73NJQ&4);I)92I#@RC8F$X.YT*HFZ"IY$)&@TL:
MF81.YW!;G'3[8AZ)86&N-9ZU-R)86`H[Q@C9PLYF)FX2`G<[!TM#<,_Q)E*B
M/5,':V03O",HDA?L_G"M,G#LXV]OZ;OLQK4BS,3ZII(G&6TF=VH>>3CA1FX^
M[+J/\W!A0C@))[]C;'$:1\!8['$@&;W'@JG+PL$/BV,O%H;K3D1J.*(:(N\&
M"H4_UNY(V.R&)S;JKJ`^*H09*H0O`QQ'=>Q6^*$&Y,1=]L5-O!U1/*-B&,1!
M7$)^`XQ$ZE<*&Y[Y;':!TW9*-Q6W`N#H>2>2@IL*,(14@IL$X(/Z(\O:>7TN
M]';8^95F9RMFF3&L!WNTYU4K\E&]^73;9\LB%'KX3,U`5R50M],R6\M%2)KA
M.7V8['DF^LTM5+'#0I<M8KMZPOP@?/MRV"YH*DUZX[!!94V'<#8N^"*B_J)!
M',C)-8A[MA62Y.B#$+LE7D+3'9JC*>QMD3NO(?U&)VB])'J%MC>!)!HSM*9Z
M[[0`NI2;7!6"A/>9:N/!)'WF&GJ;8DA[JX+3#.E>/3LA)O#L%"!3$V+0[;F3
M=I6,`.Z"*>)\ZV9]9=LBOIL/L2(IQ)(HGF8T3*/3O3TJ*PE815V&2+W:UXC/
M*JBMQSI])2DP/P.3+GFO[T@)6[60W"V2G@EZFES=M8*OY2W:M4VJ]ZTYACU,
MBSTA\C-304+]F+W9AXA?[6/I3LBY(\*6=MMZG[R;F$,E\`_<3P/D.<*"6>Z-
M&ANO5^A9M0M`>WN!7:@X*@,''_#?Z97I#(GE_MWM_WC>;6RI87\NEGI.Y`:T
M3MV-V,U"J1TU)QSS(")>XH7H9\T.PW><S"3D,BKS0`8@0SS*0[#^0!3$ZV4X
MQB^CF58XHB@VH\S298VC[U98[RP6QV76PM^>8DV8(;[FZH^6\%QXPA.*9M^>
M+)B:Z/H<ZA$KT3W7CA5_\4&MT'.K+0Z=G)@:$PO?\"T_.I0Z/[E&V9/Z\CW?
M.?+Y&6',E3SW\TFJ)A4=9-0O)27#J',KLA,B:M$E]?4EML"VOX+Z]L=6B6,?
M]C];(4#B@F[*Z4V_G/8R]<?"LJ_+:3;;;?F\;CF[;[$2U?$%CL,8*?F\LZ'_
M(9]?+G3Y%<>3:YCR_NF+7W)`66_RVVO>AGG^=@4%A\',"#PWE[_6'<,@4#P/
M3)4;1RNMIG$Z&L$!@H$!`PL8)$CP8.`#```.*`3`($``@PD&)&@0\8`"!0T2
M&E@(X&"#C0$\@FRXL:-"BQ@#."S`@$$!!2X3T#QH4B-'A@=L!H!HP('"GC19
M,CR*-&E(I0`"($AZ@($`I@F86KV*-:O6K5R[>OT*-JS8L63+FCV+-JW:M5XQ
M-G#`H$$#!`8(,!C`L``!`GH5)!`P=X%<!@[T%L#(=^3>`DD%"A2L8''@!G7O
MZN6;EX"#!@46+&#,$&/<SI\Q,D28@,!%!P$:))"Y.*]GQG,1#*Z<`('>_LV7
M0;N%RSEV9MZ+<>M>L%FT7`2",?;>W2`T\^AO>T^NC'=KU;+;V7K_#CZ\^/'D
MRYL_CYXA`P*UER](4`#DP8,A&30U<'&NW0<7?UZ<WYUZ!JP'@&OS!8!?`^_%
M!^!I`-BV77?M14A@@0E>])1KJLWGX%+MK;?@7%5!R"%$["%`(GT.IIA`B`A4
MU5I["%ZT'H`C1G??106^>&"""YZ458!B"9E>D48>B6222B[)9%;KM3>7`P>8
M!@!-#]Q%7V3LZ<<`?W,%P)&5]B%588%B:OG6E`R(>=H!MBEP0$]'M0=G3Q6J
M9M!F&:;&9I5Q5O6A9E.*Z.9()8WY)(J&7GE4_@*%BBGE<G!NJ2B:ZXGIJ&T,
MH;GCF7NE2:561((U:I.FGHIJJJJN>N1[4"+@P$$_`4"`7PLH,(""!>!G`)=>
MVF1;K2TZX,!1938@[&>\QII``,DR)"RR&Q$PIZ*U1O;>5#T)D-M<9O+9(K33
MTBJ2J_,A$.VS`+AJK:U'I6LKL[GQN)QMNR9`$+@+1)L7KSLF>V]0LA(KJEFE
MLHIPP@HOS'#"#TP%@``0#W``4A(!`-)4>$G,T%2`+?#35!=SW#%2(L^Z,0`4
M,W3Q42Z=;'+)+9_D<<0E+]0RR[,VQ?%"%$/\<E,[8PPQS!8?8/3/`+`F6-$J
MVXSSK$$SE#+0*-N\_C+)6!W<%=<-?PUVV&*/?:H#V9&M*H\5F^JU=FB_#7?<
M<L]-=]VGVHAWWGK;S7???O\->.""#TYXX88?CGCBBB_.>.../PYYY))/3GGE
MEE^.>>::;\YYYYY_#GKHHH].>NFFGXYZZJJOSGKKKK\.>^RRSTY[[;#KC7ON
MNN_.>^^^_PY\\,(/3WSQQA^/?/+*+\]\\\X_#WWTTB>?Y/367X]]]MIOSWWW
MWG\/?OCB0U_]^.:?CW[ZZJ_/?OONOU]\^?#/3W_]]M^/?_[Z:Y\D"_[_#\``
M"G"`!"R@`0^(P`0J<($,;*`#'PC!"$IP@A2LH`4OB,$,:G"#'.R@!SO8_K\/
MBG"$)"RA"4^(PA2J$(5.:*$+7PC#&,IPAC2LH0UOB,,<ZA"'*T1@"'L(Q"`*
M<8A$+*(111@#$?A@?_;S`0YB8,0?'G&*5*RB%:^(Q0VJ(`<)@((*=@C&,(IQ
MC&0LHPIBE0,5%%&*66RC&]\(QS@",58T^($<[^B_'T`A`0X@(AOQ",A`"G*0
M@10!'PDI1T/B8(@_A,%>7%#!%KC@!0.4)"4!*,E)_L\%FG2@)2&824Y>TH,O
M(``"6@#!%T`2D:QLY09[<$@""F$(`)RE$&HYA"`,<`A$*&`0A`#,6P*0E_[[
M93"%H$L6V!*!LTRF_Y:)2UP*TX#-%"`Q66!,_F`2,%9.$&((-W00&U#0!0FH
MP0#):4X`DC,!)O`?CT;`P!>($YT07.=\=H!*#MH`0`AXX`@2``-7"G2@$H2"
M#J!(P"=`0)A(@(!#E>"_ACJ4"0%D`@2,4$`E.-2A27AF$1S:!!8<8:,./0(+
M)`H!)!A0HQ!8`BU98-&)`E"A#-TH1`N(4HK^SZ(890%+.4I`'=#`FTAB00L.
M4H,:'(0`$Z2G`)VZR?D$]`8'@:<"CPI/J#9PG2/X9P+$N4&J)F`'7@UH`_]I
M5H*J=:T&_$$"1)!1A]Z2"`XU@D-YV5*[+L&9+/AH3P?8!))VE`4*?<(2(#"$
MD9)4"4)H:1,..\T`_@ZAI0HM@O\.J]`E_(^E<ZWK70E(UR7HU9E^]5]@-SI8
M`:H@`78$8O]>E$ZJBE.2,&@!`M+*@E+B%@8(6.4G6>`"`JQ2J\`]%PN4F@"K
MZC:`RRVN"5Q@2=K:=I2Y/:4J`TA.J_*(MISTGVW[Z3].!M22W0WO*KU[D%7N
M(`$WV*1PO>L"&)3W!:=$*UOOB]__K1:A`0R"7>5Z4@A`5*-*2$)*"8O8_QGX
MH@54*!&TR0*Z6C8)14A"-I>P5P.;=*0Z%>!(.ZK0(4P6HW;-Y7\7&N`!"YB`
M!E9IB/VWX)XZ&,(#C,%;@]@_<IH`""V@;7%W8(*#@!<(\P&"_\")3WKN_O,@
M.RAN.J-Z$!ZP(,C)90&1#V)D_UTY`4;V:FK*B4XJ9_G*)K!O5*T*@_0F]R#R
MI?((`LJ#<AZ7O?^$Y`NJ_+\7616XI_3?DL=:W+**=01!QFU^#RU0'.A`EA>%
MK#*9<,N&0C0(E/ZH,(.`8083T*%(0$(R&WH$$0>PH2J=;$@#^U(!EEBD*04U
MJY'06",X6@B03K$O*XUB3!^VIYSVM`&=B..BLF"]2!TN4I5J@A;<V00W"/(+
MTIP`'JSW!NC4\PW^V5LYJW.L8[WS>D>P[&8G@)+A=O:2:P#;==9@G^V$]@V(
MC5L=<W*?(^`J/H-<@V\;-<A43395C4SD]OZ/_LA@#:"UL6WO.T<;WHAN>**'
M.L`@J-32`?SH2XEPV)OZ-*6:%F!C-UH$76KTL!`(Z?\PG,S3EKR`'&9!8(^@
M495*6N)]13$`+6Y`C*]XXPW%Z,<=&O("T@#B/0QA"Y";7N?Z;[TN^#<+5',#
M(DOY!340;CFG>_34$!>=ZU5-G$?@=*BS(.SL37-6P<Q._QW$RM$V*INW;2,@
MZ/C(VJXSVY?ZXSF?E^U2%B#6E6KU=K)=G-`VM,,/#T@<$)V`%/]?8)^PT[KJ
M,M:Q)N!DGY`$A4)4L4I0J$XM:E+_G?BO`K1H$5AZA)'*'`*AKWED'W_`F!KA
MEQ>M_.4SO_,!T@`*_L$^$@!?`(1_-MFI<28`NPG]5:='U9P(0+K5GQS><NZS
MZ\D]?I#%:?VOFMW)Y&PR"]8>YRR;.?K)'<$.C$Q\+ONO^/X3_O\*G78`$OQ_
M^72G\].?Y4(C?O^!Q$$"#MAX`;8$D>5R!Q982&!13]!+$:=+([9Q&&5J_C-2
M+\5307"`!71:AP5S!^9J_A.`#36`"72`!YB`O41I+."`!)0#B^1:115\609M
M3K9^J4%O254#-Z!\`55M[,0#@+=UY01.=S8"-9A4[46$-[A]Z.14X*=^4P90
MV[9GT9=.X>=GJ;%O;\<"<19G!>=.>&9E)L!4+V("/:AUVD:%3FAX_*>&_EGD
M!`G03074>#'U4D%`!+JD835'4I8U0,B$@A``>0T54BEX6/_S82QPAP4D8C'G
M:C'W/W'X6;Y4AX;(>A^5A\K4@'Y(0+`D`[UG)&R'3RP@ALZ%2G7F=$U72G*F
MA.7$?OOT?-A53@JW`V97BC=`2;/X;%66BNFT=JHQ?%@8?5$H@T]7=PD`27$6
M3ETH9`'4`D'&5##`C%EHA:SH5*IA3H6WAM?X1CK01W"8:QD'3$'`B!IE4D90
M!.585P/D:@86B!!@61854D&`B?Y#8`'6>A6%>0@F8@QF5QU&<9@F8-](0.'(
M>N1HCA>5CBLW0`Z0`T3E>\O(3EXE9>NT`\B6_EL\&&2GA%3_)'?E1%4[(%:M
MN&WF%$YFMVP\<)$5.887>51CE6[:MG8.265/>&:NF$X.25:`IG#KM$KS47\#
M=Q!NADH=^9%.!6TU4%;8B)18Y']O.$`4AU(E-5D7Y5`+^$P=%T!T57*']5(?
M95@00%$1Z#]1^5@)MDN4Q8Z7Y8<M=7,H]I2L9WF>!0%467E8.9:I!D"PQ((M
MZ'O`%9,U@$K9%63/I67ST7<(0&5^B4[.B%31]H/FM%Y`L'U;UG=WUW9S]F4U
ML(3_QY=?-7Z!1I.;1&6?J%3MU9%5"'T`)%;)95:*64Z,J6W"F%SKE89)29M#
MY`,YT`.,AV(G5E(!_@94M625HV93_Z-S.P=Z`(12&@=8#K4$"QA37KF6M\2;
M;DE`*)5:RJ1IR5EC.N`#_%5TPF94XK5\DM23\D5=O\4"M16>`:6>ZAE`ZMD"
MJYE/YOF>G11>E-2>\QE0P-=G029`[@E``'J?_P,#:56@59AE`T2?F!1?Z8E*
M`BI?1C6;M4FA/?0#.8";$7=IQ\2'RC0$!/A,?.5Q']I?UQ2B`01-.9=+TM1?
M&WI,(HJB)(JBSI2B=ZD#&<J0G5A`Q"5(ZW0#T]=!!&",$UJA1=I*/;!$#M!:
M1FI!/Q`K.I";C`2>Y_2:B/1GQ-A!8B5P3,JE`Q4#.,!%0C5T8TJF96JF_F>*
MIFFJIFO*IFWJIF_:ICJ0`"OHG9Q8)`:$GJP47'W608ZT=UT*J*T4`S(P`W!J
MJ(>*J(FJJ(LZ`RI0ISEZIX$JJ9-*J95:1?+#1)FJJ9O*J9WJJ9_*/)@*JJ-*
MJJ5JJJ>*JN,CJJG*JJWJJJ\*J[&ZJK%*J[5JJ[>*J^IC.[O*J[WJJ[\*K,$J
MK,-*K,5JK,>*K,FJK,O*K,WJK,]ZK`>P%],ZK1`#K=>*K:\CK=1:K>;!'WAC
M`$>!(@@0$U*Q-#_!'"J#$0*`(@]"+0_R%.C"$%=R`%*B,@M`KC$Q*_(Z`-22
M*^8*%_JZ-!4S``N@KE(1L!&1KPR0KT]Q%/8Z_@`*\!3T^K#EZA3Q:DH6RQ#C
MZJ^:4:X+ZQ0Q8;#\FK'ZFK`[\Z_L*K(5JZ\+.P`.^R`6V[#MRJ_KZJXJ4[(1
M@10+*P`IJS(.V[!(0;$OBQ0I2[)-02PGD;`T2RT@&[,,^[0*N[(\Z[/Y:K`8
MPP`5L[1/4;4=N[,Q$:\6N[19>Q2Y,K(8>Q042[)!N[%3*[8RB[%6>[/]RA!;
M>[-.^[3OFK(G>[)&VR51D1ULZ[<,<+5V:[1>N[$H@KAVBRYX"[)':[8_6[0V
M*QAX\;A@*ZXRV[$0BZ_E2K1ENZY!B[?SFC?A>A[@-!]G(Q<&\A<`4`!5T2(6
MX1>]0AW;(1<%LAWO_F$0]D&[\_&NKG$E%6$3^!(2OEL?`-`KLHLO`,(>>?.N
MQTN[Z_(:C>*[M^L:K/N[<H$0%.&\K*N]P8N]S$LUP]LK\X$CS,NZ*H*[2Y6^
MM:N\X0J\!H&]2,&Z[XN[H6&\#*&[]SN^LQN_S3*\"D"]YGN_\\NZ*=*\(E&_
MY+N^.K*_-M(`]ON_]%N]OHLW8Q(`PYL<_"N]]O&_\]O`VKM4Z%N[WCO!Q4O`
MKM'`OSL?6#*[S`O#_IL:^]O`"/"^WHO"(G'#VRLAWVL0IP$@)9R_V/N_&>P7
MF]$=[VL0?M$:%;Q4^,N^/#R]O=L@_8LO!PS"[X(W9U,>`N`7!#PGJVLQ_LM[
MOQFL(RI<(+7+$/C!$;"[)4GA&G#Q'TW1+!`A(6ZLPAD\$;:+(]9[Q\4;'6Q,
M)GR,N[=+O]HKQW:<QF&\-/\AQX:L'@&2QR+1R,9"R!P,R;?+$4),QTW\R#@"
MQWT,(\V"QGY\%(*,QF4\'X\<K@=0`-;ZPZ8,R8NL`'$!RK<;*X8\R3%2R8*L
MR*L[RI[\PXQ\O:"LR+Y,&>NRP:F,RGPDOVJ\R+ELS,/LQ[CLR,/\RVH\RXM\
M&+N,S;$\R@>!Q&.BR7$1SM$1*Y&<QI,LSM@,S(FLSM5LS(N,OZRLS*G,S@8P
M);ERR]"<R<X\QZFARW]LQM%1R]M\%%X<Q$7"_B,'L3:A(<*@X;KA,KV`S+_I
M&S%\]&6J`1BI"\6O6]&IH<@;^V7<,B:I0<T+_1[B^F5RP2VQ\M`I;;X>O<X'
M\;J_G+JN@1_F#!__<1!X@<W'B\([;<E07"(-G"L^;2,GG<"O6[\4W--,7<K1
ML=(9#=.I'-+S`=)2$A,Q#2@-\M37*]`YO;P\_;I27=8O[2C9'-)-+<E4K=1`
M_1<:73%\-"=5K-938M/Y(;WXN]-/3<U"_-=[7=08_=1(W=;?#+LG?1!?3,[_
M@2=`7-;Q[!J,3=@0;2`W'<]!3-/UF]GB?->-PM0VW=$_?;M5[=E[_2(<G;[=
MD=60?=@["R`/C1X&_G*U8:PA,/LBIU$L%LT9^+LAY'+6'*(A!``2<O'%=AT2
MU(+-W$(?RHW2MIL:;US5&:W`JO&ZMYW2&U+<Q[VZ7XS3>_$`(X$?:?S%W3W2
MO`W$"E#>18V[GW+'XJW3Y@Q.O2W0(R$2TPTDN0W=S0O1?2W<+8+5]GT17]PK
M9@RSX!S<Z#W?[VW<Y/W5IM3?$![@!AO+<7P:6P+>C&PNXFW'V!TN02$T&J(B
M(-X<YPW7H<'>$6[<(VV]A['BYJV^"DX?Z/W>6YWABAT2!#X?M>S7]@'=-M'>
M;$W@^-W#R#WC$9[?'N[@XVWD(BX1`Y[AY"K@^GW:TBW?1N[<+"[E0^W!_OK-
M%+9])$9LK9@]S[O=R`,@OS31*_^MPB.!WT1-&2BR-G*Q(;&BYFL=U$2-YP81
M%;9K`(H2Z&U^RJ_QW?CMWM4<Z`A0YZL;W+&\Z(/"'[;,W9&>WFG^S).>Z(L^
M$B@"&)&NR[7;YXYBYR(1Z0.0'88\ZE,BL;8QZ'T<)@7NZ:->ZJ]1$2^2X("B
MS9:>R:#>$8:.(ZLN%Y,.YWZ1S<*.+#^=ZJ\^YXQNQ\5>%0Y`$[MBRF:"W[4^
MYX0^[(9NZ<,L[0BRNL2>[-UQX05LZ18"(:NNX[1N(%0"R>RNZ<=>$<\<W&9>
M[]E<R.?>[(-RY]/>*ZTN`*,.'V`2%Z#^ZJ'A_NO!+>><#O#L/B>GSL5TK`!E
MGAYE@MMGOAT/\,4+T!.RXN9N_"#_\1.L2\X&C1`;K\Z6_!,:?Q`6+MWY[="#
M'",B_2(@$=B%W,)F7B55`<X'8<N-K,E*;1]!S?("CLZMZ^(S+60D'^JX6_0&
M&_1,W\<X\O0-/-L9'O('_/1!/]2PK.L%G//_[//6;,A5;\TTS\-I;/8F/]`.
M3?)VC/8/4/2\C,9H'_7ST>A`G_/#W/&D?/1<3]E@[_-&O0!5K^-;3QF'4?)I
MN_'6/!47CO@[?_&2'_AB/?@-_/-^,?=:O_$-K==CC_=&G?D\7\?>>RZ1+_H(
M;?%-(C%:D[9%NS;L_DHS'C,5)[$0&2/W#],QM$\U#^WZ&`/[N]\QN2\`<L\4
M"R$QMI_014/[Q2_WS,\QT>\QQ$\R#]/\Q!\Q%*\R%5/]RS_\SY_[$4/]S)_]
MO2_\K4_\,2'\91O[Q&_\KS^OSG\26</[*C,TY2_]XO_\Y?_]U@\QU@\0``0"
M&'!`H``!`A\\&,@0(8"'!`U"3(B0`8.#"S,NK"B`H<*!`QQV!*GP(4*/'P\F
M!/`@I4N*`P4@&&F2Y,J8)Q?"A,@QY,2(,046I(B29="A!B-^/,F2:%.9*(7F
M[/CRZ$ZI$47VU)A4X($!&UVF',AU[$VF6'?^G&H5:5FX<>7.I5O7[EV\_GGU
M[N7;U^]?O`D$#R8L&/!A@0A8(F;<V+%?Q8\E3Z9<V?)ES)DU;^;<V?-GT*%%
MCR9=VO1IU*E5KV;=VO5KV+%ESZ9=V_9MW+EU[^;=V_=OX,&%#R=>W/AQY,F5
M+V?>W/ESZ-&E3Z=>W?IU[-FU;^?>G3$$\`#`AQ<_OCSY\1#.AT^_7GW[]._-
MKZ=/O[U]^.;CX]<_/S_Z_@!D[S_Y`BQP0`$/%(A`!?=CD#\$U8-P00,;)-`]
M"!6<,$,.'_30/P,IC-#"$!VLL+X+.SSQPQ%1#%'%%ED\4,,49<30Q@UK7'''
M&$&,4$0)O1-R2"*+-/)())-4<DDFFW3R22BC_I1R2BJKM/)*++/4<DLNN_3R
M2S##%'-,,LLT\TPTTU1S33;;=/--...4<TXZ/2OLSL'JU'-//BLKS(`&\"Q+
M@``"4(DR`2;"ZX!""T5(T;D(#0#2O0BMZX$`9"J4*4J)LW0S20MMR-"#&H5+
MTD,G2Q2NKOIT%;#"#`JTL+(6&$R!5!VS52\%"%M@U[IL'2PLO@A((%.Y'N@5
M`8&$3<"`!X"]2P`'.I7-6&09H]9:`)Q-("QC!2.@6\+&;?;67!N35B`#"GCU
M7;\(,R"Q.VM-P`$'$FB@LG7M(L!6`Q8(H-^X;'5@`07F+?;8N1!(@`"6#,ZW
M@`$<R`M;W#!N3.."_N_]%=-G"2C@6X,7,""!B._-=U_*I*4V`7?AE3DOPC!"
MJ-Z!;,U4@0((4$`!B_-5(%.?1QY7Z$P/Z!7:!TY6X`""[;KWW)$7$&#D!A;3
M&8`&%!`(Z:83>-IGH*]^EN&OQ<Y4L*?/S92!A[TFNP&L$Q+Z@#R1!F#NI54B
MVP&SLP;@[L'5!H`!`TY&^&G$%?_Y@,`%(*#=!*P>^>1)^V[(:4456*!;KY$>
M+/*<T3X\`8?TW1KNB;;F^>_"AR[ZX;2'!D#I9Q?B7%IC>9[Y=ZD'"T"`SV?-
MLW0'X&[`UIZ-=>!DXO4U^E[HN_:9`+B-92#JNJ8FUX&JX_[\W%YI=_[D_NP3
MV![F?RO'7*#S40X4<+?W/IO<D<77GN>3&X@_^I$IX'JEZYFM?+:`_?6,>BC+
M%P-Z)3'U/=!CXC-8^$QV+.L)<"#IPXA`N@8`!?AO@?TSH.=*][-Y!6H@B0-8
M`1*&/.4QCP#Q4][('O"_#&+O8>J3U@$.4("8`4^(<+G5[3[G,,+8BVW10AD`
M7$B0!"#`5H02F]<&$$6A66UO^3I8`A2"+S"&$5+>L]4-8>8YWYVK`5TSP-6L
M&$4"<'&*3IR7QIYX101P;&O&.AFYW(BP`C1@7C[$UAVC.,4L:JV)+@2D(&_W
MPS<B(%]T!"&^O%B`>0&-D3R;HK$P:;\`)+(L_G'T'@`<=DI#%A*-06SAOE3(
MKH")+7>E6^(<#=DK*B+`D)(4FQ9)V46X`'&(PQS(8#IX$%J5C@"M\R(E`W!(
M+S[SA<]43+[N!3<Y-E-I/^,F-[,%`#)ZD8]`2U[IB':L3SY3,-D4R"?M."]J
MZI%A!O/BK@Q`3@9\DI#HA"<T(6)-BYV+7?C4YP_[R4LGNHN<EU3H\_"Y*T_6
M\5@O*R4V2RF`T:5SAP&X)[Z.N36!P"UURSL6W)AUKF4*U)FR!``U-5K-=5H4
MF&41)C&'*;QN"8QK231GZ4(:Q4`Q<0'*`RKJZ!8`GF$2J3/52SCMIS8#?-1C
M)SN`20.5L*4"RZ0C_D.655$GS^0E;%>[ZAI'+Q+%>QI+AP@(*ED+@%16-K.L
M437I/;WZ``=X39CDU&M#Y[H^^YU,EQA\:QKIN-2R!&I?7E7K7WLJD&?V+%`#
MT!E&O58_E7HU7T--0%6+^H"C)M4`66WF0(19,9L"CVTM%8R[D&B8QY+K(">C
MG:UZ!3C:CNN*@J$LVPK`/;HX5:WERY:W/B>`W`J+D\U4EBR1A5QQ@9*6SX):
M/;V(NXG2=@#JA&YMO;C;;_GT=L3M[@"Z>[2^5C*O":TD=@<FSBCVJE<!`"^Q
MR"6V()HRBA#)K3K=&]NGJH]<YS072&7+7W'9=FKGA2)OE?O;TK;37<!-_NV>
M!M.UP6"2IZ4:%*0F=2Y,#>3#"ME*2Q<".6[1Y0"<@DBF!%#B4FVJ+",VU`-0
MK*F6PF7$GXHQ4)0"E!(3ZB,^A*R/27RH51TDR*0JLD(,HI$5V[@E#%DQ1+:R
M*DM9"ED/@#%D3ZSC&4^$R"]&\C>/S&$OH_D@'C9(&;\YXI:4N,8W+HM&DEQA
M>.%)4'ZA,)X_HV=`'T\O??9SH>42Z`WSY0`G-71R%MUH2$=:TI.F=*4M?6E,
M9UK3F^9TISW]:5"'6M2C)G6I37UJ5*=:U:MF=:M=_6I8QWIF"UBCK&U]:\;,
M"M>[YK5>=-UK8`<;+K\6=J$1<!$&I/A2R:X+_@(8'1<S*X39SI[+-ZF=:6(7
M&\_&L^]>G%<7?,W%9'+Y=JT+IK"O!133V=9V:E\I@*XQ*Y_HIDO^6@(SE&US
M`,AV(0,&T"N\[3>8AKGJY_[=67'];-\7Z7>C0]6H_#6J4>EJ][MF%<(0&K64
MD5+?MP095`?0+9!KU->S`.5`TR$3;@/H6KX.D+@&H#R$0%RC8IM8:'4B.KH5
M!UZ@9J@`C`"5977QY+V`_@#4'5Q?-4>Z-8\=8?CA.^3[PJ)@GJ[TFC<`Z10?
M9LYU;BZ>S^R5@7QF`,Q=EZYAN%UE!)IBF:XO\`$=ZES#>,GQMN^XPZWM2U_C
MU@U]PQD&/K>!GV&T_L/NJE>JTUUG#^[GG@E>T+(MZTT7S/K&5TS'T\J:Z[OX
MY%%7:78?'GA!X3).[*(2O!8@7PDQKU$2PA!1$20NJ$>(?6,?EM8;I266#KWH
M.ZW.8_J^][XG?JB'7WSD<_KXR6?^I9???.A+FE&&CW[UK7]][&?Z\K,/_E\0
MT"EJ49\NW\]+^.^R:,@Y@/QR4?:@'"#^13W;+HKB%OKI8O;N'R:E<#GV]A83
M%TKIE$>#K)A3L>]3OQ13-O/3#)U+M.YI0-@*#`B<N^R#"[BA"P/[BP:0O\,I
M@/:+B_V[BWQJ/P:8H:KJ&6LIP;P8P<-@JQ4T%Q6,BQ+<P&JK',8[#!H<_K:H
M"J2YB,&0`KN!<$'6HK6A*XL2)`"Z"4$+!$(9],#-F$`*/+0);*HIK$!QZQ6Z
M2!R,0!S&N:>J`I3$:1J"6`"\&9H<?#EH$8R$*$-DN:)]:1IH01P&,)0P=,.!
M0$.D:R(XU)TXI*TYK#PZ-``V%(P]A"*6P4,U_`JUR:?*40"1",-\&IIMBKFJ
M<<0]C$1U$@C!P,-BTI>?"<2/\!\/PD-&1)A]\\+;64070JJ6P@@[]*!Q>:8]
MM,--5!M"#,-)A$4/NL18ZCCU`<5!1)TP_(HP3$0&C,*RB,#@N0ME7$9GM,)D
MB4*,>B:N*<%`LL8&`)]?`:**04(I6J.3^JT%_@BD@-I`6F,7[!F`YB''*%I'
M`TC'=MK&;/2@H0*?&6)'!MC`;-3'H3+'-<JG>P2`=_0W)Y)'=?/'F+-'(+K'
MF,O'GIDZ!E#(=6S(?_2@?-K&@8BY;'3(@`0G^Q+':U3(F!,9KOE&BBP`21J7
M@206FP-(D5E)C31)EUS(D-/$CV3(]]/(>^''B$3(F8S'<9S')T3&3J09HM3$
MHTS&I&Q&:&R(*`P7#%J;!I!*A]%$4B*4_LG!9E(?<^$H?:&:/!0,?7RMRH&9
MC]C*&/P\<+JP8_/&&708V.N?$DPBYF$(M`0[KP1'[`E+L70V%6*K#=S+PMA`
MMHK!N=3$#?)&MN(I_@,XJ2O2Q,!D`*2;2G!JJ:ST2U)BB+KTH)CS(E\QRQ+,
MR[E,(B%LS*$@#!J<P8?90+443:C<2DWTP<Q@RKB@32EDQJ0LRF=LRCJ+PFPL
MS`U$JN`,(01X&KQ!NDR:(7`4"./D2N94SJ\Y@)@;F@?(1[8J3D.)2.GLH.:,
MP=&J&.JTSK=\R^\4("0LP?`<G.T$(1]RSN=$PLA$NO`DS$!9-+V43+6I3OHT
M3)]IS\2DS_0\'(LIP_:,3WU!`%8T3W!D*\N*S@+DFG&9SNRLEH:\GO/TF>SL
M+"&,R%2<3WE#PM5$@._,*^5$S^QDSO:43<RP3:4T2MRDPA?E35;QHG!+_D;(
MRC@%6,P<#<R?&9?*H:-GR4&RP1YST3"%L:8`\!D;O$XE70`DA9\>C<'B_)8F
M-<<#?<LI39QG*:$??=(A]4$C-=`JQ<Q>N4^D&U.VFJ,2TB`U(M,?A8B?@:,>
M-="K8I8P]4N![*`GA=!4;%(D!9B3B:4F55*6$8`XS:,'HD%;\3G"[!5U#%0N
M'9\O9<++8%'=C-$'A-'=E-&#F(I./8CER910A0C(>JZ0\%11^;^P6`RB:"D7
M(U57]0H1>U41FXA4-0E298D/6]7=BSV)F%58/=6(J(A8/8J6@AQC38A;)574
MB]4Z,U9?E=5EK8A1'0JA2`C;D=5@5=8VG`B&_N!5V$.625%56Z75ECB))I.]
MUW/64@W68\343;U-%XU73L4+!R"6>ZVT?*V+$((22T7*><W4@`VNW*Q7@Q6.
M?UW+@9V+A+U4@CU8NZ`ORK"_SQC`LK#8KZ@+:JD8ZOO`RL@C@P"_][O#]9,+
M_'L,)9R_BYT_9_/8RN"6DMV+A&U8A:57AEW*@N54[)F,(W19R1#"L@#:PZ%4
M(PPD)Y1!HM4,_ZDJ2F7!H<U!:+/!(L1!#NQ!L%/1N&"KE.4,K/6@JH77FUU8
M>95`L(58N,`>3(1#3I1#+R1%0#&<RIN<.%Q%N&##5V3##FS$1YQ;2?P9K<-%
MOU5*3FR)8AP,/-Q#_MC"VY`R@.>!EGFA+%[L'\*%EM-<+"\,E$R\G<)E";'\
MQ$+D4ZXAQ4H\Q>:T'4STF@!PQ:\DQC@L%+CYEI)#N*'!Q/$*(<19Q9<K@&-2
M6T@<W5)T1-'-5D/<Q##<PPWL6H%-7IMM4;&MS9R54>RAR.5Q((S,1JX$(H,\
M)%?*1\\)RHN86G]<R9(\QX3LF844F9.,HR04F8<L0DK$2"?"R6R<R'I\4'_,
M2'MDWVZ<R.=)QW5$1W\;R4`"J@X"2:&LQHU<WY@)+Z`,2?,5X/L]R9042'@L
MR*#TRY@;2/7QR7R,WZE3'X=TTJ&;WNYU8/2-2/,UX.]=(1VZR*"LWW;I_HN9
M+=@9UE3E-=NSM<[%M$O$U,>UV<K@E%S5A$P\G3$2,DO+_$H#14V_]*+%),TB
M/,S*7,NX'<W!^(@8S,N,),NK9.*ZY*FZI,R2:TO$!"<?Q%+C:2;3A"(B%DPQ
MUF+ZS$S\.4LB+LSV"20"R$OZK$S`C*+%;*FA^SP@SB/\7.(Z'CKF$2&D#$7:
MX0LH-$H(I,)(QF%RTV%!HJ_F+,GA;,X-5-"GY>0B'@@%I5",\&0#]=#%M,_P
MU-`H[D^\8<[L+$$3K<X1C4%/]MKP1$X0RLX-).4`)>7A#!0R9D^\.6/%+*OJ
M#*D!%9L")>3)1-`>1<*29%"Q<5#N;&8[)F4+_EU0JK-/86:KL1FZ\FQF-W9F
M9L:;/;9F5WX6^@JY"W3D*L3-29;`>:;D4;+D*1U2318;1!6@#312<O&?.?7+
M&@52QA6,3`%H,4U4-Q7HRB'4&EU3<VE26?ZYRIG2WDH(@/;:)@6GSQE3).WH
MPL$@?A;F.9K4THGC!SJ(0QU2.N5GA<;3J$H;M!G2<"&I6;F<0-UC0OUFUEQ=
M4^H5ES;GA?;G4+8FH^E1C.[EB%0W>[:.83U69TV(:EU67CW78CT(*2H+7FU5
M=8558IW68^76(IN)RPO7&7M57157;Q56F6C78+7J<N5J6=&II0#6_\-J4HW6
M7\WJ7*U67C56X?5J_F<=GG4EBF^]UK(>UO<[QUKUZYL(:UHEUUYE:[#>ZJ=.
MDGT]#)^=C,Y6C<T&C="6BW[]#"3Z[,M`[<Q>;=:64?J[B_4KV9CUODZ9;;VP
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M?6_L@&`,[M\`QF"9S$?[=>$@0IT=2F">3.`M)L+O14D'\-$SE9_DH1MY-,\@
MDEX,1F'T'?/S)4=D,>"`,N`VATGK!'..G+K"#.&:I.``/G.$S%],JN!L9%^&
M%*D=>D=$)TF*3*PJ3\(_U\?OG=Z0\V-)!\>3%.'$RD=!?[]U_-_Q_<<];W(G
MMPXQID\K+0#0\DL]]DO^A$T/ZI\#!4RXG.:A>W6MS1>&$*22PW4@WC!5IW(W
M#HO!9+2[+.-:'\FZ#,W+_&-;I\]H8IDP=O7+_OQ,5O<@8Z\9)*1U/<-U(UZZ
M)C8EEAG+'?8@3'=B31]WLS/"8Z;!;T]B;E;W4]^.8*9R8/9+!=U/&%SG@=">
MG:3R[TQG$%).^FQ0^\$F7.?D`,7U82]G:>)E1NM.<P'E;-Y.]#3X)O;FZP3G
M`Y!F]8Q)<-;X\"1EKXWXZCS"CLNK[$Q/@B]X^-QX(33W2ZX8GV9EF@]G=Q_V
M7:[.`-UWF3?U>I^..KWI7D;HF[[3-&TBB<9QC.KX!2V?4%;Z?9GI5'QZ7'=I
MD<YZL7SI'!W3?X_2B8YFL5Q4A`;4(&UHFD<BED%2^KQ3/T5H=/_Z![(5O'GZ
M05UI^JQ1JB=4KZ7/_J6^Z9Z&>K:/Z&6GP;Q_T[XOTZ'/CJJ6BKXV;'4UUF;E
M:V(]"EV%G$^UUJ@67F(%ZZR.5FB%_(X(,;_&Z[2&K(?XUK9>56A%5K!N[*%[
MBDYU?;CV:H\0URW+5;B.O:/`[,GOU''MU-??ZX<8U\\//UH#?IX(BMB+5MO?
M:\UO_.L8[=DH;>DX;=98;L`X;>ZG?O`/?^)S6=5>OP$,;KR(;64[?]XN;]76
M[=1N&/)GM,ZFV*QM/_N'M@=UC)3MOVXS0(``('`@P8(&#R),J'`APX8.'T*,
M*'$BQ8H6+V+,J)$@`P(-.TYL@$`@@@8"15I$"8#``84E!;+DZ/&BRH@,_@JT
MW'@0Y,&:"U\"X/F1@$^",1-V+#HP0((%#4QJ+-K`@(,$`1@"U:EU*]>N7K^"
M#2M69X($!0#@9(#`@($'-Q4P3:``0``&`L^F)<#6;8"Z(@\H4`"U@8($!Q[L
M'8C8P(&]-YLJ&$#8,(.Z!>`N?@!8L,#*;^,V;BLP](.@EP-D%C@@P=/`5P_(
MK4LU,0#2904(7$SZ\8+(O".3-@U7->NRP1>+Y`D;[N?-4(W3KAV[<MVRA.'N
M-E"Y0%D"J0%8=_V]P4R3N[GW'L#`@((#RRW#G5N7P6JH`,C?9[GW_?KK]L<"
M&*"``Q)8H($4-<!``@\D0$`"!A!`0`$),O#4_DT(.##3@@T^N,`"$R)0DD@%
M$.#`8!D60**$`S6P``,*>#@A`PZ0."&*(E'8@(HIECA820Q4F&`!,=Y%9(X[
M"@2A@@Y4>!\"3C5`8X1GH15CE"RZ"..'"4HI8Y=#?G@?D%`IF<!-1KHX%95.
M0CDFB2:>=&:8)SWY5(@61EDAF#8F@(``JQV`I)AYZCBE0`D,0-">7-:8H(0B
MM:DGAAXIF>A]924@P*)U1OGF?P>"&JJHHY):*D))&5`<IJS=V5&)"YZ4:@-E
M'2J2B`@D``!0#22Z:JZ'EO8KJP0PP""OX.%XIZ^Z^FBKH\(>&JVSJPJT@%G.
MTB6K2-2"=ZA0L`HK_A*QQB(P+JW=8@N`M1,Z&"VLL\Z4+6O3,MM9N]T*%("V
MK1*E;*TEC30D>)C:.RW!`!@P$@"]_FMN`U=9M6])KY:V;FGW.2"9@H?J.R^N
M]9H:LL@CDUQR1:Z:F8`#F%7(KP!R#>3@DNW!YNRV!^R*`%,L#V1```/0/&RQ
MK#*5;$DL&Y:SLQT%+5#3SO(,@`,'V/F2`A':&7700OD,M'M"DVONTW<*-+6C
M37>=X*\`7$W4M#A#Q?37`[5=M:-0?YWLBFRC9E=0_1[==V<.2,=VWN4.+5(`
M@6'M[,MS24VUW_@ML/+7==^<E<F;<]ZYYZ!:"]O+Y1;FU)W6"J#=0*+W_DD`
MXPYZ[#IK)\E%>E,#(5"8ZU>+FWCM1I-7NNS-GMX@XS`=[ZSL"Y2-*=D%I&J`
MN*4C?[50N1O/.^)A#[V[1^E695;V'F'?)Y-W1:]\85!9Z_U`T#\(>XNL3LQX
MLI@R?;NZ]`>OOP"!]6DE]MM><12``/A)CVRJDUI9KG*I!GH/@=.;W><J:,$+
M8C`CI<$-;NARE0[BIC3#&0@'\^7```@@A?DZ``@?<$('+J4E?0$`"&DH`!?2
M,(<YG"%=6"B0$N:P-#PTX0^+.,2%^5"'B5*A!PDRPP[&L(DU9&()>5A#U;1$
MB#`,0!*AN,0:<A&*6BS($NFBP@>`\8-!?``:_INHF#22,2=2+*(`6N3`+Q9Q
MA$@D(1N7<D<;KA"*&1PD(0MI2(=PYI"*7*17,J:01#(RDI*<)"4K:<E+8C*3
MFMSD(`7@@*L@`$@C08`<$5+*A)PR(:1$)4-P]D,'D'*57)%E0W#&0EBF<C0*
M\20,)^)*A^32(+\D""U1J3!C!E.8Q92(+7')2DY",YK2',A-6C*5%T4HF7]C
MB%`6HA1[825N)*+:,;7RS9UD\R9'*4@W#5)-BVA.(>U$2#R=%$YY]FLHYQP*
M4<9YJGA-,Z`"9:1M,I4?NIA)-@[82V:@TY;U+*`^AS),=.J3&9%DIJ&_XL]I
MG#/1RF"4-N?!#&TD_DJ=8NWE.@[,J&-2E="RJ&4_L2G+=PK:08Y"9@"9:4Y@
MA)33G9[F7!P=CD>E`Y?)7`X^7.SI2!T8'I**9C1[>2IJ6LH\`&3&JC"%:57;
M\AZ:[D6B`QTK63VW*,(=%%DED=*C7&0B.=E(7\1*E)"(E"1B0>A1!YQ2BV:4
M(#I%JE!PPEBR!+4H-QD*87.UF5L)=1*W[BA*9L*1B9KB5TZI<V]G91%FO\17
MQ)J(41**[)C^RB8+-<E3@'W*C3"KIQX=MDF#8E*A]E:E+56(MI']Y&.Q^:A/
M)FA6)BI)8S&[HTJ5-;G*#9FP>((?M6YK51?K2+A&8K&_0:M:XL-4=#$U_MV9
M=,QNN0)*4@#&K>J6A%L6F];%T@6K@5DGE/U*RGO#2]V#-3=>X>T=@U9%KUN9
MR[_\RI?$3#)>J.RW5_OU5WK_15[`S>I@^#(3A`4\$'!Q=R3T[5=]977?LEQW
MN2(><8&V5AZ/Z"59+.L:DUQWN,C]56ZP&8C9K.(6D:SX9RUV6N.4!;>"`4QK
MAPN<6\HF.6>Q.%TL9EERYDL4JPQ@95ACFN`,!QNA8(Z`3/8Q@(>VY1_-),LO
M21I4LKRS'J<7;D%+5WF)[#<K4QAJ?:M)U[;\-WB)9,E3=EW?S/9F$@,ZT%[Q
MGG,Q1<X)+@![`VC?`!EHE?VYKWG&:PJB%8TZ_K2D[T[#`S*BJP?AY4DZ`/)3
M=+H4O3Q(L:J\A1D``AFM/T+'2X($/+6FU\??29N.N`:5]4LVC>D'S<J`O.Y?
M\+0'%&NI3W\"O!JR:TWI8V*/UOO#<XA6W6I<AZ^7@MXVMS'R1#Y>#(@\Y&)N
MYHA%Q;AQ(`.0H1K=2&ZLJAN0.^QB#CMXQ&_OL)?KSI<*R7W%'A*Q@VVL8D[*
M.$8_ZC#>5,RW#G$3QBF:.X0*OV(8)X[#A<G;X3[$MQCAZ,25PE&0`,<W5E5H
M[X('T8W[[C;+6^[RE\,\YC*?.<UK;O.;X]QSO*S(,&L)3)=H<S3E!/HRZ1GT
M@C2SZ*MSR,XITO.%_AP](JML22J??A"K$\0IEC*ETG/N]:]W!B<5J2=2`%IV
MA>P3=Y]*2+(:DG9V8LV?Z'3(.RE"]KGKA"4=F>?=B;GV@?2F-]JF9C;!;GBO
MV]2HEOFI8SK:T]_HM/'#.9=4'VJ`JSKT8N]!ZE"7*IBFCB8V;5_8[$Z*'-<H
M9B]:35E",_/5!865@K69JD%QFAZ@8N?QZ(D,[N.RNMB(-2CL.4Q+(5\9Z>ZG
MIYWI"Y`<+YB=7OXDA$-`Y-NBT8Y(?O"'W_ZV-WM:T?+H4:"UD&?%WR33%FE+
MO!73GE8;);T&UE.Q]1&4`'97^C`VM[*]3Y;X"MP*J0R.%%>;'-=<I9^-_KC?
MC-0(:;U6:"G@:'U6D+P9I$R%`8H)!/Z6F70)CE1(9O'(8-G,^.V6`\&&F:`%
M7S56A6B)C.P?][F@H.47@<7.T`A8@W59?V782W13=1%>=B48>"R8#<Z*@R'8
MOJC$>BE+::0+>`1+AMU9@VS+Q=@7[("865Q,#,J+G018#@[A#?K*TNB7K(38
MP\!7?-U:DWT8K>3,K0BAA>E2[BB(=!4,>OW="]IA<ID8C[F-ELT9EVFAE_6A
M#@+4FAV3C/V*F<D%FLV*F@U9F?682O@9DOW,$M99'SYAO^@945"96_B9TWP-
M3V29V`3B(GKAESD*W6!-)SK)XFS9&<K7)BK(_H\Y"1N2(F%8XEU8ERVZ!8LE
M!2'VW1T"8T#!&OH`VZR53K+](8/0VDL@&UIY3TTPVM40H_34SK`-SS.2S:\E
M$"1"4'P51I]D1;0=HW45!^!86_2X6N4TD*?QA*R9RS(2VZW!XZ5I8[;1C@'1
MFBM:BX(LCZ_)#S)*6[[(A54LCZ6Q!C;^8C`J)#21',8MG,.UF\8]9,3EQI,@
MG,@=G&K8T,7AT;Q!9,--7,+MD1E)9!%%$<FAD;BAG,3QT,H%'$%T9!5%9`]-
M),?!F\*-)/^]4+W1D<#!V[@E$4F"T<:U&PGY"1$!7,E1Y$(R)5-&75-.A"-!
MY512955:Y55BY8AY_DC,X,96KH0<_1E!-)TMT9,H&437`9,#3(W=Y40`H!_/
MH:6N:-\S$5/0/=W1Q>4OH259EB5]U-+0T=#ZA9):Z(I=2AW5R5)<9N5B'@B-
M7`E3/(!C$L[:J(O9A5U+E!="7),T$L3;*<25;4Q(C`130(E%N(HV/==0&,3;
M:<X\&<0Z'43._-,^3455S*7?N9/8W8=VM(TVN:9"Z%T^?25C$F>I,(``,`7"
M+,AQ,L6X)-_JT!YN4-5X>$1R7I2#P`5>'$!E\,=L1-7Y!`7Q/=1I0-\";-Y(
M/)=Y%-_P98=YSA2%)<9GG,1,O(=V5L:%4514(=5WU$9/:13T&9]2N9[R_MU'
M80`&7?C-=$8'?I`':72G?U1>?W40?C"%9W@G&]%>=LC*^Z#%=OH,57G&:13G
MB#:F6E3%Q=`64;@5OMP6`L[6:^W-<^5*9/6)4VR(@]01I[`5E23,2K`$`]96
M7%$@2B"*HEA)571$BARI6V(681C)F,SG:MVH0<5)^V$,!JZ)_'W6;FE@H_P(
MC'[@B8S6I,0)H0C*`V7*ID")E`R6]Z45JW0*"OH57$4)<C$AAW`@H7!@"Y)H
MGXI%F*2,781)%-+-%7K+3+19A)V+C)9AGLV+K.3*@G%+`?@)O-2@HK)*%J)$
MCV)<=9'AN63J%`XANF3C<^T7I,I$=AW+LD1+_GKA#Q7"*0$!S[+L2J]0#)"Y
M*N5%B<8(BZ2"#!:^Z?W((7;]RQA":I/9#,`DI)\R:T:L!6Y,B%D\JY.P&'AT
M4![>V9U$#7[H!=_<6-W(C,JP38]%S9R0B"G:698%!>',&"$J3F"\6-WTXMRD
MRW.!:\J@E;TTS2K&1I$=BIKU#2SJ3>(HJR[&8LXPQ>,0GISYZT%53M!D&9EY
MXI7%"[=N8^[T#2^Z6,U@B.3`!+XBZYT`3[.2;%=\(Y4LR,EZB**QZ#!.F[-=
ME:*VQ*DI0/2P3L!D&JC=15DHP`/`H[3)&@T!T$A@8["1CO9H([*Y3[WR+`+=
MK%IJ5Z09K<X*T$&6_DXZ#BRY)-L"^)K1(LR;-5O]*)NBBAKCN./ZL&/%&IK>
ME(Y!8J,]2L?HH%JR+F')VFU&W%`;U1L;"4!C`!R&?)Q(ZNU'_E`?7:1#\J1&
M,M$1T<76V23)=>2YO:0=O:3B*J45F63>XD89E9!%EML0W=!..A%1?JX:31$0
M$6[%T=#%Z9%2,ARX(9Q#GAP4-63>TA%2OML8=9!+\J3`@1#JWFWPBH5N(LS%
M!)14CL53C@HD"6_S.N_S0F_T5F73.>M38IWT8F_V*E?=981GDD0=:F_XBN_(
M--5WR`=*>=5T1-_LM<5M*-YZM`?\>NA4B(8!+$RP,6F$A!YS.!_XCN___@+P
M@<R?84U*9.FH`WG?D":IH]A(^Q5`E-6HG?"0`C>@_P;P!6-P6-`AMU#,JBS8
MA1VJ##X%Q'SJMD3+JPS`OCA1@1U8!KOP"XN%+QKL#\$,RZCKQ%*8'DJP8.@,
M#S<-@[!'CQ&$F-4B#!OQ$>?=`(GM57UMU7Y(IL4,X[1C^OS.[QRMACQQ,4*M
M-B(C$GOQ%U/$X_;2"+6DO!VNPE$NY=H;#.TN('FN[!I14(+Q'--Q13#O14@E
M\CZ$\M9Q'_OQ'P-R(`OR(!-R(1OR(2-R(BOR(C-R(SOR(T-R)$OR)%-R)5OR
M)6-R)FOR)G-R)WOR)X-R*(OR*)-R*9OR*:-R_BJK\BJS<BN[\BO#<BS+\BS3
M<BW;\BWC<B[K\B[S<B_[\B\#<S`+\S`3<S'3LE<:1,,"DV+&I6)>G=+EA#,_
M1-%),^[(433G$O4B$T;PI3'WL60>A+7<ICL))]L!IE'P<;:2,TRD,]H!IO=R
M%CC94VX&76::9N%Y<Q\S)V7VC.I\QOE&J():7LP:Z$F9E`&(:&;41_!1U>LM
M7_#);W_$Y_!!'XXAZ$D4M/0X!O,U1@&H(%PLJH%B58:VU$)%E4`;+^2Q5/LF
M5',@=%CF\PN#IUA:1:X<"9FV:'#IEO\YT/N!2$E4RJQ`:0&NAP7J=)!@%IW8
M*0-WRI-BJ60=$$[[_G13;\F=#$EHT99I^?0)_M99"<I1!RF+/&#XD75P?:F.
M5(X%Q_3XSDE!4"&33LR)1@MX)*H;WD>O.,MZ@:.!8<JZ5$4!?)>S3"%@6>%)
MD/#'H`O$")BXR/5=J]4&TX7=.!?#K`IU_0NWU+6$W9JOO.JL1O9:P_"TKB8L
MF75)*"P.)ZJ=T4G1W$DD[K6WS@C5-(#'9NO1[!F=J.*[XAB]]G`K^@G,K#:K
MR'![["&8!3=L&R*.55EJ5YF3B*);L$QYX0U1@/8+G^P6S_7B8,L"+1L!A&W_
MF`Z+U([\9-NLD,WRA,\W.M!W7QMNB`3<&NWT2./4CN.F3J`5>\^H64=>_AN4
MURZ/JPR0SGXWU<JC\%QMK)H7:V!W=0.PYC*1268<WP2NZWZD((4NOVUN2RR<
MRK4$[PXNXH:;Y.JD#DWP`NPD$.G1A:\QAG^24]10N%V<N>';$7WX$4'<N(%<
MP[5X`SPX@_OQ'1.2'A>$D!<$D&.%<5@0KAB&CS-YDSOYDT-YE$OYE%-YE5OY
ME6-YEFOYEG-YEWOYEX-YF(OYF)-YF9OYF:-YFJOYFK-YF[OYF\-YG,OYG--Y
MG=OYG>-YGNOYGO-YG_OYGP-ZH`OZH!-ZH1OZH2-ZHBOZHC-ZHSOZHT-ZI$OZ
MI%-ZI5OZI6-ZIFOZIG-ZIWOZIX-ZJ(OZJ)-Z_JE+$V>C.C^;.I5CBF#H"*JO
M.I9C"D"%CX31D`/U[4.@T`_-9:XS73O'NB//^L(0P`VQJG:1(]-14&._T@%8
MRT.@SEH&^R8/^ZR@T+'OC_T^NT.,J@*LR<?J&+1SR#A/>R0/>P=9"[=H5XW^
M2E4,AUZ@1\P@"FPPC[O'A?&L!$(WA::P1GL`WJKP.X^O1ZKT!LT41E25NR$/
M>U_<T#=2WO[4[+,[R$)EBK70R-HP"'4=P,1'#VL\N\6C1U.D"@Q9BQ@:CSJ^
M2%,$X-5P9L(7<K7?#J9F'8<4!EK,Q6H\2:;`SH0@C/3,Q660GH,$P,?KO%G8
MK]#_N]!?1F\40%5@_AK;J*5<+(#(N7P@#_L`>`=:J/O^L`VM0`]"Y?Q*#.1<
MQ"'A?'US6@71B_W7(WW41HP"J.6,S.A9P+TGE46^5KT@#[N\;[W$TXJ"I-<#
M^/T6E46B`+ZE>G>N^'VJZ,6CN3U1P(5VK`Q:T+V)%,#B?'O>`W*K/\54</;,
M.TVNI$YW<'W;3Q0'N10!Q(7:.T@*#R3)U[1AJ/?DIPC4KT;A:_X@I_KGDU!.
M:$84T9"&:YM[C.YHL)"&"W^).#N5!G]M:+A.8546E<9A8!7TY[[>[_[6$\CM
MR][U4_G0%[OWB__X`V,`@&>(:(0GS81;R)$`'.</O7]&J`=(5#/0(5V`_OS2
M]1K=60([J9@_3`,$`($#"18T""#`084`!C!@0```@@,+*1:46'!B18T;*68D
M>-&B1XXC298T>7(@`@8''C!`L#`A@I<46WI,F)"B``8"4/;T^1-E@`0*$A0`
MT*`!4($,$BP02""!@X$/$CP02-6J4@8&MBYH,-,G`9$/E8Y$D#0B6HY?#;(M
M^W:D4*)&E2XP0')K5[=AQT*$6Y)LP;T#!_\U?+AB@Z90U1:T"\"!5(I0)=M]
M3+,J8LV;#S90`(!`4L4*5BI0T+``:0!4"R0X8,!`5@&>7R9(X+=U`@`'AE;E
M3;1!@=BP'PP@>L"X:XUD0W]]0/QW@`$)&CR/_CUPJX(#>0,P2"U4-X#/W5_'
M9A"@>U<`WA4$L/[`:('M.*,?,-W`OH(&7=]/;^"?L./>^ZH\^`"0[SS.@/(,
MM`9F4T"EU+:2BKT)WZL0`-L(.&XYB)I#`+JA$O+OO:4,T*ZK\]@#3Z#Q&B!N
M/?0<,L"I]PKTKJG3<%S@M`N_LPU`@3QS;4")B(MO/@65]$FQ!AR@[KWW;%/)
M(0E92X"G`VT3R+8I?23M-]],0XTT^'J$<<DT-:*.(,6>1*J``IK$\L71XJ3+
M,\4>(&H```1(@*D!\JQJ4#?O%,Z`_6#;;SFN:/RJ``((D!,!KPP@8"M)Z3KJ
M(3F?/,LAI!@0J``$_AR8=($%*#W+R83V8R`X3:NZ#4LA*XW5`5R1<B"`2">]
M-%,&^CSJU#@UA335UJB"*DLU2V)32/VH4Z"U)Q^L-@$#[IQ3`*(6';6BO!Y5
MX-A;`0#VTDF%[+35KUX5E513FU+U*)EV=74!!APH(-G]]IW4WTB-!3A413$=
MULE)?:647U5G9=;9B#4:S0#J#CV4J`"0FK/.S/X,5+S>>MV6NFGUS#5.CA,M
MZDZ)71XHT=WZ1&I9HJBKKJHRN]Q2O%$34"D\J*HE3:@]S[LYPRZ?_'GIF?[<
M><KUN(+HJYT#J+B!!8K:F;"$J#L+;%#](N!)JKC\BM69T%:LRQ=+'NCJ_K?/
MTBWMI&W3NH`G"\CJ/[MMJ_ILK,-[>:.8D5/M;ZBP0DIQJ&FNBJFF_80Z:JG)
M8MNVN)/"F^NCO&;+77L#(YMGW=9V*[,,ST8`4ZJ^:MUQT0G`F^\^8P^/.L$)
MWSU`VZ2E'%#3-Z9*9ZN$CFJ]X/U^G.BJDKN9>'`[YUW-0!4["F<%<H6^*FVU
MIE9?4AL0JKOP\O2VZN>J1DJ\`O355\)]/[OJ@?KM7\JO>MMKB=S0'#A`,>X!
M5[T"H!^PK2TP?_J,=GAS.K79:W\/"9YDQ",IQ1Q@;AA$RDLB^#^D`!!<7Y&+
M`+_"0%I%CGKA2H"@BC*^Q,WJ`8R;%?ARA;.6_@!*?O2S7_VPDS_/"+!_2?%@
M`@1HJP*"+FS[\8L"35BONIU+.@XPX>L8X#K655%$+4$@V4!HQ"S""@$FA`H*
M4_@RI-@F5S2D(5.P][BB:,TJY],-4]A(0S>F3WM-PAEU-D3#,J:I6U%['-OT
M8\/I:.AN`@&/4=B8(:<(!0%=>D`D_Y84J#1E:?JRS0`7$IAZ;:@IPLG6TD#I
M%"$-Y8!)U%J6N`(:TTBJD@\\2REY\R>PB/)2P`'E!EV)2=]E[I00*N7K7EE+
MIE'PCP,)Y,\6*</%-:!QE_2*#;66R0X1II2XA(R&B&+*T8"M7FM;I4"F]DK0
MQ%(@85QA'T-S12O"_FZ8]M(:VW#RS7BRTYBF0F8RE00GKD#S;M+4VC0?=\G,
M-`4A1!SH8N[V.$H2RG<.1:,T^;FD`61$`#RQR@`RFM'50"9O6$(/08HC$(]^
M]"H(X:%*'W#2D2($)R^M2+/\I$B<](DG%X5IFQ:0$)[\U*0H%4],8]I190;U
MI4`E"$X1<@">!,"IS7JI3G5JT@<0M:8[K>E/:5I1AF2DI![5J)^`:I61>C0K
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MK&`($^3%+9:Q;V-\2HY2)SIZ40E$_F8:]Z#I*,<ID'PDQ277H*G'^T-3B@B@
MK5%YICTU+HB4!T+E-%EYQEF&K92QK&4O>U7*_HJ1X`:GR:L7X0E6#H#5P@A3
MK(9%BBA9VL^;U^6D-6M*2&96P`)R12Q8,6I-*S:PH"76Y2\?^H]<)C2B&9W,
M,$O12>/#&NAN@[^U3:]OI<O0`"7()4O;JW.41HAH9'?B0*NXT:EVK*)5W>I$
M+_HHESQ+$$'7R`U#L(A>-.$A>]C$];1SUKD&G79"XT0EFKHBAN:,LEW=[,VP
MVMG1+C2LH9FKL^`2B6H&P#SM54K"H)*=I\F:0+3&3G)_;9;=M%6]_F;L<28;
MUE6.]Y7G+6U[&P;:]];WLV$=V)R2-:A9;2E2]>HGQ.Y4-E/1ZE4"*U.[\LHK
M6;TKO$^-X'KO&^,]_LEWQCFN%&;#EI(%1C9%/HZ8DG<<Y8-.<<I9?I*3LQC+
M+_^+S%N.\HW7'.<DO[B78[[S9?L\YRV_>=")+F_Z.I57)Q&P0D0^D(DT?3?W
M!;#&ZTUS\0*]Z!T?>M:#+F6Q>`?J%?9P04!LD(>4W2)JN;5/>HYJKK]]ZV^O
MN92/5JOQK(0XY^F.B;1#(!&MR,@%^J^(=O8EJ-Y'WE#^\75&<F#B8EWN^HY[
MY%,>YK-(IE3%ZI>]U@4PL$TS5.NB<[U`/^=CA2I2?:ZSFF.EKL8SU^V4[SJL
MK2[[5%M^=&7#W=J$]#D$:([WO\:=(K%V=H.B^WIG"3&HNR3AVMN^T9.'_C[&
M<;_$H8CG``WD/`$-2.OM/\37031^!"^MP>4'NR7.A_ST72U]]M^[^C`;%3LO
MB99O0JIBB=I^N<UYH/QKC2GB*=V@9=N0S]LB[/G>C^=H;_T4D-&D3*GP*K'V
M2LYZ"JX`+JL^:JV8RBK,BJX$RZE(JN$*;L$2T`%GS/U.L-F4C;8H0K9.T`15
M$.884`8S+@9KD,)P<-]24`<?L`%[\,%^$`AG<.6&T-FHS"M6BR($#"3JBR'&
MSNF63NN$T`@1D`:K<`5AC4=XA`0/@L36[2C"HP7)3E+"SMYN$`M_BP?34,8>
M+2(:XD18@C@N!"K:PRT4X\:J8PZ)8Y.ZXSM>_L-]=I`*V7"XUI`0)TS*>`-0
M.$5ACB5?MN=6[A!0&&-A%F8_W`7U^`S#H@T-#U&W#-$3&2P1(X(TQL=O;(-O
M0.1FU`;2M@=X;NW21DT00S'ZKI`6OTS*2F7;-JB`(L@`HL@S+.@.9>V'^$>`
M8!&"#J#8)&\0;Y&W0-$9A4O*Y(*([*F;U$E0%"#_AM':H*F;2HG;UH:2G&2?
MLC`:<=$6S[$-XTT`$(`GYFH"H:JF<*I9_$VK7FK@'BX`O.*DI*T3U7'5TA$@
M$7'G7C!-0FX6!W(=BU`AU:\AIZP9'Y*TH%$B;>L?83`B*[*B*%(C7^LB'?`C
M._)E.%(D)S(C=5"^_E)2)5>2):.KO5H2)F-2)E.R(V?2)F\2)[_K)7.2)WO2
M)Y.K)(-2*(>2*(O2*(\2*9-2*9>R_92+*9\2*N?.*:.2*JN2&;M$/VQF>J:B
M"PU"`,SP*S="`+HPJ<S0640+/0(@HT0B+)6B+97D+1_++-NJX`XNM^+26<:R
M),;2/1Z+!,N2(_A2Y/`2*G=F@):F^0JB-;I2`/ZG`#5":S8"*O1*`"JF*`0@
M,DFB,>?R)+1R7E`L,WMB,T/3,#9S($@3,5#33QS3"XGH*H@""N&2-;UR-AWC
M)&E3Y":3)+3&-ABOK6K3)'333RRS`#!SYW@32`Q"-9^R2XSB`!:`)SRS_B"H
M8A$-0C>7LR`&H!Q;4Z^@@G0(0#M+0C@/8W:RI:=(,SS#@HC2DSQ=\]P41#7'
M<\3<,Y((H+&61#X)(C]/\S;GLRO/Z3\5HIKTQCK=$R6$TSN?!#RW\R"JB4?N
MPC:MTFX@HF(<0)T2,R6&8GXVI)>VA'.<XDG:PY6(XC.@C%Q:PT$$H#4J1J^T
MQAT78``V1$6G11FUI2F>8R@FHDLX=$/ZR`%FU$'L(UNR@B.0IP!;PRDV1$A]
M<TE;"D5Y(D05\3;F)T0#H,F0E""VHF)XA-@^0TF]A3H'1VLJ!B*`E*:B=)O:
M0TMSI$M;`R)6Z4GMQDQGE$6-3#NJ=$0E0S5X_B1-$X)'R<4T]-0I^+1/N\1,
MY4TW\/3<R-1/XG0@T+1*_Q0T;-0I#/5)Z=1`-T)K$H(IZJ=BM,-2J:-9<)38
M*+51L\4]710S8_0S@)1<3/7<7*55GS0SJY1<"F@`C(-(A;)+;*>X!(-<7#,R
MQY1-JLE-HZ)BC#,WMFUIW'3/!JI.!P^-"A!:%2HJ6B,`%Q%KAK4IBJ(\-\0K
M`#5_&JPRKE4WYDE<`Z1'^6\!QHA:ME4W**-B(J<U".))&*";HH);@_%5"=!8
MJX)=!\)=(P592P9?N]4!YDE9%@I<SX4ZV+5:ZRDJY!5+\,8O&$0_*-8XJ=5;
MH^7"SLD!\N]AI]24_AP6H$*V5@IP7P"69`464*B%8MF(6U?69"&V*:*5(S;U
MG!KBA."U89?BA/Z56J-52J6"6^UB:VCVW&SF34DV,BDV4<8(7XVR2[SF5Y7)
M6Q>16Z^S*H3F,Z:C4BHV/*:#/7@D3NY"/@]`BCY3.`!TE2:3=*1B,H^V5E+#
M;$,4.J\B,O:6;SW"2.%H;J-B*/)6(/!61?>,6EYD-Y316@_D:WM#`,;S2?Q/
M/!+V7`5WSR+70"-S.@;`;JF%,.XB^U*#(7J#<K5GE2`);Q#7*";S<\\60)^"
MB$@7;-\M(E;H9VCW9^BV62+)=QVW=%V7=5VV5QYW)CAWA5XW=!=7=XGB_C'?
MEHB$UVS;5CX?@&^O=R)T%BKZ)&ZE%W0%]DDL5W-[!6T-5&V[*3*I=VO&]]R0
M0AL/UVS3]W&!HR@,@$%K,FJV%$<Q]':Q\GEI)2&>MGX3*FP?<T_NXD0BPSO*
M5Z]@I47X98`#]YPJ%'DD>*'(27O4K#&G=3=,PX,_6*_^-EZM=8.-=#71*('5
MK&VS3X+;EAICMW!U(TXJEUM+^%0V5S?`-H4':(4/P(5-=X915S=4-ULR>/Z(
M:(?5%R=<]RZ(F*1Z`SZ:>'<OES2?IFZE>#)WF'A_^'AS^&>TF%1$UX>EV'FY
M%4"SV(B5F"#RXX,].("%%7($]X:OQHBQ0XX%_IA\8=B!VR=]R[=>A5-[D=B(
M^YB`>[-RB+)M=@,ZE\G!%,."K-5S::5I)_AG],2,4?1[KL8A<M=`F:)=1S8`
M652`A:.`Y/8VM":2,_.'_JD`"FA3R/4]`S<X7)DP6CEQVX,KF`)$@K4\DV=N
M)E=R/R.(+3>29QEF*^W<^,PU5IG3OI@T*CDJA-DHA#A?7`-=-?F<0@.7-QD!
M%E-VRV=N'@`U6X.1H%F<D[=;!0-:=-F1;X.97193S#F9GP2`MMF.=YF=!3>2
M'Q-NW7F;=;DUV!,RHP)?[X*4M<<[WSF,2QF/`=H]/9DQ(C.4MP:&';1BZEF3
M)=J<IP05J;9+2A8Q_A/L3]""-U;":CQTA`?`,B<Y,G=F2(AH3T1&F2Q3.U;I
M4QOW>(;"*,!#2M.Y@S/GD%:()$38;7$W.3VK5X64B"H32,`C,IGZE$=8KZ3H
M0*;Y?W8FJ`>`1986>92:,BV3HU::JH?Y>Y!':[PZH5S#9MR#1-US,J%ZDO43
MH>!Z-W8&-7]W.#6$I]<:;FR#KKE:*M#:I,`:KGN:GXEHKS,GIN?"YY#3`++7
M=UK9-@2[`'4:CQ?;/:&ZIG6#J1F[HNWZIQN7KNM5&X\2:NS7,K=2+9VN`]7R
MZ28B+/6RJ4P*MI\N+3-J`&3C)@P"/7Y*&?]GE6+[)NHG([)O-5S[+04@_K>O
M8KE)@B5HVT]\:B**8U=7H[F56[>S(OO>4AZ%FZ2F.[1:.RRI^[\,BR4HL[F5
MJ2\5:;K!>S?.^>!B.[V-&[M-:K?MNZ^@FR#..K^O`KG]ZR^+&[;3N[S9NZW.
M6YD(/+J)5!Z/.[9AFSX&7+?WBC,%DR#<XP%>VT\4',.="L+Q^R]7.RRY:)4^
MW+[1@TCKF[O!RKT]&BAA*Z@WT1FQDS/(N21C7$+9;BIOJUWO\Q8Q2&*LU,<;
M<A_M,\>/',F37,F7G,F;W,F?',JEK2'(0@I)HLI[8NHTXPO7`S&N_$!%8NDX
MLR2\?,#^*S8-PLO)_%']!%P60,W17.3>G".>_BYBQ#SJX#PE]JO`[/PDPJXQ
MM5/._ZLB^'S07R+04<*_,.C0R[PG%CUBQ,4KSEPCMOPGUN[9]GM<WT+$4.)G
M]-,CT*XL-AT,E6\C-IW2%0)+(BE7]8\D3EU@"9T,07TS9)V^-G'+*1WM:+TL
M='T]Y"12S%+7>=TDE,_5=SW3TZ+8Q8XO'(LY-LA&1`1`2J1T]P.JG`SP5@-&
MB*P.%X\Z2P@A1B4Z@J37VR,Z>CU'<ILX#H9-[&/PU#0.I48[GMW=L29`E,P\
M:,1&\NX['LQ([OU'!F?(#F0[M,7>6X)&@@1`%.]&9(1`$`_;8R,Z!L3'D#HI
MS@,0JT1$,\R3-=''_@R/XF/DXE=D*_[0R9P.V@DP.G;F1KCB.][C[DCJ2)2Q
MR6+C0F1DLO..1M981/)CSLY]Y-54.MADDU8FRH[LWDOVX5<^7^)PY4<#/*1]
M-_BP2UQB#X]>WE)$1OP#%6$$ZJ/>??3.I-T=RBI^VZ_=Z7"^1O(NZX7>Z#/\
M/B1(3?<]2^/P*V`DW*$$R$+^+@9@`;J><"`=4LK%4@Z&S<XEGKM9$]^%5/!L
MER+Q$2^QFTV%:FX%6!"F8,PE8!H18)KL8%2']$1%791H8"BES"H_S^X,8'BE
M$OLE]*8,\55%S/Z,AY/E8:@#]8Z%5TR_\NTL.#8O;5(/+2S1\?6%]\GI_F"0
MI89:G]RZ@E)XWQ);?_<1/_G_#%#63!,S;/"%Q59*SSOZY5Y1/TXDGR`6!I32
M14X>WU[FS/L+[BN\`O@S7TZJ?X-V/\UV5U3>K%5X"E_77_3Q_U-`#R`*$"!0
M`(#!`@L6%&C@@&&#!`L8.!!(D&$`@P`:,+#8``&"!@8(,$C`@&)!DQ@!(&S8
M\6/'!0T8"FR8,0$"F!HWIE29<*&#BPTB-O0(4N0`C0@5SHQI$R<#G2DU5E0P
ML.#+H@Q"$L2X,J:"`0X(5MU)MJS9LVAW9F5`("."!'`3!#"0(&B"`@_B)C"X
MX&['O0%B$C6HES"#N743/##(MB,!!XH!(+:+_M=@RP:3W8K,J_?EW<4*%D_&
M#&`O:;URZ0KN6]GMQ\X(2A<N?9FLS;VT;7YDBQ%W7=5UB<(&P'IQ\<N^+_\%
M\)%PW,F173?@^WEYX-H8!Q38"U<`\KC8C[^5+-BE[H?D,4XN;G`R6[;)/PJ/
M^SBZ<[BE1^I=+!T^X8X[0<><8)LE1I1G>#6&@'L$Q+=39`Z>%A^#LY5FF$@$
M/,3?<!@I*!UK#308EVSX]4;>9:.-UUQ'JF%G(FVQE<;?9<7Y)]N`+-;EHF47
M)3;B>G=5"%A,]0E085I()ID6;Y8AH$``#S!`588.'*#1DU$:5*5@"AR0(798
M,@#``'!-"5(`8"EH_J0"!IFYI9C2F:D9`WF%V=&;I0D`@)D=!<!FGPJ$R2<"
M>,8)Y4:Q"7K``<$U9V)H73+Z$%%,[KEH`@V.--1'=L:&YYN71=JH8`D<X*B@
M`YT)%G:@.NEE>=.E=->>IA'5J:.M=OGE@>?I&NN>J19JYGL$B-I1J(>NN5.8
M9"80I@%H;BJ5L3%B9&:I+B%0X*39OJG@L,5>"F!*T`Y`K5M^4@MNF-9>2NQ#
MT7::DH>7O5GLH7OBV^ZNG*;ZEZG3-3"HH^U*&F.YTGH;+J/8>N7O8%$MJ(#`
M^+III5Q9MOGJ7P;DF[&2((?<85M-%@M1`709`)E<)B^@95P>P06K02WO_GD4
MR@D8X&0"`_0%H`%PXJPR7!=))_2<>;6<T,H]'I3R0PK$!K6V"IS\-*%$-_E1
MRP"V7"Q5]3I@6=4`?)WA>7WI67:@!#!JI'Q;5PV3IUDS?9G9(A)8=:PM"[WS
M41#;';..1#D@-F$NTW2WW*P2W9+,RIWW5EU<I<RTTSGW-9+9QQ)5,]"&8]3R
M5U!#]'?>?7%.Z.$JI6PR@70:V"W1/B,@=.ILW\GZSJK7%+7JMV,JM^ALOWLZ
MXZM3U[7,*V]7<\NA,R=SWD([MG=&"ES]4?1K@QWCZ<S3+OR4>PNL/4.L3QWB
M\$*O7+-!DY/J\OLBUY^DV@:I'4#1`P"@YP`'_FA/T0P"0#W]!"9JP]_^#,(?
M`?1/3P$((``>H+8G9<=_8Y(@!C'XP`WJ"8(7.4#'`,@<UCTP*$5#H0`)Z#^U
MD3!_,%R@`HLFP_P)`'\#T-]%;@A#_JP0@Q^,X0ZSHT$2)E`R-+RA_@XP0Q9"
M,(!')"`4`7#`!B20AS"$X1%KN,$,8K"*5TQ@%5/2P1<Z<8)HK.$6B_:DFZ1D
M@0U<H&0D&``>BF:(;KS@$['X03ZZ4((4/.,=,9C']@20BRI$X@8[.,@W#C&(
M$5RAG@H9R/;PD(2-5&0>QUC'_[70D$%\8`(+J4C\S=&2_P.D(N=XR4_ZKY`J
M!*$>O2A'+04`@5VL_J7]=LG+^DU.@[W<TZ^"698":-``/L2(`_JG)682\YG0
MC*8T4_++:9*EFF;!IC6M-1U@1M.;VSP+.,VRS'":99SVTZ`V>8E.<QH$F.7D
MY3K=2<]ZVO.>^,RG/O?)SW[Z\Y\`#:A`!QHR`?P$(P@PE085&L"$$O2A$(VH
M1"=*T8I:]*(8Q6=)--@YQJ2J+>/*J$A'2M*2FO2D*$VI1>%RF``@:EPLQ0^+
MD*G2FMKTICC-J4YW.E&''$@^EMD(2;`W%IX:]:A(3:I2EZI3!65K7(W!5$U&
MQ-2J6O6J6,VJ5J7I5,%`]6P@9==6QTK6LIKUK#ME2]XZ2IRZ5,T[T&,=_EKG
M2M>ZVO6N]]2?$KLX03TM1I98Q*M@!TO8PAKVL(A-K&(7R]C&.O:QD(VL9"=+
MV<I:]K*8S:QF-\O9SGKVLZ`-K341\)1JI62<;4O2`O1DJG?&9K5*@E-:!O"4
MMC@TF+?%"#!;>]JRY!:A[3PJ3/KWVW."S&5(HBUOBHLDYBK)N60);C8#J%#X
MC;.ZOI6N.X?+'.T"P+L)29)R;>O=G4`W+>?MK<@<BEWG8O>:Y3TI2*1$LI&5
M!3=(PHVCFH-?)"V@OF=9BP'F1LS4VA>APZQ4Q,@24J8N0`$/#H"!`PQ@M(PD
M20(F<,@:'+()4[A^;?-0V<`I8@:;-I\/CK"'_LVB8'+Z!$D9YG"29)RD%9>E
MQ34^@(AM7.*=T!BG(9+,7ACU)+@\P``T+=M3MO/@_I4$(E\1@`$.$*@&4'EB
M4F:32[4L)<ET.3!L6E);=G5D9!(9390K,W^RTJ6UN+0`1<;-E:WLK``8&<D^
M%%BIU-P1$2+S)#H>8$X9PAS:$L``!5CRD\[,TOT]9<!JY@O98#QFP>#YS&.J
M2Z3=PA8UJYG-$B33=`XCPD279-%U;K1+L^(`/'-%)3J&ELP"Y5)$6]`Y`L.2
MJ[%7*C\_P)@#<2>A$6!H1(OIU!%,-4D<S>I=,T``=J9TV02CYC.+>M.</C0R
M/VV`+F6G+J0V-K(9_KWL54-ZUX#.BIW=^J3#(!O7M-ZTGA>%9V!7V*1!MM!5
MD%+4$&ED(EOYMT`*0-JE+*7@A")(P@D>%H8W",9`&W!'3'*5D#!`._UFBT]L
MDI.8!.TQJ_$X2BS3<(K;KB>*P50"3(E3AHE)8`M@R5-"KA'E_&3D$^QO@",.
MDRDMY";3L;A6"I(11*ND*A37N$$L#KBN='S?B'()P+="F*0%I^8.V,A#9HX1
MK&]DY`PA2%($\E9WNAQ[,0_8S*%N<YQ34;8[S\K<3`X3H1>UZ`4P2=*I#@"+
MV\3I:P=ZS0]T\Z*FO$''VDC6O<KUC"C^Z_TN>4],QG)\DPPPJH$/53M7_B"D
M)6"9>WG-@)99GP>4_O20>4!H_(<:N,1F+2"='-%44YS9G*9SEV%2Z#&3>1&5
M*"/]0\UR:`,<HS94`4(]$5$8I)S85"@O^6N]31@#-)#J)3.LL;U4I5^7IK45
M+]:!%?-_6B&0)*8C7>76K[IJ^^#[)C_T/'[R`R.=\6>K0@K!B)%:__KJN^7Z
MM!<D5%43OB=\WO=]X8<BO==\)((;YO<0Z)<A/X4=[+=Y[D<8\%=3079HP)(A
M;"%6G!<[GL<F#=,P;*(L*.@LK$>":O,`+OB":U9?'8$J5&(E4J(O@()[E')Y
M`+,N^H(N=18E,W@IF?)Y1D5PQ.$5&V,KJ9)^_HGR@]#'0##H@@>&/8<B)UN"
M,7"B$7LA*(<"*%IB@T/(+P+3A!*8+6)5-B3Q>1$8.1`#`%T%@@OB+)?2+/2$
MA#CA*W%BALTG5@A@`*8TA50(AS+H)%<8+!?S@USHA4(H,<ID)6,(*^#"@&)5
MA$/AA!1XAA23,7U"AXQBAQH8%P$4/.^3$(XA@J?(&6M3%Z^#&T"S='#RBGTG
M)CIW8X78-Y9#-.^C/O)!(RNWB@U`BL-C&<Y"-1!A/53A-LXB5SAE9U43&/%S
M&:0(.;%!/U$H9EV'BSE#17"QBX3R@1#!-<7X,G+Q.(3S$=-(./2CC/)1.^;Q
MANZX/A!!C+_#-J03_G/,&$W.6([Q8S0IDSK4^#Y5,RO86#)RTS[=.(QN`1ER
M(XY1HTPP$XU$D8Z"L8K(Q8Z>T7SA,2J[6(QF<X_<8U(",(B"M$K?!8A:Y$'^
M0T=,Q$H2=&LPR48!0"A(8DHZ=$8O5$NQ!$0]I!XMR4@FZ3\/0$-#M$I]5'DW
M)0`(\$%@!$-`V4E-E!)(218VN4H=1$L#M$8KE$A2]$6W9$5.B4&BL5=!R9,M
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M^\2?^EE1_MD;^?F?TA2@SD&@]62@]Z2@#Q4"%^6@6*6@#(J@O22A`TJASS2A
M]*2A`C4"*%!1()``$&I5%HJA^WFA-V*BV\2A]HFB!$4"(V!1(I`"656B*CI-
M-GJC!>JB"<JC`K4")`"B)E`"-8JB+*JC^66D_CZ*I$IRI"NZI/]4`B9@421P
M`EJ5HTP:3%B:I14*I2>*42<@`A;EH5>JI%Q*3%MZIO;CI-;$IOH4`B8``A4%
MHUN5IFH:,G9ZIR#CICMZ42E`HQ5U`D%:IN*II[N4IX::I.[II?L4`B):45(J
MIX0ZG8R:J(B:J)2ZJ#(*J!3U`6):IV:*J7@:JJ*ZIY6*HZ=Z3R`PI!7EJ)(Z
MJ6?!IW=ZJ:6*GYI*42I@I17UIV1%J[4JH(7ZJTDBJ]!$K/1$IA05HB,*JV9A
MK%SJJ\*:HO_DK.%$IQ4E`A]05M#ZJ]O*K:D:3=2Z38(JI$3:JZ0:K<UZKN@Z
MG[<:45)*I;IJKL&Z_J[LFJGTFJ[M"E&>.J:#*J_V>J\/HJX`>Z``%:[2!*>O
M*E'6JJT""[#=6JL&>ZC?:DZ\&JC]ZJ^Q.K%G^K"E&K%KJK'6I*R0&J=GQ;&8
M:K(G"[):JK+2-*,6M:\EV[#WBK*6RK*\Y+'!M*KE.E&NBE8TJZ<_"[0V*[$0
M5:465;$Q.Z\#2[`9N[0!FZ\=^J')^J@^*[/T&K2S.K0?^U`+.U'82E=8N[%6
M>[5:6S\XRTOCFJRL.E=A^ZQCNZYG.ZH$]:YS&J]5J[1+V[9N"[7_!+,4-0(7
MF[3_ZK1ZFZ5Q:ZH$]0$)&U$AD*UU5;A("KF16[8B<[@.^[;1*KDZ:KG#_DJY
M>8NYPJJY-\JYBNJT;0JZWHJWG[NH[-FZKONZQHF>L#N[M$N=LEN[N)N[Q\FZ
MNMN[O@N>M_N[PCN\2DJ\QBN\IIN\RKN\S-N\SON\T!N]TCN]U%N]UGN]V)N]
MVKN]W-N]WON]X!N^XCN^Y%N^YGN^Z)N^ZKN^[-N^[ON^\!N_\CN_]/NK$``!
M$0``$@`!$Y`2^WN_$&`0$P#`_0L`]YN_!ZR__.N_`!S``##`]UO`"9S`^UO`
M!O&_]RO`!&P0"6S`^*O`%JS``*S!$<S!'TS!"XP1&.S`$)S"$_S!%<S`(_S`
M&^S!^6O#("S##@PR%H`!&M`!'%`!:$$!$V`!_AA!`1@P`1QPPP"`Q!.``4:\
M$QX@`1@1`1YPQ1[`Q!>@Q!L``%:,Q5-L$!3@`4HLQ&*<Q%"<$F2<QA-UQ3M!
M`1QP`6I,Q1B!`1QPQWC,`2*C`50,`1UPOUUL$!H0R!<``1E@`8,,`'QLP!N@
M`3/LR!`@QP!@`2V<`10`QQRPOX<LR%T,R8U\OW*<R`"0R88<Q85\R)`,P*%\
MR1P`R4*LRA4`RIP,`+&,O[4<`;5\`8L,`8W<Q_\KQW^<`4(\R`"<`;(L62@<
MPBM,PBY\PC"<PA?<P,PLP<Z<OS&LPM),PR6,PSA\S=$\PRU,S0C\S,J<S>%L
MPN-LS=`LPAFLS<U\_L/)K,,A4P$9D`$8@`%_S,1O[,AF3`$=8,^.W,7^;,__
M3`$I4<AZ;!`<8,CU3,<8``%)S,L24,_U[,>"#-`08,0#[<.;_,``;<D3I0$:
ML!.U;,:*G-`"+-+&+-(C'3)^3`'W:P$1T`%BG,(=$`$2L`$+_-*1W`$64,@&
MX=,I@0%=[-,^;0$=D,\YW<0+[-,S+=1,7<!*'<@WG=-0?=46@-0^?0$8$-1&
M?,)1;<`5T,,0,-8//<X=`-.%G-83;,``L`$3`-/]:]11/%GQC,W@7,,OK,[E
MG-?;O-<YC-?M?,[<?-??/-AZ7<V!?=@LG-CIO-CLW-A__<'=O,X8'#(9_I#6
M&)'49;$!QES6T1S%(@T`A2S$,$W'DWR_*`W$)!W)05W.0AS+<@S3'J#`9LS:
M$<#+3-W5$C7:*5'++7W29<$!&;!+][O"DBP!`VP0.MT!RAW`Q]W3ANS`?TS9
MQ0T`1GV_2;V_0OW<V`W*U8W3RXW=W!W%S8W4!XS56FW(5/W57NW=.QS?01W=
MA0P!_^O5#FS?RYW=E!U9AAW9TXS.E=W7B#W9C^W-`.[.XBS@"+[,"B[@_^W@
MA`W8#6[.CLW@ECW#25+(DLS<'9X23[R_9EP!'3X!+3WBKBW(Q(W2$"T!%V#0
M"DP!%Z#/M`P!M9W:5&P!]@T`&'#=HUS<^XL1_A-`T[T=W`81RP-\XQJ`TBE!
MW,;]T`.,U#?\PQD@Q_WK`4E=Y1#-OQ=PTS#MU2E!W4B=U4E]Y5U-Y5TNY5"-
MYMAMY@(,`!Z`SU&\YC(]Y!$`X]AMQ)L,`12`YIL\`7^^YUL^`84,Y7O^Y;&,
MYG1=61%NX08^X#HLV>\,Z8(MZ0M.Z8P=X#C<Z'X]Z9Q>X)..Z>P,,B).ZJ"]
M$[F-VD2<`<'M`9:<`0F=V],MS*/LQ]J-Y\2-Y]R=V0;M`7P^WW#NXTY>Y*TM
M`0\]S$R.$<->/[QLSQD=`=<=P'#-X_\L[0/LV1B0Y@"0V=SNW()LT'2MU4.>
M`0C\UD,NT]T>Y-/>_@'C?L/X3.[_[-Q0/=$9L`%0#>;0ON1N#=<7T-#]G@$2
MD.\+C>V%3/"LKL>9C;_6;M29C=J0]>F6#N'D'.F:3N$9WNF7#O$5K]@5CO$2
MS]<4_^"%/?&"#3*^;M)(4NHID=LA7`$1W<7TG+^P;A`1,`&FS>JUWM7TG-`Z
MKNI)3<:Z;0$-O]`!O.P]'M)&7N,2X,\CK>]DL>PB8]"7#.-4+\8T7P%4+_52
M+\9930%=;Q`70,5;W\0&C<M63_9B[/46<,E67_8H;_9JS_8840&F_<9'?,-5
M3_='WL_YJ_5-C/84@/=K__>`__7(3/*9+O(63^`1O^F(G^`33MD:K_@<_G_Q
MH+[@DQ_Y\/SXEZTDA:S/)'X6*@_V$)#L&/'#V)T!5^S'#F\0#UWK,'[T</[K
M!N'K,#[D1ZX!L.[DOJ[L/@Y1OCWW.Z[3'N#T.P'U$_7A])OY%\[\C^[\H0[]
MF,_YCN[IU._Q(P_R):\D,,W;"IW19C'Z^WOC8&_!3D[1QIS9I&W^`;R_L7_=
M'6#DK^_Z`?S3I]^_A2S:(1Q0$U#`P7_D``%!`@``&"!`X$!0(4$.&18^A!A1
MXD2*%2U>Q)A1XT:.'3U^!!E2)("#$0!(@#!A(<J#$`A.:*F2)`23)4^F7-G2
M)0"8!V7:M(E2)D&6!U_&)&ASIDFA.5L>]9F4_N;2FT-O/N6)E&I0G`J+[NS9
M52E7JT4U>H#@P8(%M!@FHJQ`,$+*"W5-;A`(H$*&A`OY$L0[<*];"P@!6,C@
MEJ2'A8$/9U`Y]P*`"Q`V`*``P2W>R2,]-XPP5['""GDQ=S`,L:%GUJU=OX8=
M6_;LD62=&LT:=>O4IEYU0A4[U;9OK&%_3J7:F^COW,%K\NZZO+A6H-#+,C<N
MU63RZ%=W9C38LJ]$N,`/.BP8D\+#OP3#IUQ/N:6&]:4[*WS?P8+[EHP)5CYH
M/-HR0NP@_1XJ;2#`4GMH-8\F6,\#"2J;K#2:Z*,@(0TNT^`@#C>P<*Z#+N@0
M@@P\K"P#"SH@2(.!_BPK\3(`-OS/1`MH=)&D#4K<J<3.<-P@0]0RB"M'&#UL
M4<84;^3PQ1VQ\C')&8/D8,BX!L0RRXJ&DPZW['9CJKNO@#ONN3"OFTZWL:R[
M#2SJA&.3."_?-+.J-LG4+D_EO..(@@@NV(\B"JX\K`)##0WTL`L(7<B"^`BR
M8-&'*+A@.X(852A22R\%]*%(,=6R(C\W7:B"1P\[52$*$MW(H+4$<LDA""JP
M``/]5LQ,)?TBZ"#766L%X$!A+>"U@P@DV&!"DGJ%X()=6<R5(&.1Q0D"9IV-
M=*<#"8K61M0`V$`E:S/#EE?,NIH6+W&OU:\R:1/M5L5OPPVU7GNY],Y-_C7A
M///.YLKD#LTY]]T.WS'_S=-@[.@,V-\OU^Q73GLGIKCB`?6;8`*42.)86@,E
M@"G8$4'&[5V1K1T1KUT3.@@E9T<\*61PK25Y)I>'U#:HD!&J<B>76FX6M69C
MWDGEFH%^^42/>=N9@YZ3LCCJUQ1.T[F&Y=37:JH'MOKJ+K,&>&NP$X[S:SRI
M\II/J==FN^V*.K#0J%CWF^#6#C3H(`-LC<4[`Q5Y"G:_88U5R0,,5B3)H`GV
M-JGOR0KO(._*%'<V@LQ,;E%R"`K[MK3$Z=+/V!DE!]R#R/76#'3+M4W4\<U1
MUNL[MV?/2.RSJXO8;(3!M!/KVY&S?7?<>]?]_F%^B<_W]X++5IMVYY^?^$`)
M0)[`K0O\EL!NE\+=56F\L`\\V`Q0(S:QO/]TR[+$RI457)5L]1ZF#=8_<'S[
M.WC1?9=,'U^X^3%@'\?H!;_MR8]^^[G?^/(7KOWE#36D@EX$%1(\X]5I3P>K
M8-HPR#`-+HQ@':Q:V)BWP0^"4'821&$*/9,J2QD*,]R*#P5B&$,7OA`S:XDA
M`"(0EPG$93TRM.$/N2474\$0,T*\H:-P&,09.FJ(0,QA#G58Q"-6,88X7.(,
M8>A$%::0@@S[X@?#V+4QBC!WR1/>\2[H03*.$"M=A&,<NW@?.=;1CB`I(]G.
M2$*MN3&$>3+AV'BW_L8_#E),;`28">^X2$8VTI&/=%X>#2DP00Z/D%Q+I"0M
M><A";I*2RM,3)T\(25+.SDA"DQ&-Y/,W'+U(:!5@T8Q@-J4-"<E$5SHEDJ2T
M2B;-R)4'@66+9@DD6Q+)ESJ*T2Z7U$ID0FF8'RHFJ$H9*DVJ4925M.8GT[B\
M/2)2C\CCHQG!Z4VT;6V:YW3;N`Y"+&BAZUA!JA:S-G<!@V#N7#"15P&3(D]V
M<LN=U%I79N99S_#Y4USY=-^RR/6L>TKKG?%<:+;L&:\5Z1.=]_(C)K]Y26Q:
M\)J@#"0HJ^E1;690D1=%:<6`UI+)U&QF^CD:K,Z#EZ4QI2=.^U;'5CI+_I<:
M;6<R-1%-3V;3G^'49S8+&LQZ2K.?WLQ$.6-:49_6L91")`%7Q6I6M7K5VF6T
MHR'=)EA-.E*Q@M&K(#5G5=6JI=3!9$6-(UWA,.`ZQ=%D/:Q32-]>USF?U?6M
MF=-;Z4XWN938M6/;&AWJ..<2S[65<8E]'`!,ISG*&>MR!87L7AD[2HXLH`$-
M@.-619O5KG:SD]ETF%E-J]%RGC6L9"7K2=<ZV]FHSU41:-\`SU=`VVZ.(`G$
MGP`;V+^"_6]SN(6:;N/7VT`!=X$AX]\#=71`Y.J3@/K['[8`X%P!0M>!R`%)
M`[C:Q=&6M[3C/"U)4RM&UXZUO:I%+VL]N=XV_JZ6(P)HP`,@(@`'#&`A#"#`
M0_CK``([8`$"6,@`''``A3R@OZ^AP`18!9$(>,#"'H#@I"0L*`Q,@`,95E6'
M#U>1"WA81A.)\(0]\D,@OE"*.V3B$1^U*B4Z48HRY**+6WQC(FI1AC/&HHV-
M>$0NLCB(1YZBCY%(8R;'F,BI\HAX$Q#:\HKVO!P5Z7O9N]JOEG7+\?UJ;-.:
M$0$4(`$,?L@!$A!@A2C``6E.@`(*,.<$&`#!!!&``>Q,D`(HX,ZLH4"'I*D0
M#I@(?"@6-(KS-E?+2(0"B\X;E/&C&?DA>E:TQ;1(I$SE*FOURA]]K9;[R&6T
MBEJ<6`XUJ<,JVXL,_D`!5T7S0M3,9H*X&<ZT1D`"$"#K!#````LXLVOF!TR*
M=$!`$QGVI<GCVQEI0"*5\:%I(&(?:5FE,2=2=J:US9%-D[?3GL8(;$V]45"[
M5]49%/>Y.3CFBS0`P,&^]4)LS6M:S_HAP&;`FE]3O?),1#,3DK1"^)WM:=]G
M`LZ6R)6H'1&44`K$+\%`O[<]<8QT6X7?!O=%T@WF+*N[A!M'-;K'W5K[;H0`
M\*:WO-_,ZP4<X``!$&^L%6)FT,9&XA0^SRTK<O.)S$5!CIY`!A`>D4(+K5<4
MX;E'<MGH*=6(E4U:%C!C&25:4LE*+?HETYO.2V:B;%93?^:4HGG,(S%=_I7+
MA'K9>Q3V6O;,F!H10`#D/G<S)V#N<]?O\S!.VG"/?+Z^2S7'5PWR<L,WY.O.
M*$=.+G."V+O-*U>(FK5*ZX707#9)5T@$>H@9H>^<X!*9B[6GW6&M-T@S>FG/
ML@>]$74>MYTR25>W^$E/O!K46Q9M?3\;&JR'!G2=M)]HM1!*+W66Z_4.!:A"
M@R91S%)T7J*O2`#VKF^]3W_*???XJ`4O\NQGTN^H!3SWMX_XDFMD\?M-P`)4
M#F<&(``!`?CS0O!-_==@/B($?<OG(5*98U,$;Q(IM/C``/10O=H`JJ%9*IAJ
MJI;(`*$2&J+BF9SRF0/LC`2,J:)H0*@B*I(P_BJH01JA:2F9\:F?@96DT4"B
MX<"IXBR*D+Z]H[S9L;[KT[CO4Z_P,[S"^S@:]#+M.[P<++^,.#^K@CP!Z+5X
MFPCI4[^8@PW[HXRA*#3/6[V;\(^)*#%"(\"':#CWN$*(8$*-:*O-$1W'*9VY
MHJS"LIS#:IV\T:S820J_$AW($JPRA(DSK+W,6BPV=*S0@:O`@APYK)S+0BS7
MN4//T8@'((!#1$0#N"I$1,0`@)X8_+22ND%)_+(>K*_QJT0<Y$%-]+X?Q(@@
M?`@'6+.7$T7_2CF)$``YPS,%V#/78$+'&`PH[#FZL`N)@,74\Q3#0(S18#C]
MZPCFJJZ$@I^YP*[$_F`V[MJ>X9*NZ;HM]+`N-2Q&5_DM!U*@[E)&_Z&NW'H?
M:&2@[*H?:@PNWI*L[WJXC+"X%()$[,/$3:1$=J2O3ES'4^-$<FM'>+PDQ4.Y
MA2BSK'I!`'"\B&@`!<@[`)`^R&.-+GP/")%%B0B+\YB(A`PX^3@(^D`Z7^P3
M&7NB(9JB&/LQ50FR)=NB&<-()(N/'5(R(*NQ)6NB*`+)%Z,B*%JRCW0R'(M(
MC3A'%$K'&>P^>GQ'GK1!'XQ'GRR>2>Q)DHNO^V*\-'N_^),UII2U@22(!X#*
M%8I"2)$4BQ@4BK"`0T$4K;Q*0:D4K*Q*BB-+@KA)"<I)BR"\>A1*-#*W_J"<
MI*+\NZ$$RGLLR[O$RXD[RPA*RRW1P;642^#YR\'<2:.TR[Q$S,1,J;U\1.N+
MQ,"L0;ITQY^\1$N41[:,2\JT1U%2S,[T3%)BS,\4S=$DS=(TS8YX.4<\S=5D
MS=9TS=>$S=B4S=FDS=JTS=O$S=S4S=WDS=[TS=\$SN`4SN$DSN(TSN-$SN14
MSN5DSN9TSN>$SNB4SNFDSNJTSNO$SNS4SNWDSN[TSN\$S_`4S_$DS_(TS_,4
MSA8$``1XL_YZ``4(`%&LLP=;``)01`.82O34S_VT30,X@'<S```P@`50`/\R
M@%T3T%W+MP`[1/YTT`>5S2DC@/8+T/LD"$7L;[4#!8!\RT\(]=`/'4T_6P`*
M35!W2U"S##!1W+4!4#\0==$714P"*`#_1(`*W36[TU""K+,SVU'5A-$?!5)M
M@S\\`X`[$X`CU4?5%(`!<,H@==(GA=(HE=(II=(JM=(KQ=(LU=(MY=(N]=(O
&=="````[
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g469192g28z04.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g469192g28z04.gif
M1TE&.#=AI0)J`Z4``/___\/%QXV/DIJ<G^_P\+6WN2,?(&9G:5A86M'2U-_@
MX71U=S8T-DE)2X&"A:>IK.'BX\?(RI.5F.OL[=G:V\W.T,C)R_'Q\N+CY*VO
ML;J\OM76UZ2FJ>7FYHF+CIZ@HV-D9G!Q<XB)C'Q]@%566$='2:"BI34S-82&
MB5%14SP[/$1#15U>8.P`C````"XN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN
M+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BXN+BP`````I0)J`P`&_D"`<$@L&H_(
MI'+);#J?T*AT2JU:K]BL=LOM>K_@L'A,+IO/Z+1ZS6Z[W_"X?$ZOV^_XO'[/
M[_O_@(&"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:FYR=GI^@H:*CI*6FIZBI
MJJNLK:ZOL+&RL[2UMK>XN;J[O+V^O\#!PL/$Q<;'R,G*R\S-SL_0T=*E+M/6
MU]C9VMO<W4\.WN'BXVX$Y.?HZ>KK[.WN[_#Q\O/T]?;W^/GZ^_S]_O\``PH<
M2+"@P8,($RI<R+"APX<0(TJ<2+&BQ8L8,VK<R+&CQX\@0XH<2;*DR9,H4ZI<
MR;*ERY<P8\J<2;.FS9LX<^K<R;.G_L^?0(,*'4JTJ-&C2),J7<JTJ=.G4*-*
MG4JUJM6K6+-JW<JUJ]>O8,.*'4NVK-FS:-.J7<NVK=NW<./*G4NWKMV[>//J
MW<NWK]^_@`,+'DRXL.'#B!,K7LRXL>/'D"-+GDRYLN7+F#-KWLRYL^?/H$.+
M'DVZM.G3J%.K7LVZM>O7L&/+GDV[MNW;N'/KWLV[M^_?P(,+'TZ\N/'CR),K
M7\Z\N?/GT*-+GTZ]NO7KV+-KW\Z]N_?OX,.+'T^^O/GSZ-.K7\^^O?OW\./+
MGT^_OOW[^//KW\^_O___``8HX(`$%FC@@0@FJ.""##;HX(,01BCAA!16:.&%
M&&:HX88<_G;HX8<@ABCBB"26:.*)**:HXHHLMNCBBS#&*..,-))%0``)/')C
MCG<D$```.V(1Y!-##K)CD44@"22.02I)10$/\'A:``8T$$8""T2!I15;4GD`
M'@T8H("7571IP)=/4&DE$EMRT6867I)YA)Q#Q'DF`&2^*84#!AB0)6IJ@D%`
ME5`,NN84AN)YYQUACKFH%(G2V42@1R2ZA:5PGBDI$9O:^:67F$K1IP`_`EKE
MC0HH\(`"`"10@#E+*D!``:P*,6L!0Z`:P*X&,%!J``^4BNJL/%+I*Q'#%B`E
MD`7@*H2Q`12I0`&E"I'`JD;H6NJUM5K[JH]U!FMK`&-N^VJC_D>22RP1KA(`
M+J>]\GK`ND-P:X2:R18;K[78QKIKONSV"^V]XN)9[:[A"HLCG<#^>J:JM>Y(
MIL3Q(OQLM;DV6V>?T::FY@,&(-`G`P.,S"J5"##0)ZX!J%SER57V*;.8"\B,
M@*('N#P``&'VV:V7.C_K<@.L]FP`R&B"W"<"YI3<Y\[P]JR`TP9`[30#C0)0
M\]**2BU`GPVH[.@!0#\MQ-59#V$TR&'W^<#9,D.]<0-E5\VSS%/'W;7;9P8-
M`-4[&]VMUC;?G:,"A!+.M:=";!URURZSK.F=7AK-<:N)USDTJS-C7-K'?3H@
ML@&B&R"`HF<>T"L!*A\@LI545HG`_M8'%%"E`&%2V^<!-3.@^+P;G]D[D*V_
M_KOM7R).NL@")-"K`"HO&WL#"#C/`/0&)*"\`*-/>WONTU<?>O=V"M\K`-MW
M3P3MMOO)I^_68R]]E;'S?C[M\4<??OW#YY\][;`"@.T:@#L#%.!K.RO9Z098
M0-V1[4X,!%^?%C`\QGF)=GQ*H.F053Q"J>Y,R_I<E4!V,Q("`&3@,)801(8T
M(82)5[Y#'Z&(10#5!>M\`.B3#`_U+!SJL(5W(Q>AR%0R<"3@``]`X`DWN+$8
M*A%D`B@BD'Q&0QNJ\&]^DJ&8[!1#'4IQ4&(B`N)@YT,#`.")3.PAW<JXPS/:
M#8I7O*(._M$H@#$F25DU/)KS;J:Z'U7Q:(S[XPW7]$(+/FR(C^LC$8#XPAR:
M436@RQ+()$DZG`F!3V8#`)]NB"8["O"#@'R<(]L(KYN-,H.7/)H=R:3$(?2N
M;7_J(9I>J;(%H/)NK"H`*#F92JB)S4ZFU.$MTR:$58I2A[3,XMQ0)@0=VC&9
M"Y`3,T<)34\209<R>UN8G'<H;+J-<9_,IIQJQDDR><F38L/A$&ZYR5%"<H25
M1.$24[@H3-J-<+QLH^T8X``K+LJ9F9-E,\UX2W(:\TNM9%7-&G"`AIYN8[.L
M4D,/((!;BFV?_0PEFBRZQ<FA29CW%)L8$?E1,RYTH@]5HYP`_FJEDSI4FO\T
MJ40=:DTA8-2&;F2>37N5T7)"D*?^C*A//W7(-?&)3['L9>..YDZ/P1,<\I2G
ML<P1)D8:0%[%)%0[R;E2,];4DJ.TJA#)^*46>DF)`6@>O-"$UN:9,'8*V*I&
MA=!"Y8VMJTN\&5Q'2M:!NG%G:9W?&DO:QK;Z:%%X->Q7Y?JVV%TUE6_CJD<U
MR53),H"J5S7D`3S9/@,60:Q--54#HAK/2L8.`:J[K,H0$":]+@J,".`3`KXV
MUU'"-H!X95W(6CO%D"&OMP<(TP"LYP"5.4N@F..G<77K,C%];;;?7)3R@NLS
M<.J0N7A#UM)^.TKB&C=JN5V:=PT(_E/"CO=52PO@<VG[MKO%,*?L9=QZHQLR
MU9'5G&>ZK2,-$$!;K9:WH9W24^=)8#6I[%@M2R]8`?!!!;A,=0[`*X-]!E&_
MXLEE3!/"!X%8@`<W36;@6.L0J!;B!"^@40[>'>GHI#3J=?2!A+VPGXBI8;[%
MF,1%4).$&XSC\EH8QQ,.8S$?7$DWAAA]1([P9%-\IA6'[,`_TFR0%?HH3F$8
M5CI<C:S0!ZLM<QEG-^HOCL0HYARAZLM>3E6=0ICFP8V94X<+()+&%,)B]I?.
MUAK`JP"@LG&Q:LM>+J8?:P7H+K,J`7HV1Y_O%>=B=@O/1BBTH]<L:"D%NLU#
M@/2S0GCF_DOWM]/FD'2LT$R`,&<ZU%V&U9MK)C=&BW%PMME4)V(G@)J9T@NT
MMC4R'H!)6!M'UIUPW&/!(&S/#8.V*4V.DSP!K#V+H=G]+8:JC%VC:EO[VB1:
M]I+J?`0H<;L)VE:"J@IVA64KZ49O-MBWEQ#N*GB["TAJ=Z[2;2UJ@T=/20#V
M@I.`R:0VP4QH>H+2)H@%8'=J9#L-Z!+:I.\J]'OA_EZ"I!HN8B+0.#RARG>5
M*ZZ$4=D;"9':.+MWM^$K&'SCCF45;7FH!$M1?`H>;[G")5[EER-7;4)63;)8
MI2U;:>QB/%_8P3"&*HBURMG/*MC`6M4O;16I8<@%5IUCU[%;_LV[7/#R%:B4
M%3!?<_=K6=IYO?I53&K-NUA*1[G,</7!-=EK[+4:6+IDQ?5Z?8O:5N_A5:,M
M]1X>BUG'+;O#DK>KK2\K[V!M5]K>WG,\16DS*(N<FJJ[.<I^274%_!$W%QFR
MD5VM5HZ[F>``M[>C+2KT8!Z=,H?0N02_K/3=6EN57-9>TF=]`*4FEZ)2MC(L
M9G+@&283Z@\>.CZ#S??W)+W@/.4WM.5<:&#CG,RJ10#59VGYE5]B>D$EL@$8
MV&W0?STKP292TD\^>];73/U2VS[JZ=9U,U39URZK1`5R?GGCVV`$#8B_Y^D/
M;`A`)OOG0"6S``_02$/P00>0`!U$_D:RLSZ[TSZV=#[^$T*J1S9ZUU"]4H'*
M4SJGXR4#>'`B(SZO4X$5"$#E8S^^DSX4EBL-&&0+.&)^<H!7!4`OV(',XR5\
M0E3N<S[O9SQ>XCSX)R85&#X%2(,?!QE7)#)7!%I4TUB)-&QT]3@F)$^"9$=T
M%$=W(DAG=2;*4F<_M"B%I$Z9ADA=9$9TE"2@]%A+V'D[`T52=$10."]X%%0Y
M=B8L1#JW\T:F0T>>Q$5^]44M.(5HTDA9-@1?4SL)<#B$(E9QB$3&LCJ*<H9+
M5(B9=28%J$4*D(4XE(A?J'[U9'H;=4_M=#>WED[O-8641$DAYDVJ1"C0Y&/A
M%%T/)#/)_N97[%1;?+5[?@5-1X!HO"4G[],KL-1*%>:*^011MF9Z#0!-U90X
MP(2+]T1CN?@VAZAWH])&U6B,J(-#TP124+-).AA2-$.,M013M@B*HPA$!<54
MNB5D1[5Z4PA5I04.-_6*+353%.5C]\A+`;!+10".2Y6,9=A7U*2/R38`#0`U
MR@-6P\A0#I50LM2/!X=$,L--+D51&5E'T#A9IT2.@]..UOA(G+)+=B22$AD[
M*@-8,4594"-9!\!1"K"1#`.0F#%50;0HH&5/?])9@4=@I`4.C(6%=A-8/L98
M7O(`"Y``!'!4`6E&8B5K!^57AD4$)9-A^S2)F-5]>.)6E/.5_C%96;HH2T*(
M`&-D6(K5D3#F5V\UB)7H0H]UC2>TE$U).G8D5F8U.>+C.W@5E6=25SYC6'*B
ME$QY5/*V&*>56G*B6ZSU.$)(=0/%7Y]5CP0V7T<#6^?E8Y;)2<\U`"STE,2S
M6X\C:[#%73IT7AQ$C,67F!O(4\NU.\*%,YM9D8ZT`&-T7N=U6]9E1MCEEHP)
M8'+9F2QT6__U.&!$7=YW)W9H6\7I6IL%FSZ3F8LBG&,I&=^G=8_B>AF&>3FU
M5`$W!$%)8$P&85/68XAU)^/I9/,"2A&79=II#L"V82V)?$>F.3(#/-?Y(T#6
M8;L#GP^39+39?78$9$#68+L)?2?V_GPR%C)81I*VPIXUMD579E,>AE^#96'O
M:4DM)C*L8IYHDD<$9W.*`2H=\V5PEFF/!GKW5`1IEFI^9J)OIFF>]J*BYB.^
MACYNMBR!EF.-AJ.91F_(LBL_DU\EBC[T-F?F`&HF2F9`0FA=1F^:AB<\(FIJ
MAFA[MFBNAJ*_J'N4MFE)DFZ8AFE=:F>"UJ0_:FG]9:.G9ADBN@2\YI:ST*9_
MD&NBM!]RF@3(A@MWZ@?%UA^'R033E@M_*@C0AFV&>JA(X2.%)Z2#RJ)<NB2+
M&FW7@G2"=J/G!J3LAJEDT*CY9FE%VG*:ZFZ/)T8/0&Y68&Y`BFY2LBOK!JJM
MZJIAD"[?_G:IK^H5EA,Z>UICA^)8Z;A4:T<$]C4G:O>=3)"K!3=S4:`\/%**
MO_@GQHH$#P>>,Q-Q4G!RQ*J2"<=R$+=O4/"LD^*1]S*L4X!O3Q%</=,`!)2K
MRI,]>H>N+O,CM-680K:N4R>N:2)R9$`I5:`\?\*L2:*66Q!SMD)RX&<%UGJ'
M%+9R1$)25."MQ0JN=WBM^#IRV@H5#2E+],(O-ZI]]Z2OJH-[EP,`.L6QK29+
M1K=M/G=<8@=F=9=T"E,N18<M[9(P&F<E`)-I9H<$]$I9[05X?N=',9JS&@MR
M/X<Z1?IU6;2R0XNS"H-V@X>PGM5V2SNUT#)W&7MT[N(Y0])W_G-";A9C,"X[
M+H<5<%"',R<K)V]',`[S=^_R%!<+.05K>T4`8:*DKZPV0'7B;'1[:W,3.9;D
M>D2S>W[[?4RE.*,9,Z8W.B1C,H;+MU&#,WX#?-&65017BH"K`,MW)Y*+?"6[
MH(';.4V$>V<6>;W'N5.X?7<R?&I7?$-CNJXK>S#6?"-#8]PG,Q&'>H;31JJ[
MEHT+MYY%1'I3!*@G.+ADL8<8.Q,(/_['KMK%7Q1F+`-0:WV":/*8*WT"1K"&
MO!647R^X?JN#O.\C0-]#7@"H-*6#?P(P@,+J@"JH11YX!&,TO>WT@U6"@H>$
MOA68FO!G)0JX+!?H,*FS.AR8?Z3B_H7CZT!W.()[5"4FN+PYPCZ38SXK."KJ
M`U%'B(`[14"Y\U=8E+X'S#@A.$';NX`.?$T'#$#%Z[;'RT9I:,)?PFK=J#=2
M9`2_!<./&T1)*8:7&$-,*$>\68>A%$-52(6D(TCK.XF!6$ER"+]G`G;M9%5L
M(TN/F$1\F&R@)9=`LH91AD-,2$=3;'AY1)`XDX=\0D!5G(8'Y<-8!`[8NU:>
MN(AWQ)0XM4<3%BU`/%3,(L>A1$B72%%5C"QW;$UMZQ1O^XTRA36U)+R8J#JN
M13)A\B>9:"NNM,AUBEPP68W"&$K!]$C(.)A9-$D$AHQ';,@<+&[YM31,58UJ
MR8V^N$ZD_LA46)QGP1B*2FF.?L*-`KA+%;F,;..,MIPE:7Q,!#6-SU<^V5@$
MHFPXB=/)'LG,0G5!OXS,)HFL*DR2>+61S3LS'64ERO,V>'LV#/``8*3-;G9Z
M&B62F9Q/.D21.DF9*-2/H]R2$LG$")5-+CF0JWQ/5`:1%$4$(AE@"LF0.I3.
M&YF2!LQ/RPE1`X>1"(G-P4Q8,BEB_VC/0P#/.:5_0*51`IC1^023V%S1'/U5
M45'(\ER4:@72_.0`#B!<E#)_I:8R;Y-B#X!1*AV;3819\N*7EX7#+8F4[4R/
M0,U82!(H?0F6<[:%]@S%:IF7?@Q8)TV(</DC<GF5YI"5./E"_H;%U.,86=49
MA$MSEB:=`%7YT&QYN,7\EW3IE*[,U>WE6#_BTVOITSL]ADW=E<LRE)DSR$U!
MTN;EFIXUR2EUE92B6QK4*V!#`#43V)7,FF3UFV:-6N>36"$37S\-E*0SFS7'
ML+8%G<GYG8C#5N#GV$R#NO/"V:CI@J*YR4ER8#U#3_5%@7Z-7F?"TDT\V;08
ML;5YF[&-FJ7ID==U8-D%4=39L_!5L.XE!)B]EIC]VF1UVLAMVY>I8!>W%'S]
M8R!6!"I3+=V<.26ST[3U>ME=ACE'N@A&.1.:GV#E3`!:V4&9GDKVG40]G_Q)
MI%7VV0-;N!EJH!#D8?1Y+Q,:8`N:_E]P^W?[6:'_J6+OC=L"2B@$>MT1BC02
M9F*TFU\0*D9)AHA%YMZ,H^%/MB_`6WP6CN!3EL)N.SAB:J1UIF:OMJ0^6FE:
MNN)D9FIDZJ486Z1BJJ0S:J);IJ2UQJ(NVN(H.^-K:BO9*SU3"BMS%JI2"N-?
M^J@D>F='"J9)JGNBQJ0$X*0N?J8\2FJ39J6*YJ`SKJ;90N5W)F=DSN6C5F@R
MKN.:JJ1+;J:DX;!EP@`_.6L36PATZKC\(>=4,"NCP.=VT*<`PJG`0.A^4*B(
MFNB*ONB,?@5ZC0>&_@4%,R:#@VZ%A^3I=BVCVNA7,-UL0*XWUP:#\E#!&CPS
M(SEK(FSU_LGI4^#I:I!Q%?8&5((K.]NN;7-9@8))"#`ZMV@B;V8QBEHLV\*J
M%U-O19"V6)LVB"=X8GLQ,7MHE,IXZE)WT/*U_Y+I`B/LQBY&0NNSL6)T,PLW
MK#)P<J.O8]@`8-1>2C.Y)*(R5WZ]@\(`[JX\I=8K\P[O9&A[*R=2EWNZ#-I5
M).1YC&NZ=1,XVLR(%VJZ]\Y?\7Y_#.JYJM)YO?)YC1-#>SLW0_!+5?+-<%GG
M)%(S`=`^(4\Z("_RMN,`)<\Q)U\O#BR$YRLK-TC``)]_Z)M<\L,_][,[J*1`
M>>+`*7]5*T^Y'DB_HT7S[RNR7P)&;8PZ[FI:51+)2]6Y)`(R_M'[-%]3JE5#
M6U6/]56?]87+P7"817;EB$H,B3$UQ"5429Q(B79$QWTT?F]H.E2O]5<O@T:$
M1$J=]FD?8AC]PAVKS5FD)E]3G[>$(I^=,WXB,N_>4+6D^(??^)*Y5(C<@[XD
M)MNXHNEM>JM(8+$HS*2T30S[C(R?^)%?RDK%LY^<^D;D635S``/`R#\;\K2]
MD/)HPRD2-@S@.BI#2/*N^XF#^[[/0QLIDRBISYD?GO)$DRWI2<^U0<*'D#S3
M^[S'0Q(IDNY<6K("^&&DKP6H)EF9\7^=(I@D`+058N-?_JG4AZ$3)%F-GCZ#
MEV#)3-L-U)49UGCUA]-G255Y_NL__F9,K=1`X``\#$*BT,$`%`P,Q[-A&``"
MA@8`0#@4JPV"P2#`"IH$[!F=5J_9;?<;'I?/Z77['9_7[_E]_Q\P4#"/R:"@
ML``+$5$1[-"QZ@`@H2G)4`'L(,I`@8#!`"$*(2LS:N#+8`$![&BHR%6(TNFS
M(!(+C!34+$J)RD!2UC)Q$?(W5U/*$U2TM?D507(A[&P`U!<,VR"@"Z"ZZ5-J
M4'R<O-S\'#U=?9V]/0V5`-/`+#<>C!Y>GL"V&UO(U<HJ!53`(:!7`-P!,V1^
M?7)FY%4_,$+XX0*PA1,`,O_X>8N8[QX_A)G,!"A(X"$L`-,^!3@C3T&5;.&X
M:<PVQ5U._IT[>?;T^1-H4"P*!@+HA(;H4'I#BQXUNC1F`J0NXZ$)(!7-/JQ8
M$DBMZA0LU*LOZ27%,E8IV9=HF:9]>D9K&K9ATSX8:/9E4Z)XWV+9%V"I4,&#
M"1<V?!AQ8L6+&3=V_!AR9,F3*5>V?!ES9LV;.7?V_!ET:-&C29<V?1IU:M6K
M6;=V_1IV;-FS:=>V?1MW;MV[>??V_1MX<.'#B1<W?AQY<N7+F3=W_AQZ=.G3
MJ5>W?AU[=NW;N7?W_AU\>/'CR9<W?QY]>O7KV;=W_QY^?/GSZ=>W?Q]_?OW[
M^??W_Q_```4<D,`"#3P0P0057)#!!AU\$,(()9R0P@HMO!##_@PUW)###CW\
M$,0011R1Q!)-/!'%%%5<D<4677P1QAAEG)'&&FV\$<<<==R1QQY]_!'(((4<
MDL@BC3P2R2257)+))IU\$LHHI9R2RBJMO!++++7<DLLNO?P2S##%')/,,LT\
M$\TTU5R3S3;=?!/...6<D\XZ[;P3SSSUW)///OW\$]!`!1V4T$(-/1311!5=
ME-%&'7T4TD@EG9322BV]%--,-=V4TTX]_1344$4=E=1233T5U51579755EU]
M%=9899V5UEIMO1777'7=E==>??T5V&"%'9;88HT]%MEDE5V6V6:=?1;::*6=
MEMIJK;T6VVRUW9;;;KW]%MQPQ1V7_MQRS3T7W73579?==MU]%]YXY9V7WGKM
MO1???/7=E]]^_?T7X(`%'IC@@@T^&.&$%5Z8X88=?ACBB"6>F.**+;X8XXPU
MWICCCCW^&.2011Z9Y))-/AGEE%5>F>4"$Q@`YIAA#JSEYEZ6.6::S9%GIBNP
M>`#H)QPP8P&7'A"C@`.&!GH(G)A^`"<%'$A@`:D*$.`!H5UJ>HDIDAX:@`6T
M#MMJI)4F0.PG`LCZ";8?0*/J)1AX6^JMTG9@[;>A9AOOGX'V>H"[^5[["3&@
M[GKPN[=>XFRVQ<!"<;X+>/MGK=U^VNNSN2Y@@,'1X)N`K\V8O'('*!]JZB5.
M9WQIP*E8_F"!HL(6&O,AQG;;=K4=SWUHT7-_O.[9VW[;]\,Y_[QMW@,0/'5%
M#C!<;YR,2MWXSI,OW7"M(X]^]^HAISUZY4O'273%%1<]:P42<""1W"E'O_#O
MAV<=)=?]]EYXT[D?6WGODT9Z=;X3P`$2,3C<E0YOU8O;U207P,8ESW,OF0D8
M?+8.CV"C?1<Y`$;F`8!5K$0`3/A$`S9X$0-@H81;&$,17D%"#N)D"U(S1!.L
ML!)L3*&%!*3A)L`P``[>Y`PYE,1&@GC#%/[BABC<("<<,$$C8F.),GPA$)>P
M0PY*PH8]_.$)4?A$*)I0A#6,81-?B`8.AO$**C1A#\]`1#56_G&$8]0&#7N1
MQ4R8<(WAX.`#7GC%,^XPCT-\Q4QT.$(3RM",7I3"!#E"PP4<L8VOD&,9`SE%
M(TIB"WYD(A<)B4=*<I!].[S)*.,H!2+F\0%HO*(=?Z'*39YA@W*\138PB40V
MYM&'FZS")Q[)13A:H8DMZ6,2<2E'(<[D#*YD!26I,<$,JD,97X1E+*UBA1.J
M4":U5"(>`<`+%4JAA(D4&Q)]X9(FPO*$X#QA%0)P3@UN\XW?-`8OT.#.(X9S
MFEL8)P#.B<\22D.?9,0B%MS9Q6M$PY?VQ&(\!UI"!MQSG=H(Z"\&:L:%1C0`
M:H0D%N@9SXB"89R:F(1!SM!/;>+S_IU.\"="PXE-B2*TFTT@Z#676,Z)6M2$
M*#TG/2]R!0$\4IL<E>E$-_I/BM:3B_=D:2H*:E)/5O2=T'!I.Q-ZS8^F8@O_
M<*@#7&H,:<Q4@UUEJB]C.=:2TC2G4/7G6$7Z4X]>HP$)(.!*N;G6D*;3AQ=%
MYT$!H%*HP@4<=W0'$;"QE;""81186(48(G)'C6:#%-*H1C6T@,$N@F(BMYA"
M08E`V<8.P)ZTM,D9.DO1+TAC*Z&%HF4/BUE^6M416X@"5Q%K2T.\%@V-I6!$
M<)M'B^0Q:;;-QC_4B=DS)A*SQ,WE-LG@EU080*Z^U&UM4[&^YN'VA\#-:7$-
M(=LB8&05_LKU[M">*Q63?A:\OGPG&8[;Q--"=R4+0"<VG(O:]):PN2:<;7N3
M6LOQIO>LOM4N<#_;U'02%PS@T"H2JX%@:_[CO`YVK1(!#-8?'A>XZ4W%7F^A
M7,16-K:"O&QW:UM:$-.WP[-D,(8_EPW#L@,CC\NG%$Y'A%O(UX:83.P6O-&/
M\-*7QP,HR@8#B^-P%!05Z30R:),JA;R.UKF9.$`U%AM@$WHCR$..)3BPZV0%
M'(`!4=!@0KS<VQO/,LSJ#2W,/`JS+P.3Q]A8,I$S469T=F[#*UGN>KE(Y3"\
M,<^9``<)97*Z?B[2JF[6KQ"R#&8Q\Y@(<TZSCZ=QWCF#^;=\_L[R:_TLA@;(
M=QMQ[C-F!XCIH^;7T8D6<F]3"(U)T[FJ5\;%IJ^\BD`S.<"!SH83NM@`(>AZ
MTA;6YRQ-G<]B6QC1M&ZTJ3]-A8Q*=\E9^[.7\=MD-\,ZR5?><WQ5[&MMRPZY
M,G;'+FD62ZC:.&R&(",#`D!">%[SH2.49`.`AI4->D,:!6BB>=4[VW3K&[KV
MI#<?Z>WN,^R7R)BV\CT';N]8]KB?#=\@)K@ZY5+4V\S_%BC%%SYP,`--"Q)?
M:"WSO>][7_P!"3C$-C4.W8\3_`$&!S.F7XXV=5/4&TV<G`$,C585:@+C_A0Y
MQ<-9<I<?@.CQ/J%)C2Y7BQNB?4!W_F'#7SOS3X2-W:$HJM)/_HN"CYSH5'?G
M`MCM0J1_]^D!AB304XY">NOSYNN+M=&7^`NM#I3N9X<P3?/>8PJG7=@YI7I/
MZ]UUL@=`ZW-[@,T!#@J3<%7B7W=[X=/N;[;7/.^P;/C*J\D`G;'#`=(S=AK0
MK0!P"(`28-@:),-!A"VX!)3;_(3IP?"X@K[6);2O=)/K#`;#-C&C/'9%412Z
MW<R&51)7/_1$C.I0VR)!O;HO=;KIH5K;\M$?+:VE]%/Z?.T/Y?2^+:QF7;%'
MZ3L_BUY0^TG]\<X15SS=X>2^45O_RHF'W_DM+6SLFUA_HH`C^+BI_O)O_-X)
MH-K/G5+O_J7B+_EB;>W:+X\$@/L,S"A.;X,:`!KN[B4L$*',P*3.KP%'[^H"
M+Y,@$)2<3_>>C16DC[!<+OL*\`1#$/@""1OL@@/G"^W4(/0(@P!Z4&?`K0"P
M`B5DIP>SP`QDYR[\8B_PP0R*<`FVP@E?`@V"T"_P80GY0@I[$`GA@@F-,!Z(
M@@F+4`R;<`F=L!.:4`O!T`C5@`K-D`N5$`SW(@O*L`N=D`K7T`>7\`FJ<`J%
M\`K!#0F_4';:$`T587'X<`SG4`VC4!!]4"D"XP[-<`L3\0D1D0#V4!'A\"BT
M4`H582`H,1#1\`NSHBP:<0W]PBY.\0Q/$0\+T105<2DB<2FB_I`0?;`+^U`5
M+5$1O*(0JY`26]$+EU`3'=$./U$.=Y$KVJ<11Q$NZ#`7%;$3CK$2&=$94\2)
MD&FP/F\W%J]FNM$;OQ$<PU$<QY$<RY$^6@`=6P``TE$=US$=W1$=L8`=X3$>
MYY$=U=$>\S$>Z9$?^7$>_5$?\3$@Z5$@]W$@`=(@W_$>$;(>%?(@'](A([(@
M&Y(B*Y(@^Q$B*W(B+S(@-W(A_S$C)](C!_(C)7(C&5(>39(A1U(B.?(=47(E
M8[(C9?(E0](E-9(F<1(D6S(G1;(G4](B87(FAU(E=S(H[=$<DU(IEY(IF](I
MGQ(JHU(JIY(JJ](JKQ(KLU(KMU(Z_B[``C3@*S5``PI`+,'2`LZ2+,4R+,<2
M+#>`*Z?C+,^2`N*R`.)R+M'2+NG2+B_@+9_#`CB@++\2+^52+PGS*],2+#6`
M+_7`!)X)*/Y2`B)3,C/``MP2#R1``_I2#B:``BJ``CZS`SZS,R>`-#N`-"?`
M-$M3-#T3-#]3#R8@T]X`-N4,=F!'!69"!1;`,>6@`U#@&B>(!>J``@Q`!30S
M#L02,,'R+BV@+@ES`S:@.2U@.9LS,<$R#TP`##)3#D8`!'[S!$"`!+)!!21@
M,>%@`[H3#$H`!2CS+#-@!":H#M[3`"S3.-D``P93.BMS`_1S`RA@`RY@/Y]S
M`R9`0*/S_BYW<PY*``Q&P`ZP,QM&8`+0P`+"$PQ(H#S;0`*PX01,@`TNP#=1
M3`XNX`3`0`3JLPV8LP`^X!`*H`)6M`#NL@/RLSD[$RU5]!!:-$4IX`XL`++L
M`#UC$PLFX#;!``3<8`*D`0Q60$?=@$?!P`+FH!`,(`5,E`W*D@/.<D`%M#(!
MU#\!=$NS]#DK4RZ1$P/N0#ZSTPXR%$330$T=H0THU`!(($+AP$&?5`Y"(!OH
MDTK/H##S,TS+%%`QX`(H`%#],TSSDCG+M`XF8$2Q@4'KH$W5"PTV(!NF=`W.
M]`04-0ZZ4P+D``-FHD3W%`W*LBZ?DT`WX#Y1%0`(%0`P0$<Q_@!,4W4_YU(#
M.$!/Y2!#?]0`+C0.(K4-L#$--"`;,H`.*/51X2!#\30]114-5E,T0U-'4S-(
ML:`#@K1:29,U*0!:*V!.Z0`,9M--Z<!7V6`FNO4,4@`;+)4.5J!(XP!=P?6V
MF!4`U+(Y^_,Y,6`"+D!1,4!0(Y1?\S5,]S,___)6X2`#XA0`E-4`CA57>W0-
M@/4,."`;.%0<F"`$`.!'VY59Z5)`)X!?\14`]-5C^94"+F`Q]=55!?1`-54.
MNI-8#Q8;S!59'58-*E4-AA0,>!40T#4SFQ0,6)9*.>`05%0Z35,ZN;4NH;4S
M75-I0Y,Y<?0#['0SOQ4`X/4#Q)5F_B4T&ZY6:^5L')KT#'"V4S<V+CM643T6
M53W69+%@;?ER4&'57A,5:S462:44:]<4#=I48\\@4CE@'-[S6,^4!.35+`M`
M95'U`B9`/T?6;46V566U/]&R8-U`09=T5;-!.WLU:[%@`QK50M5`80W`<@-!
M1`T@<X45&X"V/I_U-*NV-$^S6MG@=5]W-.>`1]45"]`5#%!@#L:U68<4!&06
M"W1U')A@!=(@&\9V3POW7O/59.=25?GU9%TU9!,7;@]T<MG@/947"T0`&TJ@
M=Y-7,D=`=TO`;]F`>,4!3[D7``27;+'T/ZMW55564!/79#75?I_34`M`=65W
M1(&64K%!_FK?(%*="'S=('T%X5,-0&91]V=%E7E1E5!)%DL?UU4_=H(O6'\E
MMV$-``0^&(1UE6'=8%PW`$X-@'W3(($#(4._,X0_.'E%U47C,D8I($*;LP+D
MDC4M('8I(#IS.$?EX#=QLX-_2TBS(7;70%>3&!!P=HAQMS[U4G^KUV/E\EXG
M>$#7%FTC5VX-]H'5P('CE8!IUD'!(`5TMGNS`4'W@`E.`(UA%@Q&US@CN$RO
M&`"<,T#W%58MX'KWTW#C(#POE@T4U(PU%V]U-53!.!OVU@_0=83/X`*R`<=,
MU%E!LW6MU5G/`':?]3.Y%0Z&TP#.=PT^-(YG%F\[P(GE.$C+_A40FG2-TRUF
MJ91>L=10`Q4+/M9?RQ1``W16S])63;E_L2",4U@-?)=O%YD-2-D`B-4.-H"8
MW_,$F'18J91C3?6*^?66L4!'1;:.^7-EX4!!>=<-</:`27AS`8"0T50-&/5[
M[P`$RAF21_21TP!.&;DO.0"?;91%+4!QZU(UJ]8S%3>'\?)&"X`#/&"`UZ!)
M*^`-/"`;5)E-SSE*B9,-^K8.*L"#V3!<,30;A)<K"Q-,]U-0\76D"55DM31,
MO]D-WA.>V0"4P8"8\_:<,5:2U^`"TCE3Y^`";C.%N[,XWR"`P8"9YQ@Y$36/
MLW2/#_<Y#10YLU>;81J0-12-CQEO_L\@J,&`8M.@<[%!3N/@`B@T<[&@26,Z
M#=*YI=_R/IDS+D^5E^W52SM62Q&U`*8Z9(>4K-'`>[%!D-G@A+-78C%W#38`
M9U4@K`,;3EEV`BA4E!'X0>M3<=6Z:)V5-%T7-4E36RO9`@;ZE2E`=XF3B=<`
ME6=B!7:S`^H6#%1@C74U%2#:M,5Y#3X`8BE@!;!!2=^``IS8`%@`HK,2/^^R
MK0VUK0FTM^-R#21`M2O4GL\SG2>H!"[V`MYYB$&@L'TV&YI;#3(`I]<S+DU@
M!!H5&]I5`DZ8J_?Z##0`!#I[@D@`=M[R`FHU,/MT.A&5.0-3+-E@`4!`,O,;
M!,C[EC\X_K_S6P3V.V3]^[\E,P2DNYA'X+]'@+_Y5`3$^WM!0`1,0#KY%K\+
M'`0>V;POO,`#?+W?<@+T&4=3=$5'7,17],0]VC)&G//D51P>>V`A.\8-M$_S
MU<6/(TQ)52WC6S!)=4MO',B#W&."V1QV6\A-(W&_DJZQ&1#TU3J/G#684VC;
MH`+P.1#^D@,^&\I1HP`R@,@G(`,*NP\R8*BW/#7N4\SY`$")'`,TP*G-7#34
M6A!\V,CI',Y5`RSKUZ6G&F0#V\UM'(RU4U\_N6!+-F15V6UO>7KAX#[OG!PP
M(`,,5P,R@`,NM+TYH,PYES+)<IW)O%8SX%;!/`,NH,LIDPWV_G,LRQS2NQS2
M`7-2*9V/2[T_/=VEVW.Q'?W*6;0Y/\!<SS)JT^`0EO1%-3FSZQ(`6C2AD;T`
M0K/%IY"?]UF3ZQ)'*>#7@[0NHY:'4;0NFYU/N=6'&1K7!>$"R'RN[YA_K?H^
M)8!EH5,QJ];4V18ZO7Q5R9Q-R5Q1Z3U8_7;<R_V6_3C,JW94]WW4`8#,B74#
M0#T-VGM`YS4#5#S<]:#--6!.:S7AP?)"_U)1OY)ET5R;G_R6R5)3ZUM"[70#
M-$".V_LL[;-6RS0L^5+)TR#E6]7-'UX0[%W3Y=@"WOV6(]UMNUQ/(]TR*4#G
M`<"9,_?@63;GV1;?T6#5@YG,7[7+_I\TYV\UYQ?3YFG^#V)4:N=2#6*>V,%]
M`G(8YCU3$?BY6<D^2,V>3^=T+E7Y+,%=H>TTL^TTAV5VV(_=Z[&^#WQ>TP&8
M,@U=K#-@2>?[U<L=`S@=#3*`>V>>3^4=TT?=`BZ4S%4\YW49Z%M5`OBX/.6<
M.2FSS_5^#RA@YB?`X\O;S0>XO5_5XB?UR?_R0MO\5?&UW?GT],E23)F>\==`
MY$M^\"5]4CD`S;]R/T%_[_%9:#T:GW<SV*<\#9+?A[,<YK.<`I+?[I._RIF?
M3SE`Q0UZ2:T<"PZZ`'K]`X3V^;6?^/M`I$]T<@>5C]4`TOW4IA7U.4]=_E5W
MT&67/@65_D\3NE4U_X[?'`@`PB&Q:#PBD\HEL^E\0J/2*;5JO6*SVBVWZ_V"
MPU^+YB(^H]/J-;OM?L/C\CF]KBP4[/H]O^__`P8*#A(B36A8%"HN,C8Z/D)&
M2AY=8!1DE$UJ;G)V>GZ".DY05%!0)(:FJJZRMKJ^PL;*SM+6VM[BYNKN\O;Z
M_@('"P\3%QL?(R<K+S,W.S]#1TM/4U=;7V-G:V]S=WM_@X>+CY.7FY^CIZNO
ML[=_043$R\_3U]O?X^?K[_/W^_\##"AP(,&"!@\B3*AP(<.&#A]"C.@00AT)
M!BYBS*AQ(\>.'C^"#"ER),F2)D^B3*ER)<N6+E_"C"ES)LV:_C9OTI10$2?/
MGCY_`@TJ="C1HD:/(BVJDPX\B4Z?0HTJ=2K5JE:O8LVJU2I%=UZ_@@TK=BS9
MLF;/HDVK=BW;MF[?PHV[B4"`N@$2\%$00,$0NG8#$"B2X$&!P$3T\C7BUZYA
MNGB'#'[P&,#BNT(<0P9\>&_?OYHIUYT<>G-B))@!6!:BUS"`P87EPN860","
MUG0.&&@P9+9&`4,69,PS!+=N([R#H\[].Z,#(<<OUIY='`#N!T2([][HFS<#
M(04N3J>N/(ET``HN/G9@P#H`X!B%QXY?C7>#!A<7V#F/WCGX!@PN!@"``-#9
M9T!B^ADP67:Y^6<``W2-IYX!""!P_M%V_=U7GA#5#8'@8_0U:$!=&/$UX'CF
M8:1@$>7IAQ\`ZEEG(@(%EB:?C<]H^)T!H.D5(&5X[,:98W4%:<4#&`W`WW2X
M#4``@$)4Z!L`1UZ4Y(HGVC>B;DZN)P25$!:GHX;BL3<EDDH.9\``Q^6!VXE4
MJDF><AZ^N!Z7/D9YHY[.:*A?<C0&\%]N?*EW@'@"9-G:B5/@IAX":`H!W`#?
M31?`:^(Y:MR)_^FE'*5$V%=`GP">R.&&!F3ZYW)K8M2<H$NB.J&<NB&('XR?
M.G?IGKLB,QL#=0&G&WVU_7=`A5O^-^"#`R8Y@`%23L$EEWSY.H``[B7@K(M%
M2'M1C<DQ_OA?<^5I2X2DO@*;&X@%LM>M@<DQ8"VVLU6(0`(3CN?NM]G1FAMZ
M,);+J\#+/%<EO%X:8"@`B3I[D77TBN?C%-\9*BFX&36+ZA$4MQ<G$04;@%]Y
M`S8WA'JL:H2R1NQQ;#'(2<YF['JQAIEPQU9JVN\!`RX`L,8#`WT,B`A8&;,0
M)Q_=Y<*R"L&I@X>%%!YP!PR`VZ/5VN=BP)0M1[755_YJJ7VLZK;US4/#[*!=
M%;(W==6R8ATR?P<`Q_9X;G]]!(L)<\GVUK8%'3@O8V:G,-(=6T>`H(FII]ZV
ME-47N>21*TP91YWVVR6N``S`P`-<:E3CF-J6]UUW0_PGZJ*J_IZ:^.5[=QDS
MG/=N>;G><]ILXGJ;=UZFX+_?0OC<""N<J(1R`Z"C`?!)8;H#SX^MH;($*-ZE
M`O\1YN#S#HS]<;Z-EL>EE-,+/R:'SD.OIO0.0GC`O1.>IQOZW*MY&IKG&0KZ
MY]B;A[W]P`,0%L)+CL*J-R-9O8\W/L((X*``'&@Y"P$:JE[&'`0>`CQP"!'T
MWD:T)(2&,4!0:0L/Z\C4,0A.:(+_896A[A._$VHPA3;C%XH49B+K@/""1@L@
M#UTQP!VB1E"U.92`F#8U*_Q'8OHYTG2<]:`B@H<O2>R0MQ:$L1+JSF/E*U67
MIJ@:AYW(B1RKT`!>Z$44S:QRJL+?_F4<)@3=-8!:,^PA'56A@`::!W"I,4]I
M%)`8BU7!CT40Y!T/T\<]"M*0@_1C(E5C&[_8II"#9`T!#O0M0D:2+X6LI"/Y
MN$@!/2Z/G;Q,C?2B($G6,97">("$]O6-!#"`>:J<939,!*UQ$$"6M-QE-13P
M`(GQ,IC"'"8QBVG,8R(SF<I<)AV3XLQG0C.:TIPF-:MIS6O>I`[8W"8WN^G-
M;X(SG.*$IC;':<YSHC.=ZEPG.X_"S'?",Y[RG"<]ZVG/>^(SG_K<)S_[Z<]_
M`C2@`ATH00MJT(,B-*$*-6AE)E.9ST#F`9+)3&GJ(BK6)(`S@Y0H,%LCT5-^
MRWZNH>1=_C+JF3MZYBX--8UG#%,7C&JT-2E%Z60R2KV4*NBA#8R,BLP34YU>
MYB\])0)//]92(JPTJ`D`:E`]4U/"&,:D?RE-49O*F,-P-`E5=<Y1C8"8SOP%
M<",=9$R1VM7_;36I(H7H5ZWZ4K"*!I%E/<)IY(I1J`JN8$,$&;3<<Y&2.:LX
M1V*`?:14/5G""7D=:]47=^2]XOAU>4HJ$'-`U@"]-A!D><@395(W!,JVRGSK
ML2P'D;,<QE[G1'R]&'3P&-F2(0@COL/LGU;+6O!$"CF@_6MN46O;Q(:RM[Q%
M8T9\EZ9*:>>T%V$>=C2ED3R,Z;7\R4ATN%BFYM[V6=,]G8Y@_D7"G*$Q/4J+
MK"YW!:+[@*L^@@J0A"ADH<[&:6PZ"LP&D7J1`[C).NVMD';]]%@H'O!=TCE`
M??HC@'4UX`#G91H'U<N^^7*.P=0I,(,.;%T$JQ%$_WEBG2;$7VC1*;TA&A&#
MH&.$_;Y7/Y)CWH*OIJ[^K%?$]3&4C&A$X`+5QS<HUJZ&`<0E_+J1"#OVC8HC
MI\L0]UA$`*918Q/D7`<_2$-#%G&&K-OD#\'X2<<I$6Z).U0:MBAI,2)0%8&6
MHXN4D$E<8L^7(NRYIQVJ>AWE6!$7L&:$&:"2:'[LG:#$X_'XMX202N"5II,H
MW`A`SE[=<YI'N[K_"B%1=S93GO&L_D4NDDT(A.Y+D+_T0B1H*('2$>T(N?4D
M`'`VT)/^$JGIS#/[*LW3CRX"G(J&Z3ZC6KN4]ABDE^;!55\$3-XA%:S8?*9&
MIVVYXAE/K94`.R?#"-><'=BH=A1=-6UN:<*AK*V?-<?LQ.NF"LAVJ`*MI,U9
M*C#5IF&O,]AK3H%K0&JDHF,;_<M90PH`\":W9#'%M&MG.K>WY'<!/GV[Z3QP
MU"=RV>K0?:E`$QS@U1(W$0AN<"0TZM\+Q[9J+Y7Q1Q4:=08JW:)"56W1LN?C
M^68X;U]UJE2!&G?HO57'\:@G=`4@6/"2%WK,!D@JA<=-2C8"?Q,6()^KR=Q_
M,AN[`XW@_GLW\6<+<G#)ECWT03)Z70Y[>H,;!%C%WLQR>:YBM:Z%GM%)/<*/
MDY1^\+NSD'\050J/E]F=_'2FTSN&:U>?@WCNY*(KN`A(+^-]\7O+-HY=P'VO
M>[;`SNG$?ZO'XU+.X'$>+*UW25\[9WQRZG6O8XE]6K-"48$2X+/@!NUEV4T2
MR83LL?<]CC?S[HO01=1ZDR6=T4IR5M4A[?2-!#S"\P;9MF2/A-]OY-XI*RU&
M7'3[I"6I97%2/=K5^/PZ$3XCPP^CT5^\_-7S_OB,OO[)5$^9V@.3_+G7OA&D
MG^PKAK_]-@.D%9NO*O6K#$D@T]S\IP_\N=F->LA/_^$,>.$/_L_X3._E57\0
M#7_$2];$W=Y9B5\I2(5TE&`,@'T0#=BQG>XMG6*QQKHYX%2AG0+B7`%TCY]=
M8&.!V]HX6MC4A>BHC=C$R>!UC-?`3=]!8`G%7P2:2^YY3E;U&N_-708J%L[%
MX-]`3;U5G@XZ7K9H(!$,WGD$X2\9`=[DX`,BCQ+F%@Z"7`O28*8U(8,T(!*R
MS0V^C8MI8?$E3-W,C&Y@X1<:(-]`QWIP8>H]&NQ8A^D0@6?Q1H6H$6ZL8`9:
MB7[PH<@5G`=*!^]X#NO\'@D!'-RI79JL(!JQ&YD,T"66RR$VS?*`3D9@#AH]
MS,85("?JV_)<G"2>RXME#GL(#R.R_@?$P5DGJDXK<DX#%*+NF6+JI"*LA8X>
M)D\8><XGDL@0A@S)G0XM;E&Q$:.W`",!S4YN-..['%P-0='N"*-QF5<>CL?T
MB,\;L8]X+,"F1<P11%!@F,XW%M&#*)UT5(]U7$_L`%K6K8Z&\(:*3%"C4*+X
MU1O*92*D$(`^JN/TS$_T="/[V.-^/-[XL$\OLML]*EQQ3(^@P1<\\H\E(AY#
M1ME!/L@Y!F,RBIU&ZMEW#4%!\IU$LL\[]@\V,L#VI"!`@H]R#"1"UJ-UF63`
M363,O`\"Q,]-@H:"[$W^R)9*QN/G[-&>_%"^K%"$.8@(!>.[P)P@TM6&%4AS
M@)!3QE:5_I#+1;R*NLUC/W($R,S>_DF,5![!(Z:)\FD$\V&$CUREP;A;A$F0
M4O*=1LS>6\:)0TX7^T7D92SE_C%E5[)@##6EP:A0_5#E<!%F"!F,7L)0W,UE
M<5!08%Y07-;77F:$!P6F4RYC6EJF#$GF7]J,"^7&9[I8AN&.#;E1#DDC$"$E
M-T;=$V61E=@';"E;.>J-H/`-.!Y;5IXD;PX*I""?1A2,G3G7%>WC6=)CL0%F
M_1G,$,QF)RH1&,6F\MP''D4GZ<E)1AAG7\;=1FX$<,91WA%!=J)=E.GF`310
M=CKF&2T1]\DF1HRG>Y;9ZF$1<G9FZ]#G&\;01AH*&<7/?G8*_FKJ#.*Q!QS)
MT>S=""H=1B:!%6LT$F5($B<E@5^$U%MU""/Y46"@DBE-4H8:DH9J$B,I@8@J
MABN!:(=0DB69:(A&Z(.F*(@R*"&1J!)`4H.6:(VJJ"BEJ(@VDH=^$K=@Z"BI
M1F)8:(4.*8^>Y25IDH.J!B(QZ2+IJ)*"!D11*9%RTHMBDB*)$H7>D98FQK5\
MJ))2Z).>DLTM5)I^!2R5EYJZJ9[DTIO*Z9S2:9W:Z9WBZ9RFU%U-E%M9J:;-
MU%K=E%.=I1`F594*541=RO^T59&RU!Z-QD-9AJ0F@%39!4VAQF2L!E99H59]
M5)"$E5<)H4R=E*9]JF#@E7-H*I$(_FI$]:FC@M5HQ*I=+%57J<:H$M5,F>JK
MFE6H(BJM"FE-`0:EPJI;?=FN`N6JZE%+$2M3.>L>V52'E!50#6E&[4NC5M*4
M>E59->J3;@::8H-OM@US8.9[@<I&.(`_;L1W`==M[=6Z"I=D$0YV*=V"<!=N
MD99E[9;<#8I"P@AT4I=KD:NXTAIW1AJZ+I9B)JQD?5H\3EZQQ:MMUIN[NM2Z
M_I;!%L&^-H=T7<ES91<D7AB\FAMM72&YAI>8+6%QY>M&0%=RH=QQL>6S<-9A
M"1Y&,*1L(4'#Z)KR,$^%)(;.MFFX]D=]Y,&4)1DPW9B!J2N#S)BI)4Q^+9C(
M#&V"+9DS_IY(B-7K7G*9<F"8C"58TE:8=(19G;!'P[B7XW78V0I`D1$MK`%9
MEX!MCDU9U1K(I]5+OG'(E(TLAF@<TR;8T?Y8?A5!W#:``,SMU#4(>$K.]C'G
MU!K*WI:8A"6-AZ48>I'M$JY8U_:8XH[8RWH9X@H*A%VFIMW7DT26-BI*PCS)
M?U1(,IH(7]P+`^`&AW5#*@);GI':HH%EXY)D2<X0SYR9M:V.M#W+F#0;1AYG
MF^`K;"KG[M+)OYZBE4#8XQE;@N!;,*KFMOC7[5+/J47)"ZD'`R0&RG'OWA8'
MH>6G>$S*[Z(M1G)OKV7)/^*MHWV7^9+NU8E=]>K9?D#O%X'L_G>-2?QBFN<>
M+[(AFJ))H78-B&]42`*\:`SYQ@(;C2`&9#$>29)8X#>D8L21HNY>8G7([\Z)
MV[J]8LV)5JID[<6XRO("\*P]8JU<;K;Q:C"&Q]A<[\3111_M&<$YW$B*R0=C
M8PVCHNY=VX7\[ZK@\%P-)L&]V\A=K[T-D/T*7,65W!#/G-+XKR1>(J=(G)7Y
MVQ=VL;?-WKCQA;/X1I4TR?$57(0)0/B=#/[`&V50CWV@Z#6TG>%-(A(O'K9X
M\'1%SM9-K38"7H!8'M<&,MY-4+!540K3RX1\GB'[[2A&\F#^2?S\2Y<$C(;6
MK`06WML5P2`OH0^N"MY1X7^$!^8]_L`4$C'W35XDEQT?@W+SBG)N%:#D>:UQ
MH3+727&$]9XJEU[_HI';7<@DV_(KGYV5:=[F\;'05>+![D5&-`"X^AJSL#$!
M)`D=0T:R@$-6TEC:E=__]7%V.=KW(17Z41_P]2"[N1_R7HG,'(D`VJ?YO7#"
M("`F_TQFEJ<WJXE=*@;ZD2?^I7.3!9DX/P#^[;*S&,K+F%\%MZ4L%U'O'4ZY
MRHWY.2<@+]]!?YM!TW/(`#,WQ_-&2.WRO>PZVR>X*.ARN!@"/,"T'4'=8!\O
M?Q8U/J5Z:K"#2)05-N$:\B,8!@#;(*$2:YH1SB49VAH,[@47:D@<LK/WT`V^
M,!&\3!54_E\J)8LM'3JU\`D!/NO=#SK135<B%#*8?PT>%^H'`@P(<L&@WW#@
M^AGCY!EUI^@T40FU0]L@&*(@W[TUV+C@O>4U1O?R6A.>>M:A[U"A5TMU#$KU
M7;-*7(M6@"CUSNV@"B:!$QFI5YZTFW%9QE0=-G-U39/0+B[/,V+=[J9E"!-B
M8R7E9V=C^%P.(R=,-`H+\X9S57>S&_G*N0(3:`?69.,B)?L7:.-!-E+A'2VE
MO0'W+C/<$2_1+>;BQ)(G<!OC`H2PNM;O*B,<KWUD'PYQ;6.Q=O::)AZCS,'C
M+%K@-,J1+9Y*)?YP)T',QIQ:^%'SP?(%`2R5F2B@-MBNN9(/_D<V$%JVCFE/
M"#JJC6SW!?\4)3*Z)%O?COM`QPNEMD-7LLWH3R>63*#@[TPR`.U,=H!G]V!B
M./48./9\6DY:UX=+\3U2Y/IT)(>;(GE^.*15<+H^,76',^N@^$*"(SM*.,Y2
MT1'#78RK>/<JF7XD@$\&>7I/Y;-L:/@=B9T=9?6L+4K9#&[`!S93\_5M0R_B
M9:G!5P%2=<B&)U(E)K^V<'BR9C27AVGZ)LX8#6G&=G@VYSRKIM+H"&/69]P5
M9N[U+GP1EF(&VI;C>5=^&I=PN0D!^IIOA,*0)5TVR9C?-_(">LR*2',"L5IF
M!'$A2:(;P:&S;W>G(F"2Y6$FB9O@_MACRB7K3"9NUBQSP%X2N:;.MAR^@"0V
MRYY"UNZLF2=\`HY_8R)'&$=Z"EO'KN4UCF=Y""@X$U"N$=Z;KV6<+R<;Y>\0
M/$!Z#E5T.F80801-4_(U8C>">O<Z!KL)<7MS8XQ&&*<XGR==`#N$C_MQG@FE
MSZ^E8P2F5XFY8R=R0OND9;&D?W1L4D_1S>?5Z4<H?F=@F.7@:H15VFRRIPFY
M\NRY_BR/:[#-W>B.QBB78BF+:K)B(#:1NJB.`FDG@2D?:6@D!8:7&H:/:CS(
MEQ*'KJAQ`#6,>CQ==3S&-U5_'^6,'LC+RWR1EOS&?_R6INB1)L&+5KQ7`3W)
M)WW&^_S&_OMHMCZPD%HI*I6IQ0?]RN-HC&:4ID8IE292U2.5B*9\3(EI7XC]
MDX94*<5\GK+]-;!IV\,]6L1IW--]W=O]W>-]WNO]WO-]W_O]WP-^X`O^X!-^
MX1O^X2-^XBO^XC-^XSO^XT-^Y$O^Y%-^Y5O^Y6-^YFO^YG-^YWO^YX-^Z(M^
M'5DJ]4BS$U!/$Z1^%*S^99P^M[R^:<0^[,M^&K3^$RA`3]V^:5!5[4]![AO'
ML=(5X-P^7?2%\"/5[`]23QVEC38&FK;^[F=!\=>\%33_&P!_UB^&D$)H`T4_
MN$I_%B`_J/6%\L.!;CZ+`!P>%:A_$[1_%+S_&ZW_$L2_%-3__A/</W3.OQ?<
MO^F5Z'\``4"8<``$`F%2F10P"("`80D@'J?7J8(A31(0!@,">[4JRT*!(2!T
M<,=$(W(\UKH!7K`8/BZ?IV>_.<$EOP$P`X:$P3&\,*JBI;U%+,FKNB6$`R'#
MPP>AA\,"H<P_N;BYP$G!`@;5I`<'N%17VMJDA(`&@0""V5K?)06%7]-35^!!
M9+YB,V;;1>&E`;&Q`NI-,64C`Z2HJ>GH6FMI!`*"AH')<*;B-+D&NZMI@'77
M<:5I<_3Y931G=H#/^B49T"!`@`.:GN4[-X`?OFL+(TZYET0!F"?\#%%1`V"`
MDXL&GC2S.&R@P"NL:C50,$\;2IB8_M(9V<)``8$#!@Z,W)3.X8"<-L\A$H!3
M)X&"!CX:*.)P*`('0!'=S+ES*(-V-:D>39J@ZI,F!AJ<6R-@)CUX0K\>48`N
MZ%:K(@LT\'C$J-6T1>%!O4L@P!9(!.%Y/=JW[T]X8\&<[0L`3.#%8=4>-;-%
M093&BP<8_JJD[V.(3PHD2#J6LTZ';:?Z24,WY)VOGY7^?/LT,.RCH`F6`S!Z
M<>RU`MHBT-K8;M[#\);>5FU3JLT[>2%BZ_KU0+H&!HV<]<C;M]+F(:7NG!:F
MS0+<Y-\N]OQ5]Z8#"#SQ2R#%@4(C2.-[JBP6Z>:O2NM%J_"2*@\J`]`+CZ)6
MGH.+IUOH_HJLN,YBLE`)!&82H`&OCCA`@0/:0>*(#3MT8(&V/`3QB`8>"+&^
M7@0XL:T%2@Q1@`]#G%$7,SB\,4<6'\!Q12-8.N#$(K1C8P&<5,Q01G1LE#''
M)`MH0P$$=!E21Q1UV;%&(%\4J4<A@1SR23-9Q,F!#7FZ#\0B'F")B;&DW+*=
M!0Y8((HWCRR2S3,'N%.)/AV0TR0ASF'@`%'://+.,[DYL4G6<E+@@06D@-3,
M.EDTL4OTDBCT4,\:6+31!@H-%$I!?9P2SCAV5/'&%L5TDTE:.P1`5GP:*$#.
M&ELLE$\$%DARC2Y,9;1(`B:EM4]/&S@@"@4@=;5-0JDD-8D,_N?Y:($%&D`O
M1)D>0L-(0%4=ZU%7G0VR1&FI=9?!(CL,]!M-VK03R`O[!2!#-(HX(A,<([*"
M1($W%(5-@N.3D:98XO#5B!H3;CC+A=NQ.$2'B[C8B#@1F*L^SX3413YZ>D$$
M9(E%F6M7`;X`A6&.,89Y8@$6N+B)B,WPN&:4;]KYB"*L,7?BEROJCN6!:S9C
M@?H*$,MENJ89V!.AG4X":5\GNL-%`X0L&H&+@V:3`)-)?/H`%Z7^%^B:72*Z
M98J5X%KI1,%^8!JN@U:YE8=9I)INF@L.G(&>\]YP;BLF9A,?1!A@\F&N`<@T
M@9'C^3JGO<5`>_%I=O8X'08"$#T._G,!N#LB`B0UH"7)&:"F1L]<1Y3E!Q`0
MO#<O>],]X<^U%'AT`$H/WAF5`H\9:PC90,*EC0OV]T*`3VGZ"/[\@?E@A>,@
M6``AY2BOVNYSYOY[.1L5T?L;PW\;^U/&82I4-!`/,>AJ#V"@`.XK+R"G#6D)
M?3@KG\[:UYW7D01]^$,?B9!@M(CX+R)R8Q_\F(`>!VRA<E9;'CVP=,"M40UO
M`A!%=ZQ@C05BK48\NQ&>!I"IUKT/?.B36_\:13_5B7`B)*2.S>:"/QSMSX:\
MH]OUP%>&\3'!?FIKG/JF`Y#*96H-\R-$":?ADB6&KGU6`%CI&C@BLTQD=4IX
M@.R(XQ`Q_EQD#??A5AG)Q@#NG%!WW9N+'+G'0B8BH8L!P".]SH>UVSEO:><#
MX?1@4CWN&:MN%_Q7'A6I.T6:3X^B\-41'KG".$027!Y;GR4%ADE-&D$3)P)`
M3DHX"D_\K@@K-(N6XN`G-K9.9$SQ),4>F3./;9)B(LLA233I@%7BDF(D&N4"
MS`5+32B-@K7,V=/N``9DFE!&P0QE$I")-P?P!EPXVI4N<1G,#LX13_41@Q0T
MJ<D:@O&22KCF1++Y!'!-`YG`M!R)"L*]:-82DI_D(B5/B3)QGN*63]0>,HE5
M2@.<D@W:-*88`!I&37*1=`&(*!A3UTYVRB%F_'``7>JC"%"0_LL(!BNFAXIP
M'VZ>Z(^-Y-Z_)OI0OR@A>6"D9XUBRLAE"K.9ACRDAL"H!7@@:P@,V$(>M5!4
MH*K!"J`@:HSJ@#CN)34`1^4&2=C"@*!:0:K;(.HP0`&A)A#U0T3ME.JJ>H0$
M$#410DC51?@G'*RJ@:IP180#I,I4)Y!$JD<=BU1)%+G+,.46:E6$TO@4U;@*
M=9%I2"M1%7%8OA)@JX-U+-X:89,T='6O9`646F_D3*PXAAZ)E>IAC5J3VS0V
M$9;]PE2BH#_'1K9Q9Q6`:A5Q5:0F=JF1XTE8%]72N1+T%+;MX@.^NH3+!I9-
MGGVM;O4X4;^"D4]*L&U%6J<(*"B%_AJMFT_DI(9=:C$!L&@E;&8Q"T;??E:B
MQ>.C9U62A)G&(;+O%<++3"O?Q/(4)C=)U!/,<8<"!)(>O#"'?_U+8``/X[]4
MX,4=D!*`!-C4P`E.%(*[,&$"!-C!B=*P@QL,`!=-`<*2!?"$%9``#!>`)_Q5
MQ'\S;!*_F&,`$*;=BX?PX0MS&,8JUK&#9?3A!-PNPRN.Q$U2'$@2#Z'$MT#Q
MDBF,7![3XPH'"=B';5SB_X[8R)X9!HM[_.0@%]C`,XXP,X8L!`%#0:AACO*9
M_WOB%(_$Q0BV\8)QT3PMNUC.%DZ4D.7,8^P*(\137O,PM$R%FVCXS4_`;ITG
M'&0HC^1V_M@=0I(]B&8-4YH*GHGQAL_\8PP_(<\F9K00\DP7ZGK:OU'6M&.&
M$>8CZU?6L\;'HM9*ZRMD4*&XQL)']-?JZ;V$U[@6]K`]8FM@&UO9%M+ULITM
MD&)/(@"[MH59GGWMZ?$OV;R>-K:7H&U:)V#;WM:ON,F=DMJ>6]W2IO:ZU6UN
M=W>!._&F=[WM?6]\YUO?^^9WO_U-[T[+6A@G'L2")V'P.QR$RLAMWH4:GNI;
M(#?B6$`XKRONB@5?G-.J"+A^^3L&"-.BX@B_Z1W&S?!G$'P)(5^$P36^X?[Z
MZ^4HOX++'U[PFT^AX[2V],DW_F^8F"5.H9!UEJ`R[U)$XC:$_B@&)\"PZVA/
MXG$U3XS0PC"2QST%"U$7B"S^,0FT`HH28E\$*)XN:]K5O+5>0P4S6-.176E.
MZ<:@Q26ZL/9'M#T@2=>>*RK!]$7X`A!?SSMU$U9VHN.:']X(/.'?L'1_2PMJ
M'?E(SH,>,RT((A"I(XE@%,[W?KD#"Z0T%E!<N@TDD!)E64@S3^=1C[JW9(Z]
MGOT@ZK.&RNM72+37!]+I$,BWOT/NTX'])/#&D'VP?>^"-T74.;]WO9.A^81/
M'04%<?MC6_Y"BQ\^Z%7Q?'XCB8UH,$>`OH`@]`BH0&_1CED*L`8E(3<OX5F,
M8:2SF_8<)2QC,9!/!E`@>.@(:XN0_K2;@@=0!*"X#H^`&G%!`DA;/6EPB+?(
M/ZL(D+=PD-/(B=D`$*Z8P$21BZHQ"Z?3BB4X!`JAC&QA@L,XO_/PB,20K+1H
M"?8KBP$P+L`@!]$@C1?,P/\(C[=S#3!(C_++C0W$P+VX#=FXC7SHC?I0"N#0
M/^$P",EXD.,@BN10BAM4@M]`P?KQ#R'LC\G8B2H,+8N(0?9(@@F9BL80%?PH
MBA4TCP11OQATD/;C#NX3PO"X"KT0BY_PB/^;PP!4BBM<CGP3*3:$$WB9EM=Q
M%&#"%4\)$46*OP(DE"Z1$4?4%R#A%8*0G$CB%$1L$>YQEPW!E&/QOBM`!Y3A
MAS)0C8<C_A%7,8,/R1!UL9=K,9-8]`^BH1(IL1LK>1V1<<6.TI4>"<8?(9*,
MRI9/3(!X6<1U:41*<95(7`-;*953899'L44L$11+I)1VL!1,T11LI)48D9(O
M0<8CV99$41944958%)2.2@=RU$5+3!%K<9':&A,Z*90>@95!H1-[21--7))G
M!*LZJ45C%`)#9`-=Y)!E#)<U$45H+$6"B)PM$*45<1=9F10MH:E+!,4ZX11[
MA!%\F\1>JB/B*9V'L8;C49[,<:8I<)RB2)MYN!B8K+4C2(?3R1WEB8.5+!H.
MD3MD2(A_F0]J*(,,TQWIV\DV2AFN41[E*1NLD9NF/#Q1B9FP_A&)F_P=NL.&
MI]2:))C$J3P]E!R;GHR#EH088$,;SDE)L@$:YK&+M&&-/&D;*2B;N,D&QBD@
M7N0=O-F<L.$;JO&;S`H8NJFC[BF<CD%+<J@<)@B9]XD/GZD@ASG,8CB>ZLN&
MZ(',KV2&L.PBJ/"=LCR"L]Q$ATB#QRR'M(%)7@(4,"K+F:R9PTD<>QN_?\D%
MJEDOE'P@W5FBEJ(B1GI)]<&CU\0>`A*N+_*=ENHLE"H#WP0\+-"9)U!`TSN%
MJ5J:4FBII12&ID0O,$HA>I#*VP0CF0*@[$"=V=N\\XR90E)(;ME.L>0CW<2C
MWB0E;$@@)K"BV4.A]@&B(^!-%X*A_KK<S_9)IR+"H3$R`_P$3-X!(OUQHMTQ
M3`(Z3@2Z'05]&8`8!_2Q*O7$GMUAC2R:B)S*4#;D%MOD'=Q$2FN03_%L3FPP
MM0#ET"4B(`*R`N5LH:61T"2ZMX\",9%`)MSDHV)ZJ)8R)4(I"L6R'$YZJ'DX
M)TX2KH@JJ1%!#]T14CD@TJ0KN4\HG:EJ)@4\!5ABDB-UH*VL*1PY*?5RI$^J
M*4<PJ5TYT]J9I83AH*V4IDSZI$@P`)#2"3/]T932F53*(X0J(5Z:&%%AJ#[]
M)7`*)[6Y('(2+2:E&`+5)QS"*$)A*'DR4S*]2;K`IST5IGT:IDGJI=V()B8H
M)B1=).UA_J85&JBEU)W+M!Z=PJ$=_2H??:[B(843H5(O32AR<-%3S9F'NB5%
MNA$I550K6%)^"E5?.=)X,P2B$@7;XM/Q\JR6.BYN*0#Z0C.BXH;TXI/-*BKA
M\JOQ<L!M[4^Q*@-K!;QL-:L\4)2QT)ZT,A4%6%<Q]8/(BE;NQ*^@XBNI`11\
MG=.VXM4C.*PY)=BK"JIO\*Y_W2/SJA9J%4]KQ2L(2:Z&_=9.22^Y+!XDD(+-
M"BK30JRZHB["8BTPL(GFBBVRBA'5T<8XP->YBBX>;2HE.-E;0P/`&BV$!8B#
M52JX`E<E$JOI2H+[VMDC==;]H8+RLE79F=9SA5A\Q+_LPEFE_O*LERW7QN+6
MA\TNNW*NF-V?5L"W>444-WL"+P,U4T.Q+?NO0?M`?=`Y!#LT2+NR&)M8)%.T
M3ENPR\@RM%VPM46Y<X@$A5.P*(,Y-T.U"].S2..P4$-<N06TM.4QQ%4"+]LP
M<9NP2&@R%^NP+.BPL4V933-;*-C;">O;.R.T*ONS'9NP4>,RSVTTSNTP6-,S
M,B/),Y,R$2NTVNU<86!<R#VPS%6PD2C=(JO="\.Q*\NQW_4T/CM;$H,TZDK;
M54NSL.V"WFU=T%U=M<6/+D`4US6)0YO;A-.JMQ7=(1!<X+VQM@6ZZ!.$9B.(
M;F@W?&M?D(-?6N@V]:VWEY!?5>`Z_L5#MOO]7UG+WZ,U)/Z=7P"^`G@3!/M]
M!>V[MP4^8`BNA02>@P=6A0EV-W"+8`V&B0O&@@KNEP[>8!$>81(N81,^811.
MX7K3-!:6."SXN!S#N(.`L09>!):C.76`."5CA!F."3C#X9E+N(FM3DJ(!!W>
M-,^(B61K8?TJ.0+P.9R[/H5;WB86JB<^N!KVC"G6N2RF!2@VXHGK@B.VA9<+
M8D$P8QPV)#0^MZ$PC?,SAS<6)"P@A<X;`LB3!A-,@`*^NSPHA;_#@O?2.CS@
M#3(X!.VMA3IPN^D;`[/CU=XX!*1K8_]ZXT'6![$PB:FS/<A["IZHY$KFJ31`
MEC;PNZ53_H8M.(0]WE^X&^7&HP6G<V3HLY`VO@E4IKBJ^V2824='@+:OV^-H
M2V7-8X8_)K>9E$"7,CV`$3U+P`C)I5#E\SR$^"R40+YY$P;P\PRB6I*A1&;?
M$R4(&V!;L`;8&SQ*H#R0X-4H*%J'\@E-Z)9V'@#2$YBJ6@3.8Z,N]8AWYF90
MGF=X<(74*3[`U04(:SU_4>9^;F5_-HB%J^,+B>>_P-;6BV=]5F;5RQYBV#K'
M"^9CR&B4@+UKOC9NXAB?R).15D:2)(C]<,'9^`NF6(P%>2(.6I"^J)!O\`[2
M\#^'J#^:_MGR'4KIQ"&7;)'J*`SS@T/T@.2^&,.OH\VBX";V_H3%4D*"G_[I
M`\1GDR8\^E,*F<#G7"BED?[I8(C!W3!JS1,+>L"(SG`(/W20Q9A#"9R*.<9I
M%DR0+ZPY"X1K,S#KUSB,VIB_&*Q#>6"=M=`@I%`._P-`,*#!):AJH,B=JL8"
MQDZ(DF[`GH;`L)X*(R0*^;/")]P)*,A",'R0H19#P@9LR05$_Q"0PWAKFSC#
M=6N=+?`"HDS%HORZ;LD&4,21>^RH9G%$:?`58"$:WXX4?J&Z:KPC->E'BV"`
M,BI#D:#MK9,=4^D%8:&265S&2VE`2)E''KF"A#S533#<#XSMH>P.Z&8KGQH#
MB&P><LFFEBCOT"'*)9B7<U%&121H_E%ZG6_4QSNZEE2YQ$>T;7B,EOM6[OE>
M2&$L5?W.E#9-1BY)$7>)1GG@1('Q1'9Q'^%^1E)4'69%[S3X@@ZWFVF0;[IC
MQ='KR$])D?FN1'8DDFGLD7]<D5&T%CB1<$H<2'9Y2'FTDW=UMYA)4=H^[UEH
M'1E9Q(3A&=+PG+3!8Z*:G)A<G/)N"Z_4.;U![N'4S*\<`/HZR@X"O\7)(+$I
MR>RXS9.<MCD:FIJ\`I(LP((@!)%!RB`G<:'LNYJ32:_YB_-;ROBVSBY8<L+<
M(U282T:9&B*ZHSA%S<5!F#GEE@%_F#WZF%,D\SG-&;89=#%7'I@\GM&4!JRP
MMIS42NXI_LM-9R=-H#*GQ@*A%')3X'**B\N$2?,0NIG`=!HD_X/,U,I/'_6O
M2?2Q8<OM5)Z/?C:4L0;IE&Q\IG,R,B,X:JGRP"*4ZE5VZ*.@^2WPV3K\I%%[
M<JCU=(Q3+O5AD"=VWKI0B9DFXAWWW*,4W=`C*I^EQ@\$`-(1Q1!/&(=B+W;+
M(>1%5R*4>KX`*!-K8F=[KXQGUQY`YP-C`M#*P7;NL1K_Q,XI2&:U>?1MCW7#
MG/2#%PDI<,\.[<]G9U'CW*+X%,\:752/%P+HI`+1>.:3#_@RJ$XO]\\BXDSU
MZ1L0RE&=57?W.4[YH4^!M]%T]YU?MZAGOC9RT>UQ$92C1W9K_M*H]!S4F?Q3
M:/>'A]J55=(D+%TH>*J18LW*7P7J:6.L4CHIK??JJ_=FA,`D9*K5]TSWBKJE
MLI]5D7`KCCC2HL^7H^?2&M12D[""LE=2KZ&=ZX@IO,=[3/A3P5?:]TNX/YB\
M<LJGK1=Z*G7XK1;3/;)Z9E7[0,B91I4"S/=410W4LC>7)^VF@RE670U4`]3[
M+RW[,IIAPC>&U6=67=4G9K@E9`JE084Z=4K6KN]3U"]\EBJI8JK5A1_Z9XO7
M1'!7?<"JD4B%ZW)1VL$>[Z(ESXKZ.$BOT<*J>%6#=;V#UK*)JR41;\TO>D%:
M>57^[D^#DB4?I'6LA9VH=(^NN>I^_H_PKD]`!*V.!*Q:*^57_D"L;2``%!B`
MHE'`2!X"!H>QF#`P$(0A@-!@-`A8+>$)0"JM`@$`,0`PK%:P8*$V&Q))1@)`
M9QC*YC+347?`UV<&5H06QG>6QA"@H&40T/:49U>6Z`;'((=7EW!9]JA7%@CP
M8%!%!#:`\/38$"D@Q:!PF;<GQB!8>/H%!FM@@$"7I3!I!"S<M55TV5E\W!P(
M*B"Z!V8M4)GP&FDZZWM$V!UP22Z;I/`=?C0]6_N^/9CX9VA_CY^O7U3EV\]?
M(!P7>W>,)!@X,$&`+]P`!#BH[@F!B/R^/)P(\$L5=5CN!0A@1,%"+@PY%J!H
MJ."5@!FO_C0P1.!CP8$K_;$<J(!AD9P:3U[1.+*C/6,HB=[[U[(FGH^.*KJT
M=U%=0VP@H21%"B8JGI\`<FZ](U2B.J]@6>X,JK%D5))I[WEEVU7G2HXO8=YL
M*S;N5J4(@0[4^N#`4S`8)?KDLI!KUY$.(=(,3)"I28UU*4E6ZK1EV"=KV\:D
M*9$QTHT&$Q/V?-@FQ\]%($.%*,!!XMBF_\%-B'*?[MV\>_O^#=QA@>#$H0XO
MCMR(I.3,BRQO#MW0\^C4\TVOWAO0\.O8C6CWS;UX^.[DGWS7YPQ3^?7LV[M_
M#S^^_/GTZUL_#G^\_?W)]8-)H!*`_`U(8($&'HA@@@HNR&"#_@X^"&&$$DY(
M88467HAAA3$900!8[("F#TTQ?7341[F!"-R&_*@T(COVC!@1BBV&:.(^,KJH
MXA4J&;3BBBX>]>-O,B:&HF*]%?GB1T%RV%1P"G"SXVY(YC.E*U%6J4]5$@D4
MY)-;8DD@F)0P)Z8A7FZ97)EEGF:@+%4Y8(!ZS12RCS,#!!/,`X;($HQ@XOSG
M!&]N%@'G$7@VD-L3=P9C"9W-')JH$8M*$64"@<HYIQO>`%`H&-[<J8X##CB*
M3WK$F7I*,`68FBDEE][#*JR0VE,`GFG\]H@4<?H6*WJDFJD'%$[TNL\#KV9J
M::RY/C$/=9;^]JP]Q-KCP*W%3>M6_K#"8KL;MZWVYBU\LA0"2U<HA:L>*T7<
MN><2=."G0&[J"GH-`.4VX^X!?MHS0`,?Z<NJ`/GN:TB__Q(,P+SFND'JN$7<
M^\0!:1Q@@)X(;*(;NOFD%P5(`S`PJIGRMK+QK](.;*8!VVW:6P$(N`R<QM_>
M`_.ZK<B,3*+Q)HQ`K#6+@[-N"O,V-+,F9YO<SBV3;'/0>QZ-3:2^MFG`2PH$
MD_``!%!\`"!2C`4++5L;<``!=I(<Q9YPV/M`OP8,,$``>C@1S`!<$X!*`2\-
MX*@L5F/=S-I1+#DO*TA\'3@4J-Q3.`(*A'WUV[#`/7;9H?C[Z-^[,JM)UP`8
ML(`>8M]=_KG9`I3N=D&/?VWWUUA(0:<#^\8FN@)NPRUW$Y^_C3HL6QP^.MD$
MI!Z&X(LSNZ_L!]01T-VIWXVG[JY`WKK88=-9^NK!=UT[A]!+7S?P.3F/@#!P
MKHW'%GGO_?;NNM)BA*U9-YNP[UQ`7\7>ISL/RQUUE[X3R)6N;@'\6AE01['M
M?0%SJ[#?\X0G,7M1[FZYN]0`I>>^V@%P76F`6_5R<KW>O6UN67L=`JJ5P/$)
M[W48*Y#`#*"`!RP@3GPX@`+*UX`$"()3"]A:&6RXBT)\;`$+:`#ZVH&`+)BM
M`0_XH390(8`&R$X!76M``>!T0_R$@6(QG.$1T#<'QEGQ`4:,_J(."_&&^$5)
M4F,TH@-ZN`LI,K&&-^2;`QI@K1=V<7-&T-O5]"8W,^X"B#^DXB`(&44]$0J.
M9<BA(-[X.#KM\`B.;&03!?;$)1)@BEV+XM9&54F!&3*1B2M"&)^P@$OU2R1(
M,!LBF<A)!Y"1C+EYHP\%&9L%1/((A+3E(&]8M3-Z!XBR1%0S?A?*5R:@`4N`
MX;H$8T4L)K$/<A1F:\J8"/IYLFNQC"8,7R;*."K2D[%<Y"UMB`9/FC.(L<1E
M.,VP@%]M$Y3&(N8?>E9(00AB<(0B)BTI><<SOO-/?*@D)!N03TON$XJY?%P\
MDVG(@T)M/F\X0&!JE0@$Z$D!HL($_@&:B%`$Z!.?ZV)`Z)C&+(0"HHG#(H4#
M[L`**PI!B@(H7R\X9]$#8+24G]/2*F;1P]BH)XVF]*FB@,H%D`K`<"W5:%S0
M@=.+\I$?%2O;VQZ9T9&*5&#XW.H!>O:JCT:Q#"V5:<B*$$]FM52H?``93%LA
M4[T)U65LK>E(A<I3EJ&53OWJ2B/.<%<GQ-6*+T,I/Y1:5[/2R:M44*I3.=I2
M9`Q';S]35UT9*U1$_)539AB539M@!J;*B:Z$T*837#98SU8,%9A5)5PG6Q>Q
MAG2CPV.:;`L*V\N.M'A[.BU8[05;`,SP$W;E*A)>*MF9_HQGNN4J0<F:",6V
M-@QNC>YP_M[0W*\JMDT+&,`,\9;1C:85%"`3Q%8%<$F;=46OI:PI-7@&PYC"
MM@`4BV)E`N==5&R.J/SD%TK?RUL\'*]@_RWO4DE:AL?68GGX>4-^P6N(!N#1
M7GBDQGD?<.$$[R*][9"=(AIYW=CM"P$]RR8AX&N[U\[T$J3-:ADX'.#^\G*8
M9PA4ALTP6)<M5QH>IH9,TY-A`S]VO'3*,=,L2X@;+T(-;S(#??<@X4L8[L1%
M:/&HM.GD),ZWOA(&[(O3HZ[!\MB\&TUQAX,X6`MO.,!&$P))Q3S#<A07O2A^
MV'Q1.F47TSE35R;$C^?,85;`$,3%4_.+_\S=*+2"AK%Q0CQ/_NS4GJ6RT$(D
MV1VOH"6!_>O1&1V.%5GA.=GA[65-R-$;%/TY3&M:AX+94(Z&1HV8K%I?F,X1
MSYX0Z0-3HZ./7FIE3BV,S]E:N-Z`DYP3,>DW)/O1RS95KJDQZ1(K[@ZG"-D\
M$NSI`J@KU/KD(;2'Q6E\/836.?JC@`/05[2"^Q+<UG$K<O1L0D2;3LO.-:\!
M#(!V'_EF\EZW&31;E32.NE979BZ5W9Q&?"H"7SSD]L!UUVR^MH+;A[!8HX5[
M8"/$F]O?YNVH;"TP;YN!V_<L0[VS701]*PK!;P#W%\_PX9;#/.)GR+;)G8``
M3M^\>//F;AQ2'8HDT!03N;`A)(Y]_NLK5&P2?#(@(4Z1A)B0S1/V<L`?F:X)
M3@RAZ<9D@RJ2GJDR;'U60S@&K`/QAW$(W7023!S&5/;U=>WJ%$2OQM'/87=8
M(%T:2J!&-HZ:A%65]NG@^(,\WN'WHZ>'Z^HX!M3;%[V\Q\(,VW"W$+Y>],2/
M(B2*#X0HALXQ3_PL[6K7^R4`7N6Z2/&/ETC[:(>1!%PL/`SQH/KJ5>97T]/)
M\%2GKA(^+_5`95X;GDB\WFM^#'30PA:>T.PFR`%U!OBB\BAU?="/#X78QSP;
M>/]&U(,NA8)?/Q)_+Q!&R,*5?O3%.1"9BV(*LS`6R<0I"3$--Y""_K"<7RX'
MF3^/](\2_NO7?P]!"9L!?^R'$0""&FVA-/OW%2GQ?Z@1(ZGA?BC2&>G'&*Y`
M@;?!$/8W&6$@&Y[1$ZO!)`3((QH8$0JA)!5H$[XP%H.!@#R!@2!"&HV!$>J'
M%TF!$O<G@5R!?O$S%CI!$PIH)%VQ&&P!&K31@CLA%RQ("1^H'.V'%%-A@S)H
M&SV(-UQP7TKX?BRA.@?A?DOQ(6:1&T2($#[A"F@Q@R.H&`J1%G&3`/&T?C7X
M&4N2(?SA'[N1A[RQAW>X'TX3'WTX(4M%'H!H('PC'&WFA_KP,<NS1HL(B9$H
MB=#RB).((,-#'@*2(0\0))IHB6"P*I7XB:-(BJ5HBJ>(BJD8_HDB8H<<0A)L
M4A]K0B6MZ(I"0HOX`!JRF"9?<";E`1<'4B6YV"57\HKLT8NXV(I8HB:W&"*W
M>(Q%>(>ZJ!N_"(N36`;),E%SPC$%-Q_8F!SA$C2`N'C9&!W@QQ[TTQW1(BA0
M8PO<Z`K:`C3DF#3P6"HF\RS7>"SW*(^&.#-#H2WZ2!SJ2"#A(I`ETRO\R"#Q
MDF>^`F8D-1\+>2WRJ#3@(H_20B<(V1OQLF/=@8[8431U`C4[`Y%]9%@FQAX;
M:9'^92Y%HRX3F0\N&3/96%G\1AP?^8?R:),6>9`5R2!9J#<)LU23TCT%!#_T
M@R<:=#=L5#7W(SSK`Y0B]#$8E$&N_I.4')0U'\1"^R,\MT-"E`,+)X25I',]
M5)4_3^D\'<0WIS.6ZV(_I5-!#C$W;DE";\E!P:!*;<D_(Z0["/0UVE,+!042
MA%@_2YDZ<EEJSI-"!$24MI-"64F6/WDG:7"4B&-*30`W\S-[;K,%`U26`R`[
M6]D__)"4=ND<78F6A[,%%50W<+.:6;.:6H.8E'F5*>0]PN.7I2,^M6E5X/,V
MXH,ZY7-"H&,(_U.574$]#H27MGF<I^276+F6]G('2W5!K5,VT^-TZ5%!XM.<
M_4-!)&0@WI1%!150D\1#/F22QS2>"45)G]1-5_1-J_)*@9%)``51Y$D-N"11
M[Y1("V4Z_@?U4`+52[J$4)(E35=$3/?94`-Z3.Q)3/RY4)R$28/#GW/R3PO:
M2?')G^UD4(PT")/&0/-$2N_TH,H41^'@2XUT1A)%H-\TH%&4GD9`2PBZ>%O`
M3<0$GDD4G\-$14Y0H?QYGXC2-0_Z.XUD;8W4GP=:24"3I/@241R*3GRSI)SB
M3\84!L@$H*.40\S$!+E!3L3D'1Q*HZ#T2>]THJ2T3BCZ2`)*;V;0"!H*H>;!
MH;,GI"D*IDU$2!-:(*K5"V4@6NEQ6^?)7$VU6\W@6ZE54ZM%`--U7#O2I\7U
M5<^56,/A68%%7<A%:-@EJ%RU781RJ+V09H.WJ2#H9FE678N*_EFE6EUSLEQS
M16*4NJC`M6(M=5N#H#=I0Z@(9V-WY5:*FG$<@EAE):FQTZF@%:BO5W>F-:JP
MI:=50ZG)]9,_\ZKWR:,]XU9(EF=\RF]I%EG:N*U>]E6W]5AFTZU&)BDWDZE?
ME5F,8%1A%ER'-5:LRJJ,-:MA]:O6Q5DP"GNPJC>LP%@2@5BSMZAU-:_>2JW(
M92!/9E^)<*T7:6"`NK`7]B>HM650]A)*5F=-DV1KQF<Q]V<6*VA_^6,Z!VB(
M5F5<]A*?REF7>I%9)F8?"U^Z\&)UYK*)L*I9YK'E\SBY55H&-@]-@#XLYI`0
M*V@PBU[4<'8]YF<AUD<F*V4L1Y*8_M!GXYBLRF6R%FMG,^5F*S=HG:4(,"-H
MUDI2HX)D*#N.^!9D'J9@^$:NZF5H1?MOZKH**O:38]:U).4R9QM$S,*S22LG
M>..AL,6O&DNWZ"AH1'9<>2NT.&L@#]=2"ZMQ%N>P++=L,_9&#B<,!"=<_E9S
ML(JQR.9RB:-PGCMSFOLRP+5S.==QRH9SV'.YNL-Q<*!P/<=PE>L$LE.ZA.5I
MNO,&MZMCG"MV_R48;T1SO,MQ269Q\T`Q#1:\X79R]J*[(CLT\2:ZTJ9TI%9P
MCEME-P.[@W"1RVNYUDMS1D!Q/\.["?=#/'2[8&N^2%:\<G)M]`9N]N9H,2>^
MM:M3^U9W_L.KKJ\V<?;[N#`7<F\4P$04O\?K*-)[NHZ2O/EFOZPPN?^K<$#F
M:2U:4P:<N<7#NP=R>R%F?0RK!(#:P>1@*.FP#55G;MT7?>$0PD=G$-JG>7N`
MPN``?B!C?.2G?4^PP9V0!`#BPG:W>8]"PIZ0PM%'#)$PQ."@JO_U#C$<=?*P
MLWVG"#<%Q,M7"-`W"T5\;'Z`0<.7".7W,%:G,JU'K.D!,[?`O2-,"R6\P=W7
MPCN<M:T!#F:L?#$T"P2GQ<LS"J3GQ.Y+OSO1>;^W=OA&?<H!6J4W>4O6")/`
M>V[,=S"+>$O\QT2KMU#<Q3<,H[NR#4RP/-C7R$%$)]%7I%QL_L51=R`_F!!@
M""):08UX@,IL>`0AJ(--2!I#:!H&T<IA&!)JB!"B08%B^!-P*(<]6&OL\(.8
M(1*WD8$@6!MFX8900"1HV,R^[!3G`LM.*,U7R!6=,1"N0:A$(A#0_,PDB!N<
MX1B>D<QZX2%0<,LA<19(&`Y<:,QR,<LX8A9&6!HNB!;VEQ@\B`?QPAC\C,W"
MN'X<@H:J?!=%B']/.(<4F'_WU1!8$8-<",\U>('D/!%S>,[VC!GWAX86S1,@
MXH;K5]$U&,VJ6#*1V(AV4!\8^1LLG0_GT8^6Z-(F71Z"^#1_0M,YO1N>N(BA
M:!\\[1Y`71W<(=236-0ZG2&>>-1(_LW43>W43PW542W5!G*,K,$>)F@CM/B,
M:E++\"&,U0C6P2$FTI@9OO'592W6_F"'9"TEO"B*S;'*`U(F6-W6L)@C'5+7
MOO&,=#V+:(TF?@W7S'B'RP+'JN*+Y1-L!<DP+PF/WJ@/J8)[\2&UBF@0W7HJ
MY.@TF;VR.`TM+>78*8D'QZ(;BCTGA%V(LY>.HBTLKL(MB1H,)7G2BC@HG#)5
M*6'9NF':KIW8JHW3Q#+9U$$LI&TA/],Q"2-]Y,$*6@@WL,W9M()G#HD/Q?TQ
M@@T=Z0&3K()DWTB.,-DM/$G9O^T;+9EBTW(VOY&3&LG<Y8C:'LG<0S.2_J7<
MO''=:%0O_A##.*W`W?JP7,F-!<L=V[Z]V=5!+#D)(1<4*+)S!$Q9-H(6G'#`
MX.?#E_!C,U]0`%'`.Z3#-:/R.%5AX/'#*%0I/#36#+]I/L*IF1-!/2F$.83H
MD_HC/A,D/+FY.WR#E"&>-3?NG+`#E7/CE>83EB'NF"UNEEMYFFH).^VPE!L4
MX9'C07AB!J7CF#.^03D4!K#9E!=NXZPI/2>^XWL9F[3@EX.PXK=RXH79G8>Y
ME8G9/L;Y-8HYE0I4KA2>`%R.X40>YO2M.5=0Y[OI03E^0J)YY:XEYW6SYZ;S
M.!<#XI9CY!C3Y<?2G(WYG'ZIF(_^-6-N(+'4HZ2BH<O43+60_J7-I"\[BDL<
MD@4Z5:6;=*#HU`03UD\[6J%5FIX#E7*.LNE:.FAA6J:5Y*%5<:.K$DJ%E$Y+
MZDGN1$AA1TUT&DGZR40/FJ#_^4L[I*+`5:#M-'C17J6B7NQ;A*4"-:0NV@<!
MNDNG7DX8QV0:ZDJ&1*%4"J(8FDF;GJ:WQ`>[;J'TI.WZ]$00ZD[,4)XE2I]7
M2IY=8.KK/DI/2E9QBB\P)$,TA$BO9#KX*:!K@^E4ZA*Z<%U2E.IU%!L59E`'
MFJ#?CJ7R*6/[CJ8=_Z6WI.^Y?D;R7B!K2^XXG%LXIZ[IJ@;:BBD?13%M([<-
M\%AP$G<L7ZP:YEQ[Y?*QBLCEX%L#_BMV.;0YRRJN)A:N=<6VYTHR[Q6IG*6H
M;G6I\23UL'I63$^VN'6OMXIA_4JP=:6^_S92F\JN6&L*^3I8ZD+VO_O*;G;U
MR$7S!_2O26^KHDI7N6I<N^JJO7H%2N7>OP7TC^JK-Q^O6D5;>/^N:+0`.851
MC,582%;U1.7S@W_S\C533R\%HDIH<A5%P5KVPY*JOOJNP!KV@S]6"H/T`E"K
MM;T?+(_@AQ``*`MPI\<(7W\$Q\$*:Z\W0\9@SDI8*]>VBB2E&H?[,9]EATN_
M/KNT%'NL%6PN`);=0+]GEU"D]HK]@58^#W5=(@NQ)(NP78:R?4:RF'"W&JMD
MV*JP)'5A_B0+_+$%.H(%N*T`L33+-$![LS#T]<X/!`*A`&!P+`!)(:"`6`(0
M!^$#,$`8&%+!8RFT)@$"AD/Z!5N[@N@4+"@DT<3F>HN@*A3#L9887@P6#`@,
MH+0>Z!Z^AHB$&MX$D``<F1P1P,+>JA"L)@L:[`#P!`X8"M(Z&QH?B1"?K`P4
M+L7(AL($)I_"]@3,=&G3BHXNAXF+C8^1+P\<`,B:P!(,$@`>!)>;M:`&`!@"
MEC:YC;"!DQP0"``6_BROR1R8%[P:P-H/GL^<&"&9(:&EJ0W4^[:MVZAF"T#E
MTP?@@(%,``8A*"`NC9!WZ6JYLI1F`;](_9S8LM41RCX_W]XT_DA%$D$\?23[
ML>P3<2(S@4@4RFQSX"#,2#[3*.*5+YU'G9H8,B-#SV%2;%]\*G%C20G/(T!9
MI2P@4%_"140:/C1XY(E/B9(HNK35RVLO31P]@C&'3MU8=1XONE1#1:&2!=$L
M$?+I4RA<*)'JW2MW+MVZ>GF'#$BECZM.K%"T!@#CU7#()&VI0N&;$6S39*=1
MITZ2@$'K!(JK8"D%@+7K@=R\L2(XH#6#!.0@7L&B(("1VKX5M&[@@$B#;;1[
MOPX-H#AS6\D;&-!\1G:!X[]UXQ8@.T_O;$NJH0.S7$'3B@*2,VA`@%SU--BU
MKVYM8*&0^/SQRPV@UIA+#@OF]`DP_I3]^I#$@?;>^*XV_OQCL`WR%%PP.P&%
ML$\`^S34[K\^JOL.C&KT<ZVZ#(50;+S6\)!/._1D(^"[BLQ;!"#UPB#OB0"K
M<4U&#C\41Y?6#J@.#!`KW!`,`H1C(`\,AXQO/CV0?*(?!H@@),``/;R/@0-3
M]`TV*`T8KCA27+.2ON;XL^5&^"P,D,;6"F"@C1P3M%`)\Y0\,@M@TE/-T$.)
M(:``]6*Y1($"&H5H48C040"=:0BH]%))T<F4TF$"V(ZV6!15KU1/\7ARTE"&
M22"!3CN%E)A'&RWU4TMI"\.!`-0+X%5+8:6&)T<W_3133VU%EL<$@#565C"(
M4]987F,E_E6]!*@E8`!?XY%6T4@)H!;:8CE-(MIC(1(WB4QY7?=9=ZW]E%E/
M737UV7`]78W45:%5]=I]P:VTC5WMC9>V=LN5UE<"@/7T@6&5(/A3>%=K]UMC
M+XUTX5B8O:1>9R-=<CL!)):TUDD]W3A?AD,I]F*3]3T6UFT3B,=?<XD)%1I+
M5TVVTE>=#1;?@B?&-M-YEOS56W63V'C4I!F6]F%$J:[:ZJNQSEIKJ5!S8+:M
MP;::-U*F"=OLL]$N)I>TO7Y(I+3/7AMNU<;V;6ZT`W#[[G*^WMOOOP&_VE74
M\@[<;U/*-EQQQ0>?NW"/$U_\T,8E+P;QRC%']/',.>_<\\]!_@]=]-%)+]WT
MTU%/7?7566_=]==ACUWV9&1.O?;,\ZU:@<AG[]WWWX$/7OC3=+P[`6:N+G[N
MXXTY7FY##1Q>^NFIK][ZS_T+.6VWJ,Y^;^[Q>5XUV*XOW_SST4_?T>RD)(!]
M7@8@H*$#T!E@&_LE,V"`AJ1\!0$'#+``^05$6_QKC_Z>-#]M9:=L"F"?I=YG
MOP'2SWY5L%]V]C<<_P$0"1,LX'#2Q!LC)2%-6!B.!_.7``5Z,$W(4]\+81A#
M&;+N"/(CV0(<.`0R*.`:%6D`%QJ@PD8DH`%)"N`!>#A$+<Q'+DA<QBVH4`X!
M2N$(.;2($Q%D"RC>0HA<+&)Q\N!$_B4V0@K1X-$M'!!$+8AQBV+<X3(>T`#M
MS9".=;3C'?=&`"#>X@T(XB,E1*)#76F1&>!@P!H.X`1^#.42J"#9)?1XBS_Z
MT9'Z>.0E+:(-W"!2D6MQPA@BAX9%<O*1G$0%^?"82E6NDI7$VP4NAH`*D?@Q
MD+4P9"OTX99*RN*5JU`%)99`R_=HLANX]*0F8!&^KACB&X8XY71:&4UI3K..
M7I&)$.KAAY(`0T>&',-)<CD=KES"FH4<PDVVV1];$B0`E_$"`LXR"3@010B7
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MVT2]:CLV@J1I`]`HXOS65+WE';X<):JF]1:XVO-MN$S[).-"_BNXPX`NN'BK
MLW4U=[N7`FZF&EC=[:XK<;Y=KG5Y2]YTB=>\/DWNP4S++M-:*E1SO(1V]1F*
M\EILNJ!BKGICNEWMKK>^Y[UOI;;C*MXA`[K[G>^2BAO31I4V5-"M[W5'-Z82
MUD(UX@,=\XR1"P^'&**H^4J#1GP:$*NMQ";F<#)63`P1MQ@9*>[1>*@P'EF4
M,("?R0]`TO2(_.CX1"5\R!5ZFQT#G&,\)8S$A7ID9"48(,>$B$T(=YPF.=Z8
MQ]MH<IJ04(T@:SA-0B#$`$KX'!SW",KN2Q-CIKQF'7]9CD06LVF@H!TR4XC'
M\2CAEJVK9";G)Q!)N+,IAFSE=0F:_CZ)WDRBTQQE,+MYR:;J<4.H$$!"5"-Q
MG![&E]W3YW4%)`F!4`":L;QG4/M9R_;%'+92P2L;?YK&H`-?&U!<:Q(?2A0O
MGO4Q;LVU0WGO-,%^V[%1DZH:\\<`\R#RE%WRA@,R`S`B;+1FGEWM,56JA7#0
M7R`&,)YH?YH0XO;/E)U-B.(XYPIB"6`@-L+L>&2GT='6MO[&$^OQK/L50DXW
ME-$,"`3&N=EL%C>\=7QO;ALAW,W^D+G=</`E$R/@X-YW.@AQ;P!B6]&Q$7C#
M.6ZN;IN;WA`O0,4'+@E+C,D!T4A3;$2%9N7V*![RH7F+F)*$0_*[W0U/Q16B
M+7%H>@X<_KHXH0*7Q'*C2\F!&F2@`@.@=#@\G8#YFT\*D1YU(Z#0@"'TH)NY
MM*>C5YWJ]!-#L]V'[><,0E'S"+CRSCX?#ZYG&KQ@H?Z^_CYH/5#K+@0[_+!.
M0(C,S^LKU/N?QD[!LFO+?@:4,;.I_.P>*3=(>AI/+`K@@&NS><J8U_R`]-2C
M!]`'T3.'\L6SS`5"`)!4I)ZR9E@_GHL#\#<_[I'GT='C'K$>(J1NLNI/3V72
M7^CW<\X/!\N=S,RCH_(D_(CM9Y_,'8\^XH1.ON<WSODI4[_TG&]^]&LO*AP/
MO]2P>',UK@!S[LS\XJ28/,4=$@V2)7,0P^HQZM_/^]`5G8MK_DPB/03`C/KO
MAFRHC9*HC`1!"7YH%)+H%N2'.190C!@B`(V`C=2H$>C#C7`H%=K@`AEPB;C`
M`GGH")BA`43%$5@/`2;#U^3HB22PU(B@&]X(`C,PB:J(`Z7(AA!0/6YP$2+P
M_QCP"JY$`W.H`[O(`D.P`<?H\5XD%3H.U*B`%&2NT+*LA,"`"I6!`62.-IQ,
MTJB,W'I$.2Y$/G2L(=8#:=X/S1`MWQ#`YJ`0"\%`]\;##)-`)<+0":',Y72/
MX,@P^30#S;(#XXA!"O-##GE,]?X0SU:C"R^NT.`0U#I.#Y$`$I.`$+VAV=HP
MW4KH`23Q$M!L#ID-@-3/V]C/A!`(_@JAA>&D@0XE`6GN[Q`O3@U%A_]&20H2
M:4]:;I"$()(FHY!L\9-R,6(*810ZJ0E*Z1=](0%(:9&^P)3Z",5JD1B/41J9
MX1`\(1HN@3FNH!K\2,2J$9Z0T=`0@#4DX0T\H1E_<1*L8UWV:!821QT7P1>)
M431"`1V)$1X'QA:6<1@329">1_;TQX1V[`#4@5>6#,W(H.-ZA"`#L1(5,B(0
M<C468$S,C"`7H!1[Y!,@9CS0;$P80M'L\/5B8PU-:,OFL"!9,0Z?CQ7MD",%
M<LHDDB*)+R`],A:;C1!2LO<V01P,T2(O,1'UAC8FDL\TH]!2\B0;$AJ&LB(7
M(!`AT@A>_J398N$D+U(H9;)I.FHB'.[,;&\+!Y(4KB0@"K*1BDA/6-(5)U$L
M+](F@Y)S^&^9V``?8`%'?H$5#`&9&J69IF`)C-$NX_(5!F4+@L(2$`&6<$T?
MF<DO!5,.`D,8P&`K^$,E3NPPY^`N1XTD4,$>M\`P_X06\+(.?<F6[A(43HTP
MG6D5#E,(C`F7@&,FP^$);>_.#B29)&-*0JX<:%..9%-/EH(;G,#VP!#_8%+#
MFH'^7._]+@\@`P"`JDQ4>*\VB^#Y>*_^V(PX8;(W#\DUB?/BQ&WU<E,!=C,Z
M15(D+V\8L',GIZ'0GK,!`N$VRV%8#HD[-XW'N$0[F//]WE/G_D)C$`+B@*2`
M*V,..--P1@04-WML.EWO%<4OT5P-<]YR).+B,[0B#3B#",Q"*[@&**Q"+:(B
MGM)B,(O"#XZBENS)(^SB(]V&)J#R*W:B)R+4(=^@'J#"*,QI,T8CGC+AFFHA
M*O)BX@:C1KFFGDS40H<T#?*+X*YLQUSB8?0G@XIC$SQ*/I?D(#VJ(1K//OD#
MS?YS20O@R8P/(U&-.@XR+"ZD(]R0V0S2\@)H"IZ4-Q@@]YZO3<E4Q\+T.K/T
M.`$R2<7-:_"P3:NT21NB.)YO2??4YKI4+N[4'@*"-^;!3\?`T1"5%P)"2JTT
M@Y!L$-1T20%(4B$&+6(0W[C2)<!J_DT#$-IN01H@#JO$M"GDU#1>D5`#B$]'
MYT&;)#9K!$>RA`B`I$:XQDY\1%>'!/180Z0VR@B^Q$]J2:-"Y!)A9$>&@3T<
M8C*G#$8RQ-"L[#M6I$J0%:"RH/(89:)J04&LI":.]2J3=:&`E5C3X*1<,QRJ
M\":')1H<`-5"S3VOS"&HDPLU3\E\`]1^,_@PTEWOU84D+8BX+!$;KH0L@5XS
MP1`'%B8%ELTHS6Z0U%WIK/:\+<CR55X-46$O5OLF=AH:(L@R-EHA==$Z*OQZ
M9&.-(#_>CL?.@5\CATS;DTZ[C%X'#M08`6:'(4W4@UY=Z!4]]L\6K'-P!6-@
MQF,L)EA4_H9H#H9'5D962&9IG>II80:G`*:[H%9HFNIJD4M89F538&MK$>9E
M'.5FGN9EAN:^>BJII&MLJ]96.D9MF<9;NO9B:H=>(.E5&BAR+"RX$.9I:&6\
M(()W!I<ZEJ51*HS`@JL]G@133,^\=@=:WD7`RBN]FH:^'BP4WB6G)/==)/=R
M1<:U;"1TUZMLVNMP`Q>I:J6Y&BP5_6M9*G=P\ZN]1C==U&MUL65)-+?`J"-P
M"5>?GNN[_K:X?/=OM8=R.#=DYM9U0Z5H6^G70*=M1HMN5'6N!N!ZJ_=TE#=U
M-F=[P3=\Q7=\R;=\S?=\_>IO)4RZ\(MOV1=<HHNZ6E>\UE=D_M[K-)3M&(;K
MOF:.PMJ%..QK?VMW&MAKY@"X8N)KNI#7PJQ+O`9L?_W7?^7KPN(7&HBWOT(A
MP;YKNQ175(:K@-]7P`RX@$F8@@?LOEJW@5WK@-.E@Y&7?1W,A+6+A1E8A.E7
M@@?XA3GXO!:XN208<@$L7`*XA(U!@*<+A*DKA`^L?O-K<FL8=PM7B'G8><E+
M@@W,@A-8O7IXP'28AH%+=)*#`-X4U$XNTKRPX9[MRZ3DC._5RTIHC>EU&R@-
MSI#,6HOV$Y*ACB&"T<!`U>*8&.I8S@BA-7R,1_Y8U1QMU4`MK/*-"=)D.^IX
MSU1-D;NLCWG,S-PSDB\9W1SYQY",_I#S3#W4>$K,^(]'F9+3S-.X(?2N@$<.
MK63=>!ZT4CC`[$*D#)6#S)0K>=4L></DDY<Y62LOT<E6#9%%C\WN[,E@F8V'
M(9"_4,=`N94?;63^3''C1)>+,ODB39`;69@IN<I4;8YY!)%##I=/4=1T6<I`
M!Q+VY^:VH-GZ[>8PB,H43>)X@N0<`I[;S9YYSB%0;ANFC12M"]Z0(:`]#MS.
M(-^*A-T4,:`;V6:W)>7Z^>04VIG=&='F+0&CC)0U(Z!]CA<4^A*#;DWI#0Y"
M6DI#H=L^FIKG\I%36A4CFI'?;5))6A`FVIY-#I^],N"*(ZP4[J;3A)2!#N=,
M]4Q'>DGU_MED,[K>B+H*3CK13,Z6.3JG296B'2[]'EH:DAJK@'JI'67D"@ZB
M>SH5C43HL'*A^ZT1DV^IL[K)IKJJLWJE_SFAKSJ1X;JFF=H-NOK<UIG9\!-!
M[_GX]"=)T/#BLC/Z&J+U_E,S#@FPQ\\-0$^@/1$+ANX2FD_TR$\EBU.Q+5LV
MH@SX5KD->02PG0\Y_?!"8.\?H@PR\^.RQ;.T\3/_5!NV4=JU]W"U1U8SFJ\U
M1!NU?1/\'#L_XA/Z!-LK0_M-+P3W@MLA1E:/=TPSW`__4"^X4UMEB\$0.4XX
MIXRY'UFZ!?05/QL@,657$%6QP:^S";GXK(RWD=M:03GZ8J$X_N;/O*U/MFLO
M\B"/M7_2ED';$+FO9].RG(F[NO&/NDG'&[PA#.7C+#,R$WDEIV@.@`+[$Q8<
M))VP(P+B+#N1(;3090745>`)&2R1"VL9P#_R#+-0YIK0SK`LY^H0+;U0F]-$
M]2B\L+'@RZ"[P[=C#SMVQMG0YBZAQU^.P[WRME\$QXE<.\0LK"*<IFO\Q%]\
M3VEZ$W_<.6PUY011&2S\R!7V$,<0RZ#P12K\#*O<"Z]7R"%OQL<0Q\/<R\73
M^/JPT$YM6UR\%<L\Q0FT#ZT5RT><+<5T%+:\OLM\Q9FM/KL;%K$`#U][PX,\
M+7G,S`?]$,]2S-&0=-CP`!@\*@&-_MPZ:BI+DH<"O=,9O&8H\BF9P;C)J;)'
M;2>1A]3CI-&AO!6?Y""ADB85S2.U',7?7"P#D2J952HOA!263#M,';9?V]<U
M77MZLBD)H=A?>\J$_5)IG1EPW9:'(]EC73+?>$I\,ME1O=H=<A@F/2#&Y`JN
MP">#'2P;K=LQ$=,#?4Q,4BUG;MFSP]>#O=P)E-W1?==[I",U[<J>;-SA/61,
MW26K'=R+W<_E>]RS.0R!W>"9+=KSO2`AWMA=O<1>D2&3C]T'?B%1,M`U\G2F
MVS@#>SF_\/$&(''VC3F#.^5Q4['/,SQ1?3-4'<@Z"AOTT\1)>\\["IJ''`I"
MK[Q[S_X"_MS@!OP^"0Y-P_/9L1NUD5ZS3=OFL<#8N4SIZ1/HR<WE)^\^6[YL
MO-OD$P$XV]`\OS.XFVP\G-NW57S`7W[H5_Z9"Y2VH;I``1)-O][$C>\UQ^-5
M)N+)J/OII;X^7W,S@C[P3?L`(GJ^AQ[-TM,/[]/GF>WL"71!!_^USQ/O[7I!
MP3ZV#1QU4*]5A2Q-U08X]PU301__0']3M;12`Q7-1#75F4"9'?)*39Y331ST
MF>)*TZ].L?Z^QM15B][X8%7TIVPB=)SU"_')#''X,=7$HQ[Y-</(\_GX`54[
MQOZY4;OY3Y^XF1\+7'^@>G]*H?1-M]_XT6RHMZ!,3[7VAA\K_C<A+$I_ZE/5
M^7^95+%J/,R?0&%U24L[[U$M&H"@,5@8%H!CP(`8'`P%@2%`,#".Q^:`J30`
M!@;N$5&U8K4!Z,+!:*P=AD=RV2P4#(?!&@"54O5<KP%4'8/769&`P`-4U]=1
MT9&;@->!E:/1GI_?`J)BU%05&F><UE,40(%1I>HJ:ZOK:ROF$:"!PQ&FU\"J
M[*UI+JTM+^.7+4'#%T."W9&R`ZV!KA4"0F;E%"5`LS%R@NKC<*W5-7,M&`,8
M@-@JL-4CYB+4EQ(N=*^"G5<==C/`=W]JO"\(Z$6SU"N`GW'9POGS<^^.DV4+
M':BKQ(L@N&"F>LD;Z`N:O'H5*]$J_C!+GL:'7A"$I,;QBP`_'7FQ(QA0B3>`
MIJ#<=.D07Y2>/0W",\?E@;P&W:S4_!A-83.CTL8`@%HKH%*D.#->D6?2IE$H
M*H.V7`3@G,&JQZ@L;7=I)Q>A3H<V16@6%MZ\>E<10%A)00$%XOP"""!855_$
MA`T#`'PXL2K'E0)(*4S`2@(%?2E7MJ)`,(&V5CIG.TSYLJK,G@.K(IW@]1$%
M;66SDHP9M-_053D;AESX<;?,B5T+5LWL,6_-BP\?/P)9-_'2UH(KMWR;MC7"
MNT<?MNU[-^?J2!+POHP],NO5P$OWW4R9N7ODX;\W3N^[=_+4R)TG<,^8/WL(
M^:=<>,WI_J9;8TL14(!HZCFWW&BH90-;@IZ)1MQF;9'W5WK,V+<<@K+I)IR`
MR86XE'%(D';;=E5U,^!]!+X7VX>QH;,7CCGJN".//?KX(Y!!"CDDD44:>222
M22JY))--.LGD``\\.26555IY)999:KDEEUUZ^26888HY)IEEFGDFFFFJN2:;
MK6FG`&&A;<;<@_^!]^9_%,KVGV_/+04GG=GQ:2)G;K9FGE^O->A*9Y`!RDQY
M`P+HYU_:[2;AI9X-2ME@=C869VYMM7>GG97!R0QLY'%&*:2K^BFIG(4**FI^
MA25:WJ&.]C=C=LB95N)\H:IZ6B7#2A&JBRHJMJFECTX8&WG[_NWVJZ:_/=BI
M@K7>6>=[C?KE;(OM$>IILJQ:=^J$LKIH+`$'(COM*NBR6^FUR0[:ZFFQ4BNI
ME]LH@1I+?O&4%',!,2#83;K0HDL3_2G!P!@LH?;.'_+H@E1;6"EPTR8AZ>(O
M`JA-84034A9QE`%+86R-1$0HL/!9(2$2DDY^2'E7.AL!H)431_!L$LP)RV1`
M`X<%W,O-8/S,L7./E/P/%^?(0[$54L-$,=,#6VS%35_1##(!5@<R62"8$*&Q
MS_*\U<`I7QBB-A1)BQU3U3+#E=!:(7,MS\%"@\-PRE.($;$!ET'!=AT;!0QQ
M&(6_Y`33CP]P4Q/8N`RS'P@=PQ+<_@3O;7,U(P/P],E;0S%W44GOK+8J1\]=
MR=%Q9\)XSI>A'@C1;9/%NI>Y$*'+/>'X@081/A&_3"C'U"$$2PP>$D4N211$
M<1+,.U'(W@L4'XH`I6QR#`&^UW-$`]2<XX`RC6#/B*5-',$``M4/T/SD1`M@
MR";=]^('VW<%;\M"EG".T"@!#Q&QGO<$`+[C4>-_O>@?%Y0AP'+DSR3D,U\M
MTO>'PPD@=NBH7P/NA[5#Z&]@WW.<)@20!^X50'Q9X*!VDC`SA)RM",5;B/4Z
M88"-N8V%A_,#".]'$@YZ$(C0^%WVB'"`Y!5.?LU31L<"$+WQQ8.'IOC?%*=W
MB#6P,'L*_J0@(@K@OK/$CVCSZ]D>W%"_"C+P<S^\2_EBACZX+1`:,"P*!)61
M0\\0HPLPY&,XWEBQ`4AO%G?$W0[C@;\P?BEN!-`?4F@W,(2XX3"8@%_F`."&
M)H!F&420",3$("&*5;(J0"$,)MQ`!%2:P@T)<*3^CN`R@2"%)>P[B:7RH0P!
ME%(AWQ!&)N+1"2M$<@QB.84#'KE#9/;2#JE,V3,54$R.#/.8!7"`&RP%@%DJ
MH9;H<,?=*O%+N`ACDII,V4%&!PJ=P=*"#4%"V4Q10THF$IT$<,#;Q-A#=GYA
MF/]H!3CM$A?</>"1%LPD_)Z9@&92XI/8""4#)O8%?9IBFA`=_J4I#L``8&9R
MDSK392`8.KR`[HV>EASH&^["301XDYZO!,,X9=()*+P(G\2D`E7>.4UAFN6B
MXM1)/"AJ"&UR28.IT"CVS)F/7J0!>4030P/&"(`&L"UX?M%*08;V!:E2=7V9
M],):^GDXJ"[D"ZDX"12:``4WW+*M?'1&RKC*MG]J54K!I$((T8%4>=YHFS>2
MZUA7^!$Q$@(N7.0"$2P2$KLR(JVX8RM10M+7<=I-'DD+[%S](#5=W.0!1G7+
M*F1H-MPA)!^)?1DA3Q>0MXD5KV9Y)VAO,M#/9F^3F!T=.JC:&+>E;7R:7:TZ
M"X%5Q6ZVLWLKWV$M>P^X)D"N0_.:_F7I8<&B')8IN%-K.9`+P;10-Z^GS0)A
M]NJ7=XKW='GM;5;I.K"-RH.U;P!3`A9P#@$(S@L:D>Y+#J99HBG`N4GHV?OZ
MFM8%'$.N7J5'@;5GB',4C1GR'1L\J9"X\Z[/JU:@JD9Q>^&YCO,`"MX?%+R`
M%E,N(1Q2[4HE`$L%_GXU(B76B(BY<.(!+V`QR)CP7<#IX6/DI!<[ONZ'U\MB
M'VNT`<KT<(VS\6"ZP5:T?)5N8@'1,8UNP1!(-D2,T[(*'1-XH$J>[]Z0P4,&
M"\:_$ZV;8JD<L/J&8\1[.T"1-_GA7I"9QIJ+:A6<>SK!7AF_=\URA!F`XQ4W
M^+4U"_&*_J-LUJ:]6,LDMB^BW>QFT(Y4S62Y\I<<\%"6AF2=%#OI`#(6!3<\
M0*0LR4,8J)+.M2[S&@>&RRI+2FI-;EH<6PW>$BOF%PM#8M$B5:_.0!RU1JR.
M;^<4S`"*5LID<]*4N0[`K"G&LSXL0FK'[D(#8HV86V\UQV\1:(\S:<Z]I?&]
MZ2P$+S3]/I<TY`XR]$(WYND0FB[H>?'8PT6&#=.S]IAJ:ZUU+T)]D%F;&J]3
M4>R]HS#M*HSDW%7>Q:A3&FPW/$*D@HA;O@5ZTMD1VY1VP'6Y50=LCN.N/W5(
MQ<(=O?!J=[SAW,5=PH<JIDA,H@Q-,`0:U)#9<GJ""J.8`U(D_C$^EU.O@'/P
M0OY>FH;#YJ\3?*@"S25"OK&=HWZ,R!_2$=&6_YKDYP`>9].%/8RN9.'FHX!8
M7PH(L3K(`7(]7^?2HPH-,RP"$(51.P-4R8E*'",F5?>VN">K$X%R[[)O]^(Q
ME,Z)J&.C(6UX@S[PX%V=XW`(SQL$NDDX3+O_$Q7]OANKA8Z-3![D$W=O>P&"
MGHM4*Q;S4;!Y%(A^B`)KOJ2?*/S=>^9UKSV]\#E']5W'?F&JV_'PAA8[(/1H
M^:/._>9T);L6;,GY=*CZY8*@0N;#WJ^U)$,BS=`:T42M'8*P@PWM0COU54$U
M=CRC?E]0BEQ*"PU_)2/%/5MEW3WF_C%QHI`=+^^(V,6,LY&#+93$29Q973""
M^X6?]UV%5(!#*0`@&=P?6<16.%':"`&@4E&1S&A5R'#?4C2$5KA$$TP45JA,
M4KS46+B71P189'T>N$$!_8E?22D@5YA?V$14^NW-6.@#`<K>U`R%PTD6N_4?
M2JR:9,U#"KK1`W:%2>#?7.Q;`*(%SRC%`$[$\UD%9+F9RP&;6)R2$'X)L6#(
MK@1`@]!'C-2':73'MYSANWA'I%!&M@0+=Z@(IH2+@+Q(>>`*9HB&;30'J:S'
MB2"!A!C''ZJA@[3(;V0((=[&(-((;A3(8%P+@DB'N0#BJ^1'K-3AG<@'KQ`+
M(&*&=B0`_FLPHC4P"("02"`^HFI4HH$@"X*`8KW,XG_81BVVX70$B'4<QWEP
M2R3RBB*:8:U0""1.XGB,RQF^R)^(QG.4"'<@B'$<R#(Z!RI&"(NDR"Y.R#1"
MRRI$8W]01V+P2YN,(SF6HSF>(SJFHSJN(SNVHSN^(SS&HSS.(SW6HSW>(S[F
MHS[NXY3,";>(PY_8B7ND!JZ`"[Y(029*XBXZ2IY$RJX`R(,$"KLDY'L,)+?<
MHB<2%3]N)$=VI$=ZB<%8T1=P5L6,I.34S=1@3H`%(3G13--8S@[!S.W(CEGP
M#+_=#N'1C-`P3="$Q$%])%`&I5`.99$<3ZZ=D#(Y$1K-7O_!_I`9-0]3'%).
M5M`$KIM2MM`A"5+EL01C!9',F5`8,9$R5=!5<D^@$"5:IJ5:KF4Z)50K05,Y
M=!(E*-1/79M"8&!+:A-(\5*K2<0X\=1L585-U67@9=PYO11A,!1'L25C-J9C
MZF/..=-3\5EN09!V]9AS$:9L&9>-,%=F_J5K(187H):E4-;4+-9M=9:*04QF
M/:9KOB9LKF-(G@Z+.=:&[5>#U65FXN6/V1G?X9F&D0^'`15(H(6BO5.'=9F=
MT6:AV8&"J5CYC%YL3B=U5J>9A-A2A)P?6%S$,99!_!I>YB1149P1_!IHQLQL
MU1N_`9MXRMI[I5M?/IMUSB=]UN>6_F2<Z>V!T2WET_78[H7;"&E?A'7=?KH3
M<8Z=\A'!>H[35'+"'N2GYNT>)GB>?5:HA5XHD1AF+N1?'[585GV#_VEF2TI@
M.QAAAWKA`U9A@S#H2,U$%`)@`N(,ALXHC=:H*WQ'C(1(AZ0ABQ1C-TI+K"@D
MJG`(G7CC(U9%->I'O01I18)(K<`A1-JHE$XIE5:IE5XIEF:IEFXIEW:IEWXI
MF(:IF(XIF9:IF9XIFJ:IFJXIF[:IF[XIG,:IG,XIG=:IG=XIGN:IGNXIG_:I
MG_XIH`:JH`XJH1:JH1XJHB:JHBXJHS:JHSXJI$:JI$XJI5:JI5XJIF:)/[("
MOZ#+:.2&_K9X2VPTY*IH2Z?0B;S$H9!Z:D*>I;(D"[R$RZ(XB[E,9*B(HT4&
MHK?`B+J\JCCZ:AG"AZFR*BP"XS\&8C;L(3=:Y"5N:JY^BJ\HRZ;."R?VB1Y&
M*;L4JT+R:I2.2BL8)*>LHK&**X#LJJE6BGQDI*O6:4BNS..DPM&HA4`H$^\H
MQ.5LS=RXI/IY3LX@Q.WP3N,(S'LBTI`Y1]XH4[&!D\A9ETG2)#K@9(LNVDE2
M3LN4CED)#=A$CKS^"_@U)\#V*]+<U?L5C,<P3;[2$$J-I,,JEI@)34\BSCZ)
MV=RL#.U(C+`M[,F*K,1J5<>(W,^XZP'60\;J)+_RK,/:J\46_@'0_LW0](V^
MZJE1OAI5.I`"_DX7H1@97640L015[JOVX(0#>>75[I;P"%(;69?EU8_R<:56
MCL93NMUV&9+]?"7N=&T*U5$%C9%;LA%3AL\1%9_=NI`)W=#84JU6GNW=@I'^
M;"U?):X;Q"U3*1$3+<\91:`5X8\2>27V9!$30B[CQB`)'90/Y<XB2)`!>976
M_NT:A:4-;44*=8]6ZJU'5!#JOJWW2&[H\NDEE1@K:<<TV8Q!<=1>FN>WN4(T
M_2Y[KL+O`F8T[4U!P6[)">;;^%.OR25@`FA>0IQ+T803[))ANE([<53XDM:Q
M<=3RME9'+5/Z.A\,^M7ZHF\-NB4]_C7;-015"<H<)M'5^OB4L$E<^Q:%-N6;
M_UH37"5F?(YO[UX;Z<E4_CG/#%F7`5NO*<COGT8F1+"29067*7P69^Z69U9F
M9&7POLH?8:V/:9J;!@O48?E968'3=Z56:-K?AIF7C)XPP:)P:B[6<L%;9]T6
M!R\69K#.!D9@/Y%!8:GP>?D99G4P2276$L=P;4FF=JWF:EEP6JS/<#%A==6E
M;-55F+56=246!%>E</YP=`W6XW1"=>TP7%J65ZE84^6:"$,MW[P,/UT9FP%0
M?,V7;VY8AGWF6V#:"#,"V]G7RPER'AO1?*$Q9BP9&I1DQP`:UDY57DGR(2NG
M<R89G=5F_B;?688M)Z$=QA['DR`[&!^3;S[T<2)'VD"1\"8731__TVCA)@]9
M\FR&LHI9&FOIE_[JS*3]V8I]WH_Y02F#<I:=V!N#\"C/3)\QLC$',R5_<B<G
M\PS7<2SG*7;B4@WV%C+0VKHM)GG:I5\6;RS`1<HE;R6D',N1[S%!PJ8-C,D]
M#WI6@F+J&_:VYPA'V\0M6L81W#L'FSM_,SO7DZ6HLSU_VL!)G#8]`KRY;\BM
MLV()7.:06CW'7#93FE?)'LG];RMK[^=8V[()@<XPE+J1D6&V<[[-\SF1E#97
MK[-=]&+B*?<F7>'!'K0%PB3@GMOJ7H%&5M-1*%/IG$T#F_;9_C2'_EYK,AY-
MF9&"<BC9H)Y3BVB#)H+M45OM<=WK.IWI*77M]9KHF1#EZ;11EZ0F4%[I48%.
M=QX^"%;OD?4V9\XG2&A$'#$P@2@))8!&1[4%@JZ`^AY9GUUA)=WN<773(;47
M)4)48W7A99T`D$>!YMM/KR>[?E3)AD2!$>`,AJ$CF*CPR')9W,@)-J`MG#`U
M:&%/$:P5B@,(+H**GK8J-(4+2G7$NBY82.`7&,YGR]\`9'9+J#8W=&PW#(5I
M2\4)UN`S"`2EE2!_@D-LIY/#9<$1?N$%UW4JM%]>-V%D@2Z)RD5LET3[<05O
MN^C[B9J+-O=M>^!W)^#CM&">XJBJ_G9+(?[*9?SJLR3B*X;'/<Q*(S9'--8*
M&4*+*89692#(@BC(-A(I1/:B=,@JKCJI)%((MR*!?"/K9`QX&=**)/YWA00X
M+1H+<Z0(*4I+8>@),VI'&GH'.#JCDI(*`2BX-')CL>#&I&@+C!RX9/@':APB
ML?"J&2Y+11XXA(\+*$)II_QXIB9)E!RYDB\YDS>YDS\YE$>YE$\YE5>YE5\Y
MEF>YEF\YEW>YEW\YF(>YF(\YF9>YF9\YFJ>YFJ\YF[>YF[\YG,>YG,\YG=>Y
MG=\YGN>YGNN(LRX*G_NYE;@BD-"'(N9()0JZH*SKGN/Y+0.)C!()`2P`H$,<
MD?`:KT4Z_J!C^ET\^A?S\J+ON5%R>HZ(>I#PFBL`=:D#M*4#-`3?!:I[K1)]
M^J+O[B(0`$L<0(L?0S(D`)G9NAU@U#%\S*VC!J_S%QYT017@`0,L@*_C^F:+
M)@.,(IGA0;,G0[*Q!-TTAJXGP+6/C:\?0VZP!+@KP+;+0[-+R&EB^[$7>VXB
ME``M.Q%$>SH4#0)H5#!4GZR/N047!1[PI7TA%2&$V$9E#TO4\L`'5\![&10L
M@<#338$A'?@8,1[4#T^`.QK84J]!6A'84L5O1,??M'T56,,/WU%BNXP1`B%$
M<:Z56)?5VSD$0(8Q@'3FN[Y;,Q>(@0I1P_+%.WWA?/YF0AT4_H#/NP3/(VQ1
M7,;0XY(ZU`%C%?W"LTWF^2UA+)\,%@("0+WB8'UI*:C5;]3/9YX=VU+1=SH/
MV7H5,#UN40)2H#W-ESE,<P$;:`\VG0RS?Q*!P3L``?T;Q'T:.(?=%T4U\#T`
M63W;)`%C1?K%*H'6YY]?J)(\$WY;73W[./X"%(+@MWK%V!+B^\/;S_O=24GE
M[-8Y*'K;<WE*:U0`-`!%-$``+/L!Q`_\H+[JDQL1-%>TS_[HP+Y'"+V7J5/J
M#SXTD%JS78'NLUJR5>#Z7'WK=\SDOT&\DEK`*/^RYX+LY_V&9KZ,Z?Y;+X+P
M[U`2O'S.(,"KE[Z7IW2Q[P[\)$[W_DH-*YV#$9R_7ZB_\\A#-<!_A/E+5LF_
M#.HZ\GL\,K0@$`P,`07#8`P``,7C4&`X(@+0A'&H!$P-3X`080`4H(8"]IE4
M<@D-Z`"`8!0;W2T7>\?G]7M^W_\'#!0<)"PT/$1,5%QD;'1\A(Q\)$!3(DBP
M+%!0(E+`5-#,W,2Z5*@D",4"'36]!'`5O4O`S**]6WU-&%A(>")PI;SK3`!&
M"ZY\34(;!IA]3<6:+8;%)46&K>7<-`5X(K:5#!<?)R\W/T=/5U]G;W>_$X,Z
M>&?_0J#'S]??Y^_W_P<8D$\``0,(")04P"!"A@T=/H084>)$BA4M7L284>-&
MCAT]?@09QU+D2)(E39Y$F5+E2I8M7;Z$&5/F3)HU;=[$F5/G3IX]??X$&E3H
M4*)%C1Y%FE3I4J9-G3Z%&E7J5*I5K5[%FE7K5JY=O7X%&U;L6+)ES9Y%FU;M
M6K9MW;Z%&U?N7+IU[=[%FU?O7KY]_?X%'%CP8,*%#1]&G%CQ8L:-'3^&'%GR
M9,J5+5_&G%GS9LZ=/7\&'5KT:-*E39]&G5KU:M:M7;^&'5OV;-JU;=_&G5OW
<;MZ]??\&'ESX<.+%C1]'GESY<N;-G3_'$@0`.S\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g469192g95l79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g469192g95l79.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0H84&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@``````````````+P```*X````&`&<`.0`U
M`&P`-P`Y`````0`````````````````````````!``````````````"N````
M+P`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````!WL````!````<````!X`
M``%0```G8```!U\`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"``>`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U55\[/Q.GXYR,I^QDAC0`7.>]QVUTTU,#K+KK'>VNFIOJ6*'4NI8W
M3<4Y.0202&55,&ZRVQVE6/CU_P"$NM=]!O\`Z+7(=:QLEV5CYOU@NBRUKC5T
MS#>3<UD'U<2B[]#5AXS*?^6.MNNJ];^B>M@87Z/+2G;Z1US.R?VAU#J0HQ.D
MTO%>)#MUFYI->1]HO:YV-;9ZVRC9B>K7]H]7%9;?Z7JVUL?.ZI]:<L'$]3IW
MU>QK079()9DYCZS_`#%$>[$P/5;^M6?TF[9]E_1?K/I`PNC9'7Q5=FN%/2:@
M&XN-CAU59K`V-KP6Q397B^E^A_:#ZZ<O-K]3[!3TSIUG^4>LJJJIJ932QM=5
M;0RNM@#6M:T;6L8UOM:UK4E,TDEE]9ZM?B&K"Z=2,KJN9/V:EQ+:V-;`MS,R
MQL^EAX^]N_\`PEUGIX]'Z6U)2?J76,#IGI-RGN];(+ACX]3'W76%@WV>CC8[
M;;[/2;[K7MK_`$7^$6?U#ZPYO3@S,R,`.Z0ZQC'95=I=<QMKFU4Y%F`ZFMWI
M^I97O95?;D,_T"M8'3\7H]%N;FY`MRWMWY_4K]K"X#7N=F+AT_X#&:[TJ?\`
MA+O6OMJXEMWUBLIS=KZ.B4O;=B,>"RS+>P[Z,NQCX?1@U6;;L6MWZ?*M]+(_
M18[&?:DIW4DDDE*2261USZS].Z*T,L#\O,>6MJP,8>I>]SOH?HI]C?ZZ2G75
M'IW6<#JEES<!YR*L?:'9+`30YQW;JZ,C^;R'5;?TWH[V5[_WUET=*ZOUH-N^
MLA;CXLAS.BX[]U>@.G4\INUV=]+^BU>G@?H_TK,E=!77756VNMH96P!K&-$-
M#1HUK6CZ+6I*?__0Z2JGZP]1ZQ?GC#=1EL=;CX>5G!OV?#H#_3WX6%5:Z[.Z
MAG4_I[LE_P!FH^AB_:?2J]/(>WZI]6?GWM8^A^)<YEEF7EN????<WWB[,Q*V
M8U%E&*[]'T[IS,BCIV+_`$O[)=;Z-=/8))*>>R/JG:^RC+HZKE,ZG387'.N=
MZLL<UU5U->#^BZ93N8_V;,/V/8RS9:NA2224I<[]D^L^/U3J.3C8^'>_,<WT
M<R_(M;Z=-;0RG%^QLQ[/YI[LB_\`1Y5?K79%C_T?T%T222GE^J=!ZA;6W(SL
MZF]["ZV[*RF!N)B,8'O%V%TMSG8[\EF[VY?4LC)^S^F^WU/^TRYZPT9!J^L5
M3'96%BVMLQ,WJ+W.?==N--&0UMAI94U]UOZATS#;@8?_`&KZEDX7I58R[KKG
M['_9K_VWZ?[.WU>KZ_\`-3ZE?H>M^9Z?VCTOYS]%_I?T:AUC_F_]AJ_;/V;[
M#ZC/2^T[?1WP?1_G/T7T?HI*<FGJ7UHZOTDLZ4[&JRA6X6=5<QXQ7W0?;TNE
MYMMR*&/_`.]&[]5?_.8]&9O_`$)\#HG7'5>CU#J%E./N+WUT7/MOM)+7.];J
M=M>-]GI=_P!QNF86!Z/^"R%T*Y[ZT8_UAR@VO"RV].Z96W?EWTLNOR[(/]&Q
M\?%:RVNK;_.6X]_VO_1^G_A$IQ6XO5<>?J]TGJ=F<*?4?D65`T^F7/W[>K];
MMNS;6V[7_P!&Z;1C]0_\)T_IU:Z/D?5WI;W#IC;>O=2)#;;<&KU6-+_<]K<I
M[_L6+^_=]JZA]MO_`.U>1E6^FH48WU'Q\/%;F91S.G.`.,^YKF],!W/]NW'J
MIZ)ZOJ^K_2O4S/4_G;/4784>AZ%?V;9Z&T>EZ<;-L>ST]GMV;4E.,W)^N66`
MZK"PNEL),_:K7Y-L#Z.ZC#;10W=_)S[59QL/ZPMN99E=2HMK!E]5>(:P6]VM
M>[*O>W^LM1))3__9`#A"24T$(0``````50````$!````#P!!`&0`;P!B`&4`
M(`!0`&@`;P!T`&\`<P!H`&\`<````!,`00!D`&\`8@!E`"``4`!H`&\`=`!O
M`',`:`!O`'``(``V`"X`,`````$`.$))300&```````'``@``0`!`0#_[@`.
M061O8F4`9$`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!`0$!
M`0$"`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P/_P``1"``O`*X#`1$``A$!`Q$!_]T`!``6_\0`:P`!``("
M`P````````````````@)!PH#!08!`0`````````````````````0```&`@("
M`@$"!04```````(#!`4&!P$(``D1$A,4%2$Q02)"(R0R,T,6&!$!````````
M`````````````/_:``P#`0`"$0,1`#\`W^.`X#@5([C]O5.ZM;#4WJE!ZUL#
M9^^;/M"LZWED3IY0Q&-='F6N]EM$./MB2N*KZ#')I`C`M=V^/`"8ZGQ]F<G8
MX"9M1F*LA;;G.,8SG.<8QC&<YSG/C&,8_7.<YS^F,8QP-:+;OM^NC::^\]<'
M2HTH[4OMT+2CNG=Y>T@>M9]5H&H<US2]R]H?E"=4P61)T)C8I)1G$A5M!RXO
M*1%^37@.3)0V+*ZC#G":_@\->I:^3UYBD1CD<=IS)S"C9',G-D:$;:OE+\82
M$!(WA_5)AJU.08P'YC1>,>.![+@.`X#@0.LCM'ZW:>GJZK[1WMU.@=@M+J>Q
M/T3DM\5NV.\8>TIF2E3/+2#Y#@,2=4Q@<X,3N0DIH/XAQC@35C,GC4UCS++H
M;(6.6Q22-J1YCLGC+L@?H\_L[@2%0@=65Z:E"MM=&U:G&$PD\@TPHP&<""+.
M,^>!WG`<!P'`<!P'`<!P/__0W^.`X%'.^G8_DA-:E4:\VW'J8@E1/26#[;[Z
MO#.9-8M04F=CB$)&OFMT';TKHNV,W?DQRL*1''VQ*O0Q-48'+F`]RP2SG!C/
M1_7J#ZK1N2;[;71Y)J=2=<,<F?Z.K:Z9"FDMT1Y39>4J*Q]K=R)J:)[73_>[
M8,GZ[02E0*EZ]@:711'$>5"MT5I^!'_9O8K;'L^MI3IEKW')%4T$=FAI>)W!
MY.E=F%VB%327)@2+9W^5M:Y"Y0:*SV/#-_Z5KHVJDL[G.1X5351'X^4M:U(7
ML:7:44CHK4"6I:9:#A#6J27NP)^^`1'SFT9@%`F;393,7)$D1)S#24",I(WH
M$Q1#:SMI!*)"00F)++P$NN`X#@12VVW!J_3^$,;_`#-')9O/["?@PBCZ(K5N
M)D=R7Q8R@@2A+"*TB@U23[ZDA,'*IR<%)J9I9&\!BQP4ITX,CX$`2=,NP?;M
M6CN?:K=FWM+GE&YM,DI_531F7M;1"JM2)7)$[DM>R5FO3&XN&T,N<$:8")[0
M)BV>(IA"4EH0*RQEJ^!:I8\`I1RJ690ZU(;7"NDLQA]'.HS,&"/CKH,2*0*E
M,A.?VEQ2_@BF@ENP<:H&:#```P(><X\>>!5_T,:Z.&MG7=$(Z4Z20==6/;-X
MWAK_`!*3*5RA57.MMK6.]2.AHNF*<\_DFX#Q6IC?)%2-2$M4D<GY44>`!X3`
MX"Y?@.`X#@.`X$0-O][=8]&H@T2?8*PBV9YF#@%AJZJHJUN,XNNYI<H,*2ML
M-J*J(P0X3*<R!S<E1"4/U4WTTIJ@L2L].4+)F`K_`"*2[".QB61>8[0R-XT(
MTE0/3;)FW3&LI"%5M1?#2@5FJVYIVVN2..!D;K*'/H2$PW2#1(YR-5(5!Z!Q
M<PFXSD(7?\#_T=_C@59WE:5G[E6;*=-]3IR]UM74(=/P6Z6W\/$GP\P)-E*`
M]?K5K:]'%+&XS8^4)E91;Y(<E*$=>-!IHPX,D!J(E*$'9116JG7K=E8S*P@N
MFR-Y1T+]$NK?K>U]B!0$U2,`R\(7J5PV'2.6.(9);3V0I-73RZYZZMR-.$U0
M(CZ(A?"I#'\:@>U'8)?@'B23Z(NT_JJ7NR256E#$>9;J5UTGX"H;G&L=/T$H
M:R&W;?L2);SLI':TI"W&Q*O#<G#1MP%&,,3@%_.N^MU0ZLURDK&FXSEC9/OK
M'^0O+FX+9!-)_,W<0#I%8%CS-X.5R"<3R4+`_.X.C@><I/,SC'D)80`"&=>`
MX#@0PWBW3A.E-6-,G<8W(;3MZSY0BJW6[7R"EE*;$ORZ'\@\<=@T;*.$%*TM
M*<)(UKX]J\@;V-H(.4G"$/!)!P8<TCTVL>(RAUW%W9D;#:V^=I,`FAX<&()Q
ME7:QUJO5_E4>N&N+8LR8)HB#,:('YU^'[/$N<RLJ5APB`)2"`GM9]HUS2L`E
M5J6W-HU75<0=H4OTMFDN=DC)'F!I28QDU6X.*TPLDK&1""`L&,Y,--$$L`1#
M$$.0J%B"6Q>W]^1SVP(S**HZKF16C=:NJJ3HE\7M+L#>4"LM4AM&Y&)2!,]5
MYJ2@/3A,C</48)=IR+.')[`G;/JMIX77I4J9$F3HD2<A(C2$%)4B1*46G3)4
MR<L)1"=.04$!1)!)0,!``.,!"'&,8QC&.!S\!P'`<#R4[GT&JZ(OL_LJ81B`
M0>+H#G21R^8OC;&XTQ-Q&/)JUU>G=2D;T*<'G&/8PP.,YSC&/USC'`UBKW[B
M=^-V+_D.D_2WK4G2N35Y*L3?'9=)AMJNL(XM+6E(9E'*\PG<W!*!Z*RG<(Z?
M(T:MQ>$8L&DQ=2D-+68"T'0KJ:JK4*3+MA+<L&9[D;VS1NRGLC<*\QX=9CX5
M$A+71JHHV>I<6FFZ]+_F+(;FT8U64XLE'JSBL`++"V'@.!__TMDG;_:"[]FM
MFW3K$T;E;E63]%F./R[??<IJ`F$/5.H)0F+<$%:5*M6)UC3_`.J+;CYOLTJ%
M)9A<6:S1NGQ&'@+&D#P<8V:&]1TC0SHTKJOW]DJL9L)L'<^6X=)+I_KHKRL+
M43%:DDZ1:I>-O-F59ZY2M4-:-Q&0<]J?NR!W\94E&A4M"+QU82V'.8=$MF["
ME3!8C\ZP_8[=%N<'2T.T+M;FS&['MKS0&B-?U8@62^E-2V"18-9U<BB*%M0E
M)B@M\>-1J`'R4(71P6*=D=OUU'JXU<@5*].VL$99DK-6X)K7$=V+VN%&DIOL
MVC34BT2&/Z[4,>H0A_OIW=TL!?E0>(9Y)1H1X,!U:[,;ERFP;IU%V>@%U6>M
MUOGFRK3)MY+,@S/4\6GXF?8E?']=:_A\=C5?1.'6.]2N@3@2IV>6(29O9",H
M$AA)YZX0DH78\!P'`H$U8O362ZMC=BNS[9F]::A+57LILO5739AMFTH7#VZC
M-?JDDJB)W#;)S)*9*@3Q>R=C;?CSJ:N<U29.X`AK,RHRC<)C5&%`9Q<>WF&W
MF^+*XZR:=E_8+/R5);8XV;#SU5?:8UNM-RJP,VS=J7QC<HX>8D)2B."VQ1OD
M[HK#C``%%^WR!"N_8<49DNP\/IS;='/.XCL38QL5HQ;0:@2Q51U_Z?A4GM#A
M&I7=B!P<EK,C90EK`&II);*J:OCF')1K6PMQ*HLC(>AW,>.R/*5CJV8[NG0S
M;B\(NJ.I#1GKLC<%KJ"T]'4)QZ%ZOC9[:^[8;:MO9HBL2E107=]:VV`$.J\@
M*%J1Y4G8RG"=>D&_^H309K+H'!]J+2W7NT5?R%A4;$YCEGV=%+:E%1M2)=<T
MV=-@EJ%WK]T`WO3P3DXM*_N9+5AR0-_S9&,@(P[OLD[EM7^N-$;%GU%*+WV(
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M/QC(QH!J_(0)UF3!>N`A=2NJNUG:5(V&X[VNFQ7RETKL6_1R_II6!511AW:5
M!^5R9/UWZ6R0V0,U9QM6V+`!;;XMK,OL0X@(5$;0-0Q)W4D-DNCZ#IG62NT5
M:TK!V:OH2V&K'162E-6+7-\>5PQ*GN7S>6OJMRE$WF;\JR)2Z/CTM7.KBH$(
MY4H-,$(60B==O;EUE:[/:F+6UO!KLPS!&:`A9"&6PFJ>SM(I-P')"17!Z^%*
M96E6*,##DLHQ&$PS&<9"'/G@8?CO<UK[8P3E5'ZW]B-^,9:D:4B6U=HC?PH4
MO-`+(<?1F,YC$(CAY8_'G`OLXQ@/C.?&,\"2D;W>!)*QL>Q0ZC[Q,;G6Y454
M&U7)-?3VBSILEE;V6R$G5PA-DXXC+S6+V&K=4Q+R!8WHBLFFE8]BL&!__]/8
MR!T1T2_S:[G"UMG-Q[,IB_+JM2\[%U?)M9FJ:F)O*[;DRF1OR&U%=)1"N[7N
M-@:23BVQL0R23+TB-G3DHPE9)*+"$+?X93]55Q6;=3%=5U#*^J9G85<79ZY@
ML=:XA#6>/KBU!:QJ:&".IFUN:TJK"LT0\$%EY$88(><^XLBR&.*$T\U.U8)7
M$ZU:TT10F75,%&[J:BJB#U^XO24!H#PDOCI&&1M<GH`3BPCQ]HT[^8.,_OC'
M`D=P'`<!P'`@9,.K/K6L&Q'*V9SH1J%+['>G(UZ?)=(]>JM=W5_>SSA*5#Y(
M!+HR<0^O:A0/(S%BL!RDP?C(AYSC'@)KQJ,QN&,#3%(?'F.*1=@1$MK%&XTT
MH&)@96Y.'U3M[2SM:=*W-R(@/Z`*)+`6''[8QP*<.RC:]IZW8@ICVE6L:6Y>
MP_?.<2-15-8P6'GN3[94Z86QI12B[;L?6\)3DM@51,CLVD"-<5Q!"=,-*A)-
M1MY1QR0,/ZV]9SI$*$L&Z.RUR-MBP)FP&W7M)6S*^J)>*ZI7#(^K>L(-B+!;
M4<>/NV&PM(2H016K6="Q4_&VXP*3#$]K"_SJ@(4];JG>C>\$COZNJ(D.A^+J
M:DL,E>W]H0QA0RVGM8XTZ?-6VF'6QKW(&C#5%8/%6,PI2\6(_(/PKU,#5[D4
MU+LDMR9M#89K?K]T]K2DY1K\11$#L"N;&=`R2Y$]U,B*ZGZ_)IEQ+>%,^ON2
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M$5Y[S/I%F76:V'F!3(':,ZGT^^810Z0E$^R@I/,9-_*+`0*4&,8R$8=%CI+C
M-Z%'K^R;<_;[L'<7=*A`_P!=2&S7?6O5@2Q&$(LGL&M>MCC`F!&08>'&1%N;
MF\B-``.#1F9]Q#"Q^A-(].M62TV-<-6Z!I%4F1Y08>*SJ>$Q*1JDPP?&:%SE
M#0S)I$\&J`8\&F*U1QIO]8A<"47`<#__U-_C@.`X#@.`X#@.`X#@</\`C_8S
M_L_;^''G_1]CZ_N+U\_\GP_)Y\?T^WG^/`YN`X#@5T]D"?L@D]4LM7]:Q--P
MVT;'6.K1+MA[LDQB)AH6,$I4V0OT:AB&*S-RFLV>AJ#2D'LWGH4`R,F'@'[@
M]0IIZ[NIBBH`EO&,[`]IF-D[@C;HK=MVHKK3>K92+\IE*UQ>%KF;N1<==3C.
MX5@?*,I4$"*9RUK9D@<*RDK6G)&>6(+S-'VSKH980_M/76;J`=!6]VPEFANI
I;O4C^VF20HO`1"G;U5RUQ,<Y1DO']PYU/-7#_<8L\"<'`<!P'`<#_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
